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The bacterial pathogen Mycobacterium tuberculosis is responsible for the disease 
tuberculosis. To promote disease, M. tuberculosis exports proteins from the cytoplasm to the 
bacterial cell surface or out into the host environment. Exported proteins are in an ideal location 
to manipulate the host. All bacteria, including mycobacteria, utilize the Sec export system for the 
bulk of protein export. The Sec system is composed of an ATPase protein, SecA, and a 
membrane channel complex, SecYEG. Mycobacteria, along with some Gram-positive bacteria, 
contain a second, functionally distinct paralog of the SecA protein. In mycobacteria, the SecA 
responsible for housekeeping export is called SecA1 and is essential for bacterial survival, while 
the second SecA is called SecA2 and exports a smaller subset of proteins and is important for M. 
tuberculosis virulence. The mechanism of SecA2-dependent export is not well understood. Past 
data support a model where the mycobacterial SecA2 export pathway is integrated into the 
housekeeping Sec pathway, and SecA2 shares use of the same SecYEG channel as SecA1 to 
export its substrates. Like SecA1, SecA2 requires ATPase activity to function. In this 
dissertation, we take the approach of characterizing suppressors of a secA2 mutant allele to better 
understand the mechanism of SecA2-dependent export. Intragenic suppressor mutations map to 
the surface of SecA2 and help identify functional regions of SecA2 that may promote 
interactions with SecYEG, SecA2 substrates or other partners of SecA2. Extragenic suppressor 
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mutations map to a new component of the SecA2 pathway that we named SatS. In M. 
tuberculosis, SatS is required for the export of a subset of SecA2 substrates and for pathogenesis.  
SatS functions as a protein export chaperone that protects and promotes export of its specific 
substrates. Structural studies of SatS reveal a new fold combined with hydrophobic grooves 
representing potential sites of substrate binding. Taken together, the findings presented in this 
dissertation advance our understanding of the mechanism of the SecA2 export pathway and 
expand our appreciation of the diversity among chaperones by identifying SatS as a new type of 
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In 2016 alone, there were over 10 million new cases of tuberculosis (TB) and 1.8 million 
deaths, making Mycobacterium tuberculosis, the bacterium that causes TB, the leading cause of 
death from a single infectious disease worldwide (1). By current estimates, up to one-third of the 
world’s population is infected with M. tuberculosis. Despite over 70 years since the first anti-
mycobacterial drug was introduced, we are still struggling with effective treatments for TB. 
Further, the World Health Organization reported that in 2016 over 490,000 people worldwide 
developed multidrug-resistant TB (MDR-TB), which is resistant to standard treatment with the 
first-line antibiotics isoniazid and rifampicin (1). Treatment is still possible with second-line 
antibiotics; however, these treatment plans are more expensive, have severe side effects, take 
longer to complete than the standard course of treatment for TB, and only have a 54% success 
rate (1). A detailed molecular understanding of the mechanisms of M. tuberculosis pathogenesis 
could lead to novel therapeutics for combating M. tuberculosis. 
Spread and survival of M. tuberculosis 
M. tuberculosis is spread via aerosols created when a person with an active case of TB 
coughs or sneezes. When aerosols are inhaled by an uninfected person, M. tuberculosis can reach 
the alveolar spaces of the lung, where the bacterium is phagocytosed by alveolar macrophages. 
                                                          
1
 Adapted for this dissertation with permission from: Miller BK, Zulauf KE, Braunstein M. 2017. 
The Sec Pathways and Exportomes of Mycobacterium tuberculosis. Microbiology Spectrum 5(2) 
doi: 10.1128/microbiolspec.TBTB2-0013-2016. 
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Typically, phagocytosed bacteria are delivered to membrane-bound compartments called 
phagosomes. The host then mounts multiple anti-microbial defenses against the bacteria. In 
contrast, M. tuberculosis is able to block these host responses in order to create a hospitable 
niche for replicating in the phagosome. Consequently, the mechanisms by which M. tuberculosis 
survives inside macrophages are critical for virulence. In order to promote survival in the 
macrophage, M. tuberculosis exports a variety of effector proteins outside of the bacterial cell to 
the host-pathogen interface. 
Protein export in M. tuberculosis 
Approximately 20% of bacterial proteins have functions outside the bacterial cytoplasm 
(2). All bacteria possess protein export pathways that transport proteins made in the cytoplasm 
beyond the cytoplasmic membrane. These exported proteins may remain in the bacterial cell 
envelope or be further secreted to the extracellular environment. Many exported proteins 
function in essential physiological processes. Additionally, in bacterial pathogens, many 
exported proteins have functions in virulence. Consequently, the pathways that export proteins 
are commonly essential and/or are important for pathogenesis. Across bacteria, including 
mycobacteria, there are conserved protein export pathways: the general Sec secretion (Sec) and 
the twin-arginine translocation (Tat) pathways. Both Sec and Tat pathways are essential to the 
viability of Mycobacterium tuberculosis and both also contribute to virulence (3-5). In addition 
to these conserved pathways, bacterial pathogens commonly have specialized protein export 
systems that are important for pathogenesis due to their role in exporting virulence factors. 
Mycobacteria also have specialized protein export systems: the SecA2 export pathway and five 
ESX (Type VII) pathways.  
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Protein export by the conserved Sec (SecA1) pathway 
Due to the large bulk of protein export carried out by the Sec pathway and the importance 
of exported proteins to physiological processes and host interactions in bacterial pathogens, the 
Sec pathway is important to both bacterial homeostasis and virulence (6). Of the 4,024 open 
reading frames (ORFs) in the M. tuberculosis genome, 997 ORFs are predicted to be exported 
out of the cytoplasm due to the presence of an N-terminal signal sequence and/or transmembrane 
domain that direct them to be exported by the Sec pathway (7, 8). In support of these 
bioinformatics predictions, our lab recently identified 593 of these proteins as being exported 
during M. tuberculosis infection of mice, using an in vivo selection strategy to identify exported 
fusion proteins (9). While the specific pathway responsible for the export of most of these 
proteins has not been directly investigated, the majority of them are likely exported by the Sec 
pathway since they possess conserved Sec export signals and only a small subset are exported by 
the specialized SecA2 export pathway (see below). The essentiality of components of the Sec 
export machinery presents challenges to comprehensively identify members of the conserved Sec 
exportome of M. tuberculosis. Essential proteins are required for bacterial viability, and the 
genes that code for them cannot be deleted without providing another copy of the gene. 
However, a dedicated effort to conduct such an analysis is warranted, particularly for 
understanding the contribution of the conserved Sec export pathway to virulence.  
Mechanism of protein export by the SecA1 pathway 
The Sec pathway transports proteins from the cytoplasm across the cytoplasmic 
membrane. Sec exported proteins can then remain in the cell envelope or be fully secreted into 
the extracellular space. Sec exported proteins are transported in an unfolded state through the 
SecYEG membrane channel (Figure 1.1). SecY is an essential integral membrane protein, which 
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forms the central core of the channel (10). SecE is an essential integral membrane protein that is 
suggested to stabilize the open SecY conformation before and during translocation (11). SecG is 
not essential, but improves the efficiency of translocation (12). Additional membrane bound 
components of the Sec pathway also serve to improve export efficiency: SecD, SecF, and YajC 
(13). In addition to fully exporting proteins across the cytoplasmic membrane, the Sec pathway is 
also involved in the delivery and insertion of integral membrane proteins into the cytoplasmic 
membrane. Complete export across the membrane by the Sec pathway is a post-translational 
process; whereas, the role of the Sec pathway in integral membrane protein localization is a co-
translational process that involves the conserved, essential, ribonucleoprotein signal recognition 
particle (SRP) (14). SRP is composed of the Ffh protein bound to SRP RNA (15). SRP 
recognizes the transmembrane domain on a nascent integral membrane protein and then delivers 
it as a ribosome-mRNA-nascent protein complex to the SRP receptor FtsY (16). In turn, FtsY 
delivers the integral membrane protein to SecYEG, where a lateral gate in SecY allows passage 
of transmembrane domains into the cytoplasmic membrane (17). Further discussion of Sec 
pathway mechanism below focuses on post-translational export of fully synthesized proteins 
across the cytoplasmic membrane. 
In addition to the Sec proteins discussed above, Sec export requires the essential SecA 
ATPase that is peripherally associated with SecYEG. SecA is a multifunctional protein that binds 
to Sec exported proteins in the cytoplasm, targets them to SecYEG, and harnesses energy from 
repeated rounds of ATP binding and hydrolysis to drive stepwise export of proteins through the 
SecYEG channel (18). An unusual feature of mycobacteria is that two SecA paralogs (named 
SecA1 and SecA2) exist (19). These two SecAs have unique functions, with SecA1 being the 
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essential SecA that functions in the conserved Sec pathway of mycobacteria to transport the 
majority of exported proteins.  
Proteins exported by the Sec pathway have specific characteristics. Sec exported proteins 
are synthesized as preproteins with N-terminal signal sequences. The signal sequence has a 
positively charged N-terminus, a hydrophobic central domain, and an uncharged polar C-
terminus containing a cleavage site (20). Additionally, lipoproteins exported by the Sec pathway 
contain a lipobox motif at the C-terminal end of the signal sequence with an invariant cysteine 
that is the site of lipid attachment (21). The signal sequence and portions of the mature domain 
are recognized by SecA. After export, the signal sequence is removed by one of two signal 
peptidases (the type I signal peptidase LepB or the type II signal peptidase LspA) on the 
extracytoplasmic side of the membrane to release the protein, which then folds into its mature 
confirmation (22).  
Another feature of Sec-exported preproteins is that they must be in an unfolded 
conformation in order to be exported through SecY (23). Cytosolic chaperones, such as SecB in 
Gram negative bacteria, can help preproteins maintain an unfolded and translocation-competent 
state compatible with transport through SecYEG (24). SecB also has a role in delivering 
preproteins to SecA (25). However, not all preproteins require a SecB chaperone and Gram 
positive bacteria lack a SecB ortholog. While there is a SecB-like protein (Rv1957) in M. 
tuberculosis, the available data indicate Rv1957 is a chaperone for the HigBA toxin-antitoxin 
system and not a chaperone for Sec export (26).  
The SecA2 Protein Export Pathway 
The first report of a second SecA paralog in bacteria was in mycobacteria (19). However, 
two SecA proteins also exist in other actinomycetes and a small set of Gram positive bacteria 
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including Listeria, Staphylococcus, and some Streptococci. In bacteria with two SecA proteins, 
SecA1 is the name given to the SecA with higher sequence similarity to the well-studied SecA 
protein of E. coli and SecA2 refers to the second paralog of SecA. In mycobacteria, the two 
SecAs are demonstrated to have unique functions. Even when SecA2 is overexpressed, secA1 
cannot be deleted, indicating that SecA2 cannot substitute for SecA1 (19). Similarly, 
overexpression of SecA1 does not rescue the phenotypes of a ∆secA2 deletion mutant. As 
mentioned above, the mycobacterial SecA1 is essential and functions in the conserved Sec 
pathway. In contrast to SecA1, the mycobacterial SecA2 is not essential for growth in vitro and it 
exports a smaller subset of proteins. However, SecA2 contributes to the virulence of the 
pathogenic mycobacteria M. tuberculosis and M. marinum in macrophage and animal models of 
infection (27-31). In other bacterial pathogens with SecA2 proteins, such as L. monocytogenes, 
Staphylococcus aureus, Streptococcus gordonii, Streptococcus parasanguinis, SecA2 is also 
nonessential but has a role in virulence (32-35).  
SecA2 systems can be divided into two groups: those that only possess a single copy of 
secY and those that also include an accessory copy of secY. Systems with an accessory SecY 
(SecY2) are referred to as SecA2/Y2 systems. The best studied SecA2/Y2 systems are those of S. 
gordonii and S. parasanguinis. In SecA2/Y2 systems, a single, large, glycosylated substrate is 
exported, presumably through the SecY2 channel. The genes encoding SecA2, SecY2, and the 
substrate are arranged in a conserved locus along with the glycosylation factors that modify the 
substrate (34). However, there is only a single copy of secY in mycobacteria. Furthermore, the 
mycobacterial SecA2 pathway exports multiple, diverse substrates and is referred to as a SecA2-
only or multi-substrate SecA2 system (36, 37). In contrast to the SecA2/Y2 systems, studies 
suggest that the SecA2 proteins of the SecA2-only systems of mycobacteria, L. monocytogenes, 
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and Clostridium difficile likely work with the canonical SecYEG channel for the export of their 
specific sets of SecA2-dependent proteins (38-40). We will first discuss some examples of 
proteins exported by the SecA2 pathway in mycobacteria, and then describe what is known about 
the mechanism of mycobacterial SecA2-dependent export.  
The SecA2 Exportome 
As indicated by the virulence defects of ΔsecA2 mutants of M. tuberculosis and M. 
marinum, the SecA2-dependent pathway exports proteins with roles in pathogenesis (27-29). 
Compared to SecA1, which is responsible for the majority of protein export in the bacterial cell, 
SecA2 appears to export only a small number of proteins. Early studies identified a small number 
of SecA2 exported proteins using comparative two-dimensional gel electrophoresis of cell wall 
or secreted proteins of M. smegmatis and M. tuberculosis (19, 41). More recent quantitative mass 
spectrometry analyses of cell wall and cell envelope fractions of ΔsecA2 mutants of M. 
tuberculosis and M. marinum identified additional SecA2 substrates (29, 42). While the mass 
spectrometry studies dramatically increase our knowledge of the SecA2 exportome, further 
studies are still required to validate the SecA2-dependency of many of the more recently 
identified proteins. Below, we highlight some of the validated examples of SecA2 substrates. 
Solute binding proteins (SBPs) 
The best studied SecA2 substrates, the Msmeg1704 and Msmeg1712 lipoproteins of M. 
smegmatis, represent one class of SecA2-dependent substrates, solute binding proteins (SBPs). 
SBPs are cell wall localized proteins that deliver solutes to permease components of ATP-
binding cassette (ABC) transporters for import using energy from ATP hydrolysis (Figure 1.2).  
Although M. tuberculosis does not have a direct homolog of Msmeg 1704 or 
Msmeg1712, quantitative mass spectrometry reveals numerous SBPs that are also SecA2 
dependent in M. marinum and M. tuberculosis (29, 42). In M. tuberculosis, nearly all of the SBPs 
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identified in the cell wall fraction (13 out of 15) are present at lower levels in the ΔsecA2 mutant 
cell wall (42). All of the M. tuberculosis SecA2-dependent SPBs are lipoproteins with predicted 
signal sequences. Three SBPs with predicted Sec signal sequences were also identified as SecA2 
dependent in M. marinum (29). The trend of SBPs being SecA2 dependent may also extend to 
other SecA2-only systems, as there is some evidence that SecA2 may also export SBPs in 
Listeria (32).  
Although most SBPs in M. tuberculosis have not been directly studied and their 
substrates remain unknown, SBPs can import a wide range of solutes (43). Thus, the role of 
SecA2 in exporting SBPs could be important for nutrient acquisition and affect the ability of M. 
tuberculosis to thrive in the host. 
Mce transporters 
Another class of proteins exported by SecA2 is Mce transporter components. Mce 
transporters are importer complexes that are thought to function similarly to ABC transporters, in 
that they recognize an extracytoplasmic substrate (in this case a lipid) and import it into the 
cytoplasm using ATP hydrolysis (44). Mce transporters are composed of two YrbE membrane 
proteins forming a putative permease, five exported Mce proteins, one exported Mce lipoprotein 
and in some cases, one or more Mam transmembrane proteins (Figure 1.2). All of these 
components are exported proteins that either possess a transmembrane domain or a signal 
sequence. The five Mce proteins and the Mce lipoprotein are proposed to recognize the lipid 
substrate and deliver it to the permease and, therefore, are functionally similar to SBPs of ABC 
transporters (44). Supporting this speculated similarity, there are presumed lipid importing SBPs 
of Gram negative bacteria that possess Mce-like domains (45). M. tuberculosis has four Mce 
transporters. The best studied Mce transporter is Mce4, which imports cholesterol (46). Because 
cholesterol catabolism is critical to M. tuberculosis pathogenesis, Mce4 has an important role in 
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virulence (46). Furthermore, studies in mice suggest that Mce4 is required for M. tuberculosis 
persistence during chronic infection (46, 47). Mce1 is proposed to be a mycolic acid re-importer 
(48, 49). Mce1is required for optimal growth in mice and in macrophages; however, there are 
also conflicting reports concerning these phenotypes (48, 50-53).  
Multiple exported components of Mce1 and Mce4 transporters are identified by 
quantitative mass spectrometry as being SecA2 dependent in M. tuberculosis. Six components of 
Mce1 and six components of Mce4 are significantly reduced in the ΔsecA2 mutant cell wall (42). 
Although Mce2 and Mce3 transporter components were not detected in the M. tuberculosis mass 
spectrometry dataset, Mce3E, along with Mce4D, was identified as reduced in the ΔsecA2 
mutant of M. marinum (Figure 1.3) (29, 42). This suggests SecA2 may also export Mce2 and 
Mce3 system components, in addition to Mce1 and Mce4. Levels of MceG, the presumed 
ATPase for Mce transporters, are also reduced in the ΔsecA2 mutant of M. tuberculosis (42). 
While MceG is predicted to be cytoplasmic, MceG levels are shown to depend on the presence 
of other Mce transporter components (52). Therefore, the reduction in MceG may be a 
consequence of reduced export of Mce transporter components in the ΔsecA2 mutant. 
Collectively, these data suggest a link between SecA2 and lipid transport in mycobacteria. 
It is striking that SecA2 impacts multiple components of Mce transporters. This result 
presents two possibilities. First, SecA2 may export multiple components of Mce transporters. 
Second, SecA2 may only export one or a small number of proteins that make up the Mce 
transporter complex, but when that protein(s) is not exported (i.e. in a ΔsecA2 mutant) the entire 
Mce complex may fail to assemble and/or be destabilized. Because of the proposed similarity 
with SBPs, our identification of Mce proteins and Mce lipoproteins as SecA2-dependent is 
intriguing in terms of common features of proteins in the SecA2 exportome (Figure 1.2). As Mce 
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systems are important for virulence, the role of SecA2 in the export of Mce transporters may also 
contribute to the pathogenesis of M. tuberculosis. More specifically, because of the impact on the 
Mce4 transporter, SecA2 may be required for cholesterol catabolism during infection, which 
could translate to a role for SecA2 in persistence.  
PknG 
The eukaryotic-like serine-threonine kinase PknG is also dependent upon SecA2 for 
export (29, 42). Recent studies in M. tuberculosis and M. marinum identify reduced levels of 
PknG in the cell wall of the ΔsecA2 mutant compared to wild type or complemented strains (29, 
42). PknG lacks a signal sequence, yet is found in both the mycobacterial cytoplasm and its 
exported location (54, 55). Intriguingly, pknG is transcribed in a proposed operon downstream of 
the gene for the SecA2-dependent SBP glnH. The connection, if any, between these two SecA2 
substrates remains to be investigated. 
PknG functions in both mycobacterial metabolism and pathogenesis and an M. 
tuberculosis ΔpknG mutant has an in vitro growth defect and is attenuated in mice (54). In 
addition to regulating glutamate metabolism and redox homeostasis in the mycobacterial 
cytoplasm, during M. tuberculosis infection of macrophages, exported PknG is detected in the 
host cell cytosol and is considered a virulence effector (54, 56, 57). A hallmark of macrophage 
infections with M. tuberculosis is that the bacterium arrests the normal process of phagosome 
maturation (58, 59). Consequently, M. tuberculosis avoids delivery to a mature, fully acidified 
phagolysosome (58, 59). Although the mechanistic details remain unclear, PknG plays a role in 
phagosome maturation arrest. A ΔpknG mutant of BCG localizes to mature phagosomes, and a 
strain of M. smegmatis expressing the BCG pknG prevents phagosome-lysosome fusion unlike 
wild type M. smegmatis (56). This specific role of PknG in phagosome maturation is intriguing 
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because studies of ΔsecA2 mutants of M. tuberculosis and M. marinum demonstrate a role of the 
SecA2 pathway in phagosome maturation arrest (28, 29).  
SapM 
The most recently validated SecA2-dependent substrate in M. tuberculosis is the secreted 
phosphatase SapM. Like PknG, SapM has a demonstrated role in arresting phagosome 
maturation and preventing delivery of M. tuberculosis-containing phagosomes to 
phagolysosomes (60-62). SapM has a Sec signal sequence and is fully secreted out of the 
bacterium in vitro and in vivo (9, 62). One role of SapM is to dephosphorylate 
Phosphatidylinositol-3 phosphate (PI3P) on the M. tuberculosis-containing phagosomal 
membrane, which limits recruitment of PI3P binding proteins, such as Early endosome antigen 1 
(EEA1) that promote downstream phagosome maturation (60). Consequently, the ∆secA2 mutant 
fails to prevent EEA1 recruitment to M. tuberculosis-containing phagosomes (62), which 
contributes to the ∆secA2 mutant’s inability to arrest phagosome maturation. A ΔsapM mutant of 
M. tuberculosis is deficient for growth in macrophages and is attenuated in a guinea pig model of 
infection (61).  
Mechanism of protein export by the SecA2 pathway 
Studies of the mechanism of SecA2-dependent export in mycobacteria have been 
conducted in M. tuberculosis and M. marinum as well as the non-pathogenic model organism M. 
smegmatis. Cross-species complementation experiments show that the secA2 of M. tuberculosis 
and M. smegmatis can substitute for one another to complement ∆secA2 deletion mutant 
phenotypes, indicating that SecA2 is functionally conserved between M. smegmatis and M. 
tuberculosis (63).  
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Although it is understood that M. tuberculosis SecA1 and SecA2 are functionally distinct, 
the differences that contribute to their individual roles remain unknown. M. tuberculosis SecA1 
is more closely related to SecA proteins of other bacteria than it is to M. tuberculosis SecA2. 
When aligned to the well-studied SecA proteins of E. coli and Bacillus subtilis, M. tuberculosis 
SecA1 shares 48% and 49% sequence identity respectively. M. tuberculosis SecA2 shares 36% 
sequence identity to E. coli SecA and 37% sequence identity to B. subtilis SecA. Additionally, 
SecA2 shares only 38% amino acid sequence identity with SecA1 and is approximately 20 kDa 
smaller. Most of the annotated domains from E. coli SecA are conserved in SecA1 and SecA2, 
and both have demonstrated ATPase activity (64). The difference in size between SecA1 and 
SecA2 is predicted to come from the lack of a helical wing domain (HWD) in SecA2. The 
function of the HWD is unknown; however, the HWD undergoes conformational changes in 
response to substrate binding and may be involved in signal sequence recognition and binding 
(65, 66). One distinct difference between SecA1 and SecA2 is their subcellular localization. Like 
E. coli SecA, SecA1 is evenly distributed between the cell membrane and cytoplasm (63). 
Alternatively, SecA2 is predominantly cytoplasmic, reinforcing that the roles of SecA1 and 
SecA2 in protein export differ from one another.  
ATP binding is necessary for SecA2 function in M. tuberculosis and M. smegmatis as 
shown with a SecA2 variant harboring an amino acid substitution in the ATP-binding site of M. 
smegmatis SecA2 (K129R) and M. tuberculosis SecA2 (K115R). K129 and K115 are 
corresponding residues in M. smegmatis SecA2 and M. tuberculosis SecA2, respectively. Both 
M. tuberculosis SecA2 K115R and M. smegmatis SecA2 K129R mutants cannot bind ATP, and 
are defective in protein export (63, 64). In M. tuberculosis, SecA2 K115R fails to carry out the 
SecA2 role in promoting growth in macrophages (64). In M. smegmatis, SecA2 K129R is 
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dominant negative and is associated with phenotypes that are more severe than those exhibited 
by a secA2 null mutant. These results are indicative of SecA2 K129R being locked in a 
nonfunctional complex with SecA2-interacting proteins. Expression of secA2 K129R also results 
in reduced levels of the sole SecY of mycobacteria and increased SecY levels suppress the 
severe phenotypes of the M. smegmatis secA2 K129R mutant (38). This suggests that SecA2 
K129R is locked in a non-productive interaction with SecYEG and that increased SecY levels 
overcome the effect of this dominant negative interaction. These data also suggest that wild type 
SecA2 uses the canonical SecY channel to export its own set of substrates (Figure 1.1). In the 
SecA2-only system of L. monocytogenes, suppressor mutations of a secA2 mutant also map to 
secY, which is consistent with SecA2 working with SecY in other SecA2-only systems as well 
(39). In M. smegmatis, we identified additional suppressor mutations that alleviated the 
detrimental SecA2 K129R phenotypes without directly increasing SecY levels (38). The causes 
of suppression in these strains are investigated in subsequent chapters of this dissertation. 
Along with SecY, SecA1 may also be important for SecA2-dependent export. Numerous 
reports demonstrate the ability of SecA proteins to dimerize, and a recent study demonstrates 
heterodimer formation (as well as homodimer formation) in vitro of recombinant M. tuberculosis 
SecA1 and SecA2 purified out of E. coli (67, 68). However, it remains to be demonstrated if 
SecA1-SecA2 heterodimers exist and are biologically relevant in mycobacteria. Further, the 
oligomeric state of SecA during protein export is controversial. SecA is either suggested to 
function as a monomer or as a dimer during translocation (67). However, another finding in 
support of a role of SecA1 in the SecA2 pathway is that export of SecA2-dependent substrates in 
M. smegmatis is compromised when SecA1 is depleted, although it is also possible that this 
result could reflect a role for SecA1 in assembling the SecYEG channel in the membrane (63).  
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As current data supports a model where SecA2 works with the conserved SecYEG 
channel, and possibly SecA1 as well, to export its specific subset of preproteins, an outstanding 
question remaining to be answered is how SecA2 recognizes and exports its unique set of 
substrates but not the larger population of SecA1 preproteins. Recent observations suggest that 
ADP binding induces conformational changes of M. tuberculosis SecA2 that are not observed in 
M. tuberculosis SecA1 or E. coli SecA (69). While the biological significance of these structural 
changes are unknown, it is hypothesized that the conformational changes result in the closure of 
a clamp in SecA2 that is thought to bind the mature domain of the preprotein (69). It is possible 
that closure of the clamp prevents recognition of SecA1 substrates by ADP-bound SecA2. In this 
scenario, SecA2 binding to an unknown factor or a SecA2-dependent substrate could promote 
ADP release and open the clamp to enable SecA2 activity. Additionally, the absence of the 
helical wing domain (HWD) in SecA2 leaves the signal sequence binding cleft more open and 
solvent-exposed (70). This structural difference could help SecA2 recognize its unique substrates 
and exclude SecA1 substrates. An improved model of how SecA1 and SecA2 cooperate for 
export through the SecYEG channel, and identification of additional proteins that work with 
SecA2, are important next steps in understanding the distinctive functions of the SecA2 protein 
export pathway of mycobacteria. 
Features of SecA2-dependent substrates 
As described in the previous section, studies in M. tuberculosis, M. marinum, and M. 
smegmatis have identified proteins that are exported in a SecA2-dependent manner (29, 41, 42). 
The list of SecA2-dependent proteins includes examples with N-terminal Sec signal sequences as 
well as proteins lacking recognizable signal sequences (e.g. PknG). Interestingly, the SecA2-only 
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systems of other pathogens, such as L. monocytogenes, are also associated with export of 
proteins with or without signal sequences (71).  
The best studied SecA2-dependent substrates are the M. smegmatis SBP lipoproteins 
Msmeg1704 and Msmeg1712 (41). The lipidated nature of these proteins does not confer their 
SecA2-dependency for export; an amino acid substitution of the invariant cysteine in the 
lipoboxes of Msmeg1704 and Msmeg1712, which prevents lipid attachment, does not eliminate 
the requirement for SecA2 in export (72). Further, although Msmeg1704 and Msmeg1712 
require signal sequences to be exported, their signal sequences do not contain any distinguishing 
features targeting them to SecA2 for export (72). If their signal sequences are swapped for the 
signal sequence of a SecA1-dependent substrate, Msmeg1704 and Msmeg1712 retain their 
SecA2-dependency. Thus, the mature domains of these proteins, not signal sequences, impart the 
requirement for SecA2 in their export.  
One possible defining feature of the mature domains of SecA2-dependent substrates is a 
propensity to fold in the cytoplasm prior to export. In support of this idea, when the Sec signal 
sequence of Msmeg1704 is exchanged for a signal sequence that directs preproteins for export 
through the twin-arginine translocase (Tat) pathway, Msmeg1704 is exported by the Tat pathway 
(72).  The Tat pathway differs from the Sec system in that it requires preproteins to be folded 
prior to export. Thus, the fact that the mature domain of a SecA2 substrate is compatible with 
export by the Tat pathway suggests that SecA2-dependent substrates can fold in the cytoplasm 
prior to export. Furthermore, it suggests that the role of SecA2 may be to facilitate export of 
these problematic substrates through the SecYEG channel, which requires proteins to be 
unfolded. It remains unclear how SecA2 may assist in the export of these substrates. Three 
nonexclusive possibilities for how SecA2 could be influencing export are that SecA2 serves a 
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chaperone-like role of keeping preproteins unfolded prior to export, that SecA2 is capable of 
working with chaperones that keep preproteins unfolded prior to export, or that SecA2 
cooperates with SecA1 to provide additional energy to translocate substrates that have a 
tendency to fold through SecYEG.  
SecA2-dependent features of the mature domain may also help explain the SecA2-
dependence of M. tuberculosis proteins lacking signal sequences (e.g. SodA and PknG). SodA 
proteins lacking signal sequences are reported to be exported by the canonical Sec pathway in 
Rhizobium leguminosarum and by the SecA2-only pathway in L. monocytogenes (73, 74). 
Further studies are needed for these unconventional exported proteins lacking signal sequences, 
as it also remains possible that the effect of SecA2 on exported proteins like SodA is indirect. 
There may be unidentified signal sequence-containing proteins exported by SecA2, that are 
themselves components of a different specialized export machinery, responsible for secreting 
unconventional proteins such as SodA. 
Protein export chaperones 
SecA2 exports a variety of proteins with a wide range of functions, some of which 
contribute to M. tuberculosis virulence. Despite progress in our understanding of the SecA2 
protein export pathway, it remains unclear what distinguishes its substrates from those of the 
canonical Sec (SecA1-dependent) pathway. Prior to the studies presented in this dissertation, the 
only known difference between the canonical Sec export pathway and the SecA2 pathway were 
the ATPases, SecA1 and SecA2. We hypothesized that there were additional proteins involved in 
SecA2-dependent protein export that distinguish it from the SecA1 pathway. As described in 
chapter 3, we used a suppressor screen of the SecA2 K129R allele to identify one such protein, 
which we then named SatS and characterized as a protein export chaperone involved in the 
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export of some SecA2-dependent proteins. SatS is the first protein export chaperone identified 
for any SecA2 system.  
Nearly all export systems utilize cytoplasmic chaperones for at least some of their 
exported substrates. In general, protein export chaperones maintain their substrates in an export 
competent state and target them to the appropriate export system. A comparison of some of the 
best studied export chaperones reveals key similarities and differences in their function, substrate 
recognition, and structure. 
Molecular chaperones 
To guard against inappropriate protein interactions, all organisms produce molecular 
chaperones that promote proper protein folding and prevent protein misfolding and aggregation. 
The best characterized molecular chaperones in prokaryotes, DnaJ/K and GroEL, are primarily 
responsible for performing these tasks in the bacterial cytoplasm (75). As a subset of molecular 
chaperones, protein export chaperones also prevent inappropriate interactions of their substrates 
prior to their export from the cytoplasm. Inappropriate interactions, if permitted to occur, 
prohibit the substrate from being exported. Protein export chaperones accomplish this task 
through roles such as preventing substrate folding, unfolding substrates, and preventing substrate 
aggregation or degradation. As an additional function, protein export chaperones contribute to 
targeting their substrates to the appropriate export machinery through interactions with 
components of the export apparatus. This targeting function helps to distinguish protein export 




The best studied protein export chaperone is SecB of the canonical Sec export pathway. 
While the essential components of the Sec pathway including SecY and SecA are found in all 
bacteria, the cytoplasmic SecB only exists in Gram-negative bacteria and is a non-essential 
component of the pathway since SecB is only required for the export of a subset of Sec-exported 
proteins. A few well-studied examples of SecB substrates include maltose binding protein 
(MBP), outer membrane protein A (OmpA), and maltoporin (LamB) (76). Proteins exported 
through the Sec export system must be kept unfolded prior to and during export. Through 
transient interactions with substrates, SecB prevents inappropriate interactions by keeping its 
substrates in an unfolded, export competent state. In the absence of SecB, these substrates 
accumulate in the cytoplasm as folded precursors (77). SecB also functions to target its 
substrates to the Sec translocon through SecB interactions with SecA. 
SecB function 
Ultimately, SecB functions to ensure that its substrates properly engage SecYEG, while 
in an unfolded state for export. To accomplish this goal, SecB first inhibits substrate intracellular 
folding and/or aggregation. In an E. coli ∆secB mutant, signal sequence-containing MBP (pre-
MBP) folds in the cytoplasm into a protease resistant, native conformation, which is not exported 
(77). Further, urea-treated purified pre-MBP folds quickly into its native state upon removal of 
urea. However, in the presence of SecB, pre-MBP is maintained in an unfolded conformation 
bound to SecB (78). SecB cannot prevent folding of the mature (periplasmic) form of MBP, 
which lacks the amino terminal signal sequence (78) because mature MBP folds much faster than 
pre-MBP. There are also cases of SecB-dependent substrates that misfold in the cytoplasm and 
form aggregates in the absence of secB, which are also not exported (79).  
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In addition to preventing folding of its substrates, SecB performs an additional role as a 
targeting protein. SecB delivers substrates to the Sec-translocon for export through the 
cytoplasmic membrane through its interactions with SecA. SecB affinity for SecA is greatly 
increased if the SecA is bound to SecYEG, encouraging SecB:substrate complexes to be targeted 
to an active translocon instead of cytoplasmic SecA (80). Once the substrate has been passed 
onto SecA for export and released from SecB, SecB remains in the cytoplasm, where it can 
engage another substrate. 
SecB substrates 
Of the hundreds of Sec substrates in E. coli, there are only 22 known SecB-dependent 
substrates (81). There is no specific sequence that distinguishes SecB substrates from the larger 
pool of Sec-exported proteins. Moreover, the genes encoding SecB substrates are distributed 
throughout the genome, rather than being clustered near secB. The commonality among SecB 
substrates is that they require interactions with SecB to avoid folding in the cytoplasm. The need 
for SecB in protein export is decreased if the substrate is mutated in order to fold sufficiently 
slowly (82); this result is consistent with the role of SecB being to keep substrates unfolded in 
the cytoplasm. The signal sequences of SecB substrates are indistinguishable from the signal 
sequences of SecB-independent substrates, and signal sequences are not directly recognized by 
SecB. However, the signal sequences of SecB substrates can play a role in SecB recognition by 
slowing the rate of folding of the mature domain of the preprotein to give SecB more opportunity 
to bind (83). Substrates must be unfolded to bind to SecB, and SecB will even bind to proteins 
that are not its natural ligands if they are unfolded (84). Unfolded substrates wrap around SecB 
to simultaneously occupy several low-specificity binding sites. This binding to SecB disrupts 
secondary structure in the substrate and prevents the substrate from folding.  
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SecB structure 
SecB is a small (17.5 kDa) acidic (pI 4.1) protein that forms a homotetramer. Structural 
studies with and without bound substrates reveal that the tetramer is arranged as a dimer of 
dimers (78, 85). SecB monomers contain two long, continuous hydrophobic grooves that make 
up the primary binding sites for unfolded substrates. When bound to SecB, the mature domain of 
the substrate wraps around the SecB tetramer and ~9-12 amino acid long hydrophobic stretches 
of the substrate come in contact with the substrate-binding grooves on SecB (86, 87). There is no 
obvious consensus motif in the sequence of the substrates’ SecB-binding stretches. Instead, 
peptide studies show SecB has a binding preference for sequences of 8 or 9 aminoacyl residues 
that are enriched in aromatic and basic amino acids (76). In SecB substrates, these binding-
compatible sequences occur frequently, allowing the substrates to bind to SecB multiple times 
and prevent their folding. 
Through defined mutagenesis, the hydrophobic grooves on SecB surface have proven to 
be critical for substrate binding (78). SecB likely binds its substrate with a stoichiometry of one 
substrate per SecB tetramer. It is interesting to note that in the course of its function, SecB 
displays two transient modes of binding. In its role preventing substrate folding, SecB binds to 
its substrates using multiple hydrophobic grooves on SecB, causing the unfolded substrates to 
wrap around the surface of SecB. Conversely, when SecB binds SecA in its targeting role, the 
interaction occurs at two specific sites on SecB. The hydrophobic grooves of SecB that interact 
with its substrates overlap with one of the SecA interaction sites, suggesting a mechanism for 
substrate transfer from SecB to SecA and from there to the SecYEG translocon (88, 89). The 
primary region on SecA that interacts with SecB is a small C-terminal domain (CTD). Of note, 
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mycobacteria SecA1 and SecA2 lack a CTD. A summary of the structural and functional details 
of SecB are found in Table 1.1.   
Type III Secretion Chaperones (T3SC) 
The Type III Secretion System (T3SS) is a mechanism used by many Gram-negative 
bacterial pathogens to facilitate host-pathogen interactions. The T3SS delivers bacterial effectors 
from their site of synthesis in the cytoplasm directly into the host cell where those effectors can 
manipulate host pathways including immune responses, cytoskeletal dynamics, and signal 
transduction pathways (90). T3SSs are needle-like secretion systems, composed of ~25 proteins 
that assemble together in a stepwise manner to form three components: (i) the extracellular 
needle filament, (ii) a basal body composed of inner and outer membrane-spanning rings, and 
(iii) an ATPase-containing sorting platform at the cytoplasmic face of the basal body (90). Once 
the T3SS is assembled, it remains ready for secretion until the bacterium senses contact with a 
host cell, triggering secretion of the effector substrates through the needle. The needle channel is 
too narrow to accommodate folded proteins; hence, the T3SS, like the Sec system, requires 
effectors to be unfolded for secretion. Secretion of the effector substrates, as well as export of the 
needle filament and basal body, requires specific cytoplasmic chaperones. The best studied T3SS 
chaperones (T3SCs) are those that function in exporting the T3SS effector substrates, referred to 
as Class I chaperones. Class I chaperones are further classified based on their specificity for just 
one cognate effector substrate (class Ia) or multiple effector substrates (class Ib). T3SCs form 
highly specific, transient interactions with their substrates to promote their secretion through the 
T3SS. T3SCs perform many roles, including stabilizing their substrates prior to secretion by 
preventing inappropriate interactions, targeting substrates to the appropriate T3SS, and 
orchestrating a hierarchy of secretion through the T3SS needle. 
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T3SC function 
Ultimately, T3SCs function to ensure that their effector substrates properly engage the 
correct T3S apparatus while in a partially unfolded state for export. To accomplish this goal, 
T3SCs form transient interactions with their partially-unfolded effector substrates in the 
cytoplasm. In most cases, in the absence of their cognate T3SC, effector substrates are unstable 
and are rapidly degraded in the cytoplasm. Thus, one function of T3SCs is to prevent or protect 
their substrates from inappropriate interactions that would lead to their degradation. For example, 
in the absence of the enteropathogenic E. coli class 1b T3SC CesT, its primary substrate Tir is no 
longer secreted, and is present at much lower levels in the cytoplasm (91). There are also 
examples of aggregation-prone substrates such as the Yersinia effector YopO, which 
accumulates as insoluble aggregates in the cytoplasm in the absence of its cognate chaperone 
SycO (92). Binding of a T3SC to its effector masks an aggregation or degradation-prone region 
of the effector substrate and protects it in the cytoplasm. This binding also keeps the substrate 
partially unfolded and prepared for export. 
T3SCs also function in targeting their effectors to the correct T3SS via interactions with 
the cytoplasmic T3SS ATPase, which then triggers chaperone-substrate disassembly and 
substrate unfolding to facilitate substrate entry into the T3S machinery. Because a single genome 
can encode multiple independent T3SSs, mechanisms must be in place to ensure that effectors 
are secreted through the appropriate system. Chaperone binding to the substrate ensures 
successful targeting of the substrate for secretion through the correct T3SS pathway.  T3SS 
specificity is conferred through associations of chaperone-effector complexes with the ATPase 
on the cytoplasmic face of the T3S machinery (93, 94). T3SS ATPases form a hexameric ring-
like structure that sit at the base of the T3S machinery peripherally associated with the inner 
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membrane (95). One function of the T3SS ATPase is to take the partially unfolded effector 
substrates delivered to them by T3SCs and unfold the remainder of the substrate prior to export 
through the T3S needle. In S. enterica Typhimurium, ATP hydrolysis activity of the InvC 
ATPase causes the SptP effector to disassociate from its chaperone SicP and fully unfold (96).  
T3SCs may also orchestrate a hierarchal secretion among the multiple substrates being 
secreted through a single T3SS.  The role of T3SCs in establishing a substrate hierarchy is still 
understudied; however, chaperone-bound substrates have a competitive advantage for secretion 
over chaperone-less substrates (97, 98). Further, multi-effector, class 1b, T3SCs may have 
mechanisms to establish a hierarchy of secretion among their multiple effectors. The multi-
effector T3SC CesT binds some substrates with higher affinity than others. CesT interacts with at 
least 10 effectors, most of which require CesT for translocation into host cells (99). However, its 
primary substrate is the translocated intimin receptor (Tir). Tir secretion occurs prior to secretion 
of other effectors (100). Recently, two CesT-binding sites were identified in Tir as well as three 
other CesT-dependent, highly translocated effectors (101). The presence of two CesT-binding 
sites in these effector substrates may contribute to differential effector recognition and preference 
by CesT. Once the substrate has been passed onto the T3SS and released from the T3SC, the 
T3SC remains in the cytoplasm, where it can engage another substrate. 
T3SC substrates 
T3S effector substrates do not have Sec signal sequences, but contain non-cleavable, N-
terminal, 15-20 residue long signal sequences (102). Adjacent to the signal sequence is often a 
Chaperone Binding Domain (CBD) that encompasses the next 50-100 residues of the substrate. 
While the N-terminal signal sequence is sufficient for protein secretion (102), the CBD directs 
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substrates to the correct T3SS through its interactions with the cognate chaperone (103, 104). 
When chaperone binding is prevented by deletion of their CBDs, the Salmonella enterica 
Typhimurium effectors SptP and SopE cannot bind their respective chaperones and are not 
targeted for secretion through their cognate T3SS (104). Instead, SptP and SopE are secreted 
through the non-cognate, flagellar export pathway. Not all T3SS effectors require a chaperone 
for export, and chaperone-less effectors do not have a CBD (98). When bound to its cognate 
T3SC the CBD of a substrate is unfolded. However, unlike SecB chaperone binding, the 
remainder of the T3SC substrate is usually folded and even retains enzymatic activity (98, 105).  
A striking feature of T3S effector substrates and their cognate chaperones is the 
colocalization of their genes. Particularly for class 1a T3SCs, the gene encoding the T3SC is 
located adjacent to the gene of its target effector substrate(s), linking chaperone and substrate 
expression in the bacterial cytoplasm. In the case of CesT, a multi-substrate T3SC, the gene 
products for CesT and its primary substrate Tir are adjacent to one another, while the gene 
products for the rest of its substrates are elsewhere in the genome. 
T3SC structure 
T3SCs are all small (less than 20 kDa), acidic (pI 4-4.5) proteins. By and large, class Ia 
and Ib T3SC structures are remarkably similar despite their lack of amino acid sequence 
conservation (105). Tertiary structures of Class I T3SCs alone and in complex with cognate 
substrates reveal that T3SCs function as homodimers. T3SCs bind their substrates with a 
stoichiometry of one substrate per T3SC dimer. A few CBDs have been co-crystallized in 
complex with their cognate T3SCs, revealing that the CBD wraps around a chaperone dimer as a 
non-globular (unfolded) polypeptide, interacting with hydrophobic patches on the chaperone 
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surface. Like SecB, the T3SC structure does not depend on the presence of an effector; in the 
absence of a substrate, T3SCs maintain a dimeric state with similar structural folds and a surface 
dominated by electronegative charges with hydrophobic patches (105). These hydrophobic 
patches are required for T3SC:substrate interactions. Through defined mutagenesis, the 
hydrophobic patches on the T3SC surface have proven to be critical for substrate binding (106). 
In contrast, electronegative residues do not necessarily affect substrate binding, and they may be 
more important for recognizing a component of the T3SS machinery, such as the system 
ATPase. The highly conserved T3SC fold and substrate recognition pattern raise the question of 
how T3SCs are substrate-specific. It’s possible that differences in the surface distribution of 
hydrophobic patches may be a determining factor in chaperone-substrate binding specificity. 
Although the crystal structure of a T3SC in complex with its ATPase has not been solved, T3SCs 
with mutations in their extreme C-terminus retain their ability to bind substrates, but are still 
defective for substrate secretion, suggesting that interactions with the ATPase may occur in the C 
terminus of the T3SC (95, 107). A summary of the structural and functional details of T3SCs are 
found in Table 1.1.   
EspG 
ESX or type VII secretion systems (T7SS) are specialized secretion systems present in 
mycobacteria and a small subset of Gram-positive bacteria including L. monocytogenes, S. 
aureus, and Bacillus anthracis (108). Pathogenic mycobacteria have up to five homologous 
T7SSs, called ESX-1 through ESX-5. Three of the five ESX systems in M. tuberculosis are 
important for virulence, with roles including immune evasion and iron acquisition (109). The 
known components of the ESX membrane channel likely only span the mycobacterial inner 
membrane, and the mechanism of ESX substrate transport across the mycobacterial outer 
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membrane remains unknown (110). ESX secretion systems are encoded in operons typically 
containing ~5 structural components of the secretion machinery called Ecc proteins, ESX 
substrates, and the protein export chaperone EspG; additional substrates are encoded outside of 
the ESX operons. The EspG proteins of different ESX systems are distinguished by a subscript 
number; for example, EspG5 is encoded in the ESX-5 operon and works specifically with this 
system.  
There are three families of substrates secreted by the five ESX systems in mycobacteria: 
Esx, PE/PPE and Esp proteins. All Esx proteins and many PE/PPE and Esp substrates are co-
transcribed with a partner substrate. Several substrate pairs in each of these categories have been 
shown to form heterodimers in the cytoplasm and are predicted to be secreted in their folded, 
dimeric conformation as they are co-dependent on each other for secretion (111). While specific 
chaperones for the Esx and Esp substrates have not been identified, most PE/PPE pairs studied 
thus far require a cognate EspG chaperone to prevent inappropriate interactions (i.e. aggregation) 
and to target the substrate pair to the correct ESX machinery.  
EspG function 
EspG is a cytoplasmic protein that ultimately functions to prevent inappropriate 
interactions of its PE/PPE substrate heterodimer prior to export through the correct ESX 
machinery by forming transient interactions with the folded PE/PPE dimer. PE/PPE pairs are 
prone to aggregation in the absence of their EspG chaperone. In a ∆espG1 mutant of M. 
tuberculosis, PE35/PPE68 is found in insoluble aggregates that cannot be exported (112). 
Aggregation of PE/PPE dimers results in their degradation, and consequently PE/PPE dimers are 
also prone to degradation in the absence of their EspG chaperones. In a ∆espG1 mutant of M. 
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tuberculosis, there are reduced levels of the ESX-1 substrate PPE68 in the cytoplasm (113). In a 
∆espG5 mutant of M. marinum, there are reduced levels of multiple PE/PPE substrates in the 
cytoplasm (114).  
 Like T3SCs, EspG is also predicted to be involved in determining system specificity of 
its substrates. Of the five ESX operons in the M. tuberculosis genome, ESX-1, ESX-2, ESX-3 
and ESX-5 encode EspG, PE, and PPE paralogs. In addition, numerous other PE and PPE genes 
are scattered throughout the genome. Because each operon is thought to encode a complete, 
independent ESX system, it is generally assumed that PE, PPE, and EspG proteins from a given 
operon will interact specifically with each other and only associate with other components of that 
ESX system. Targeting and delivery of substrates to the proper ESX machinery may be 
orchestrated by interactions between EspG and ESX conserved component A (EccA). EccA is a 
cytoplasmic ATPase associated with membrane-bound ESX machinery that may be involved in 
dissociating the EspG-PPE interaction because (i) eccA mutants accumulate PPE-bound EspG 
(114), (ii) EccA interacts with both PPE proteins (115) and EspG (116) in yeast two-hybrid 
assays, and (iii) EccA proteins are only encoded in ESX gene clusters that also encode PE and 
PPE proteins. One model for the transfer of PE/PPE substrates from EspG to EccA is that 
transient binding of EccA to PE/PPE-EspG might allow EccA to dissociate the complex, passing 
the PE/PPE proteins off to the rest of the ESX system for secretion and recycling EspG to recruit 
additional PE/PPE proteins from the cytoplasm.  
EspG substrates 
Each EspG chaperone specifically interacts with the PE/PPE pair encoded in the same 
operon; for example, EspG1 specifically interacts with PE35/PPE68 and EspG5 interacts with 
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PE25/PPE41 (114). In both cases the PE/PPE pair is encoded in an operon with its cognate EspG 
encoding gene. Additional PE/PPE substrates depend on EspG for solubility and secretion but 
are encoded by genes located elsewhere in the genome (114). Of the four EspG chaperones in M. 
tuberculosis, EspG5 has the largest substrate pool, and most PE/PPE proteins are secreted 
through the ESX-5 system (112, 114, 116). EspG does not interact with the other families of 
ESX secreted substrates, the Esx and Esp proteins (114). The Esx, PE/PPE, and Esp substrates 
all have conserved, uncleaved signal sequences (YxxxD/E) on one of the partner proteins, which 
are essential for secretion (114). For PE/PPE pairs, the secretion motif is always on the PE 
protein. The YxxxD/E signal sequence does not define system specificity, as the C-terminal 15 
amino acids of an ESX-5 substrate containing this motif can be replaced by the homologous 
sequence of an ESX-1 substrate, and vice versa, without changing system specificity (114).  
EspG does not bind to the YxxxD/E signal sequence. Rather, EspG specifically 
recognizes and binds to an EspG-binding domain on the PPE protein of the PE/PPE pair. This 
EspG-binding domain is a conserved, hydrophobic patch on the tip of the PPE protein. Mutation 
of the patch on PPE disrupts EspG-binding and reduces secretion of the PE/PPE pair (112). This 
patch also designates the specificity of the PPE proteins for its cognate EspG chaperone. For 
example, the ESX-1 secreted PE35/PPE68 pair can be rerouted to the ESX-5 system of M. 
marinum by replacing the EspG1 binding domain of PPE68 with the equivalent EspG5 binding 
domain of the ESX-5 substrate PPE18 (117). This domain replacement makes PE35/PPE68 
independent of both EspG1 and the ESX-1 membrane complex and instead dependent on EspG5 




 EspG proteins are acidic (pI 4.5-6) proteins that are ~30 kDa in size. The crystal 
structures of several EspG proteins from M. tuberculosis (EspG3 and EspG5) and M. smegmatis 
(EspG3) have been solved with and without bound substrates and reveal that despite low amino 
acid conservation (less than 25% pairwise sequence identity), the tertiary structures of the 
chaperones are highly similar and are not affected by substrate binding (112, 116). EspG proteins 
do not strongly resemble the solved structures of the smaller SecB or T3SCs (Table 1.1). 
Intriguingly, the overall EspG fold is approximately twofold symmetrical (112). The two halves, 
or subdomains, of EspG have the same topology and connectivity despite having low sequence 
similarity, suggesting that the EspG family of proteins may have evolved by an intergenic 
duplication event (112).  
EspG proteins function as monomers, and bind substrates with a stoichiometry of one 
PE/PPE pair per EspG monomer (112). Unlike SecB and T3SCs, EspG binds to folded substrate 
pairs; the crystal structure of EspG5 in complex with the PE25/PPE41 dimer reveals that the 
PE/PPE dimer is fully folded when bound to its chaperone (112, 116). EspG exclusively binds to 
the hydrophobic tip (EspG-binding domain) of the PPE protein, distal from the C-termini of both 
the PE and the PPE subunits (112). Because PE and PPE subunits often encode large C-terminal 
domains (of unknown function), binding of EspG far from the C-termini may prevent steric 
clashes with these additional domains. Additionally, binding of EspG at the EspG-binding 
domain does not interfere with the C-terminal YxxxD/E signal sequence, which is also located at 
the opposite end of the PE/PPE complex from EspG. The EspG-binding domain of the PPE 
protein interacts with a deep hydrophobic groove on EspG (112, 116). It is not known how EspG 
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interacts with the ATPase EccA. A summary of the structural and functional details of EspGs are 
found in Table 1.1.   
Asp1, Asp2, and Asp3 of SecA2-SecY2 systems 
As described briefly above, the SecA2-SecY2 accessory Sec system is conserved among 
a few streptococcal and staphylococcal Gram-positive bacteria, but not found in mycobacteria. 
The system is encoded within a single operon and mediates the transport of a single large serine-
rich repeat, cell wall-anchored glycoprotein to the bacterial cell surface (34). In addition to genes 
encoding the serine-rich substrate, secA2-secY2 operons contain genes that encode proteins 
mediating its export and glycosylation. In Streptococcus gordonii the substrate of the accessory 
Sec system is GspB  (118). GspB export requires five highly conserved proteins: SecA2, SecY2, 
Asp1, Asp2, and Asp3. SecA2 and SecY2 are paralogs of canonical SecA and SecY.  
Asp1, Asp2, and Asp3 do not have homologs beyond the accessory Sec system, and their 
functions in transport are largely unknown. One possibility is that Asp1-3 function as protein 
export chaperones for SecA2/SecY2 systems. In S. gordonii, the Asp1-3 proteins are present in 
the cytoplasm. Asp2 and Asp3 can bind the unstructured serine-rich-repeat domains of GspB 
suggesting that these two Asps may function to transport the substrate to the accessory Sec 
machinery by facilitating a specific interaction between GspB and SecA2 (119, 120). SecA2 
serves as a docking site for Asp2, which in turn recruits Asp1 and Asp3 to the membrane (121). 
Although these Asps bind GspB directly, they do not meet the definition of a chaperone, since 
they are not required for GspB stability, prevention of folding, or anti-aggregation.  Thus far, 
there are no examples of protein export chaperones that work with any SecA2 system. 
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Overall comparisons between protein export chaperones 
Protein export chaperones are non-essential components of the export machinery, but are 
fully required for the proper export of their cognate substrates. In all cases, only subsets of the 
proteins exported by an export pathway require chaperones. All of the protein export chaperones 
highlighted in this chapter ensure that their specific substrates engage the appropriate export 
channel in a conformation compatible with export. In order to accomplish this goal, these protein 
export chaperones all form transient interactions with their substrates in the cytoplasm mediated 
by hydrophobic sites on the chaperone. For SecB and EspG, these sites are deep grooves in the 
chaperone. T3SC hydrophobic sites are more variable, and are generally referred to as 
hydrophobic patches. For their role in targeting to the export channel, all of these protein export 
chaperones target their substrate to an ATPase at the base of the channel. While the chaperones 
function in an energy-independent manner, ATP hydrolysis is required for disassembling the 
chaperone:substrate complex. However, this has not been demonstrated for EspG. Another 
similarity between these chaperones is that they are all acidic, although the contribution of acidic 
residues to chaperone function is unknown.  
SecB, T3SCs and EspG do not resemble one another, either by primary amino acid 
sequence or by tertiary structure. Further, all of the protein export chaperones highlighted in this 
chapter have different oligomeric states; SecB forms a tetramer, T3SCs form dimers, and EspG 
functions as a monomer. Furthermore, although all of the chaperones interact with their 
substrates via hydrophobic sites, the effect of chaperone-binding for their substrates differs 
between all three chaperones. Sec substrates are fully unfolded when bound to SecB. T3SS 
substrates are only partially unfolded (at the CBD) and the remainder of the protein remains 
folded and enzymatically active. PE/PPE proteins are fully folded when bound to EspG. The 
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folding status of the chaperone-bound substrate is important for ensuring that it is compatible for 
export its with specific export pathway. 
Bacteria often encode multiple ESX or T3S systems. Consequently, EspG and T3SC are 
required to target substrates to the correct machinery when the bacteria have paralogous export 
systems. It appears that both of these secretion systems have utilized similar strategies to ensure 
their substrate:chaperone pairs are appropriately targeted. In both cases, chaperones and 
substrates are typically encoded by genes adjacent to one another, linking expression of the 
chaperone and substrate. Additionally, the specificity of the T3SS substrate CBD and the ESX 
substrate EspG-binding domain ensures that substrates are only engaged by the correct 
chaperone. In the case of SecB, the substrate binding sites are less specific and can accommodate 
a larger variety of substrates, so long as they are unfolded. 
Summary 
It is clear that the mycobacterial SecA2 system is responsible for exporting a subset of 
proteins and it plays an important role in the virulence of M. tuberculosis. Nevertheless questions 
about the mechanistic steps of SecA2 export remain. A better understanding of the SecA2 
protein export system has the potential to reveal new drug targets to combat infection with M. 
tuberculosis. The goal of my dissertation research was to fill in gaps in our understanding of the 
mechanism of SecA2 protein export by searching for additional proteins that are required for 
SecA2-dependent protein export. We previously established a suppressor screen carried out 
using the dominant-negative M. smegmatis secA2 K129R allele. In this dissertation, we describe 
two outcomes of this suppressor screen that improve our understanding of SecA2 protein export. 
In chapter 2, we report the crystal structure of M. tuberculosis SecA2 and compare it with 
the previously solved SecA1 structure. This is the first SecA2 structure reported for any 
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organism. SecA1 and SecA2 exhibit a high level of structural similarity, and features of SecA1 
that are important for the interaction between SecA1 and SecYEG are conserved in SecA2. We 
also identify some structural differences between SecA1 and SecA2, most notably the absence of 
the helical wing domain in SecA2. These structural differences may be important for recognizing 
and distinguishing SecA2-dependent substrates from the larger Sec substrate pool. Using this 
structure, we mapped intragenic suppressor mutations of secA2 K129R to the surface of SecA2. 
These suppressors allowed us to develop hypotheses for regions of SecA2 that may promote 
interactions with SecYEG, SecA2 substrates or other partners of SecA2.  
In chapter 3, we identify several suppressors affecting the conserved hypothetical protein 
Msmeg_1684, which we renamed SatS for SecA2 (two) Suppressor. We provide evidence in 
both M. smegmatis and M. tuberculosis that SatS is required for the stability and export of some, 
but not all, SecA2-dependent substrates. Specifically, we show that SatS is required for SapM 
and Mce export. Our data led us to identify SatS as the founding member of a new class of 
protein export chaperones. Comparisons of the newly solved crystal structure of SatS with the 
well-studied protein export chaperone SecB reveal that, while SatS and SecB are not structurally 
similar, both proteins have similar hydrophobic grooves positioned on the surface which, for 
SecB, are crucial for substrate binding and unfolding.  
Taken together, these studies greatly expand our model of SecA2-dependent protein 
export by structurally characterizing the mycobacterial SecA2 protein and chiefly by 
characterizing SatS, a protein export chaperone of the mycobacterial SecA2 system. By 
identifying SatS as the first protein export chaperone of a SecA2 pathway, our studies expand 




Figure 1.1. Models of SecA1 and SecA2 export in M. tuberculosis. A) SecA1 uses ATP 
hydrolysis to export preproteins through the SecYEG channel in an unfolded, export competent 
state. Sec signal sequences (black rectangle) target preproteins (blue ribbon) for export through 
SecYEG and are then cleaved by a signal peptidase (SP). B) SecA2 also uses the SecYEG 
channel and possibly SecA1 to export its own subset of preproteins (green ribbon). The signal 
sequence (black rectangle) is indistinguishable from canonical Sec signal sequences. Instead, the 





Figure 1.2. Solute binding proteins and Mce proteins are exported by the SecA2 pathway. Two 
classes of SecA2-dependent substrates are SBPs and Mce proteins. Both SBPs and Mce proteins 
are involved in solute acquisition. In the case of SBPs this involves import of a solute through an 
ABC transporter permease using energy provided by ATP hydrolysis. Mce transporters are 
thought to function in a similar manner as ABC transporters to import a lipid substrate through a 
YrbE permease in an ATP-dependent manner. Although the diagram of an Mce transporter is 





Figure 1.3. Multiple components of Mce transporters are reduced in the cell wall of the ΔsecA2 
mutant. The M. tuberculosis genome contains four mce loci encoding putative lipid transporters. 
The genomic regions encoding Mce1, Mce3, and Mce4 transporters are shown with Open 
Reading Frames (ORF) colored for Mce proteins that are reduced in quantitative mass 
spectrometry studies of the M. tuberculosis and M. marinum ΔsecA2 mutant cell wall or cell 
envelope fractions (29, 42). In dark blue and/or green are mce genes for proteins that are 
significantly reduced (p<0.01 for M. tuberculosis and p<0.05 for M. marinum) in the ΔsecA2 
mutant; in light blue are genes for mce proteins that are reduced in the M. tuberculosis ΔsecA2 
mutant but did not reach statistical significance. 
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Table 1.1. Structural and functional comparisons between known protein export chaperones 
Feature SecB T3SC (Class 1) EspG 
Location Cytoplasmic Cytoplasmic Cytoplasmic 
Size 17 kDa 15 - 20 kDa 30 kDa 
Isoelectric 
point 
Acidic (pI 4.1) Acidic (pI ~ 4 - 4.5) Acidic (pI ~4.5-6) 
Oligomeric 
state 
Tetramer Dimer Monomer 
Interacting 
partners 
Binds substrates and SecA 
ATPase 
Binds substrates and T3SS 
ATPase 
Binds substrates and 
EccA ATPase 
Substrate pool 
Not all Sec substrates use 
SecB; SecB has multiple 
substrates 
Not all T3SS substrates 
use a given T3SC; some 
T3SCs have one substrate, 
some have multiple 
substrates 
Not all ESX substrates 
use a given EspG; some 
EspGs have one 
substrate, some have 
multiple substrates 
Gene location 
No genomic context with 
substrates 
Often in operon with 
substrate, additional 
substrates not in operon 
In operon with substrate 
pair, additional 




folding state  
Whole substrate is 
unfolded when bound to 
SecB 
Only CBD is unfolded 
when bound to T3SC; 
remainder of substrate is 
folded  
Whole substrate pair is 





Substrate binds in 
hydrophobic grooves,  
wraps around tetramer  
1 substrate/SecB tetramer 
Substrate CBD binds in 
hydrophobic patches,  
wraps around dimer 
1 substrate/T3SC dimer 
PPE substrate of 
PE/PPE pair binds in 
hydrophobic groove, 





Without SecB, substrate is 
stable and accumulates in 
cytoplasm, some 
aggregate – no export 
Without T3SC, substrate 
is unstable – no export 
Without EspG, substrate 
aggregates in cytoplasm 





substrate folding and/or 
aggregation, target to Sec 
Performs multiple 
functions: Stabilize 
substrates, target to 
correct T3SS, regulate 








SecB tetramer  
(PDB ID: 1QYN) 
 
SicP dimer  
(PDB ID: 1JYO) 
 
EspG3 monomer 
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Structural Similarities and Differences between Two Functionally Distinct SecA Proteins, 
Mycobacterium tuberculosis SecA1 and SecA2 
 
While SecA is the ATPase component of the major bacterial secretory (Sec) system, 
mycobacteria and some Gram-positive pathogens have a second paralog, SecA2. In bacteria with 
two SecA paralogs, each SecA is functionally distinct, and they cannot compensate for one 
another. Compared to SecA1, SecA2 exports a distinct and smaller set of substrates, some of 
which have roles in virulence. In the mycobacterial system, some SecA2-dependent substrates 
lack a signal sequence, while others contain a single peptide but possess features in the mature 
protein that necessitate a role for SecA2 in their export. It is unclear how SecA2 functions in 
protein export, and one open question is whether SecA2 works with the canonical SecYEG 
channel to export proteins. In this study, we report the structure of Mycobacterium tuberculosis 
SecA2 (MtbSecA2), which is the first structure of any SecA2 protein. A high level of structural 
similarity is observed between SecA2 and SecA1. The major structural difference is the absence 
of the helical wing domain, which is likely to play a role in how MtbSecA2 recognizes its unique 
substrates. Importantly, structural features critical to the interaction between SecA1 and SecYEG 
are preserved in SecA2. Furthermore, suppressor mutations of a dominant-negative secA2 mutant 
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map to the surface of SecA2 and help identify functional regions of SecA2 that may promote 
interactions with SecYEG or the translocating polypeptide substrate. These results support a 
model in which the mycobacterial SecA2 works with SecYEG. 
Introduction 
SecA is the ATPase component of the bacterial Sec secretion pathway (1). SecA 
recognizes proteins destined for export from the cytoplasm and provides energy to translocate 
them across the cytoplasmic membrane by way of the SecYEG translocase channel. The proteins 
exported by SecA are synthesized as preproteins with N-terminal signal sequences. Following 
translocation, the signal sequence is cleaved to release the mature protein species. Both the signal 
sequence and features of the mature protein are recognized by SecA (2). Some Gram-positive 
and acid-fast bacteria, including mycobacteria, have a SecA paralog referred to as SecA2. 
SecA1, the canonical SecA in these organisms, is essential for growth and responsible for the 
majority of protein export that occurs. In contrast, SecA2 is typically not essential and is required 
for the export of a more limited subset of proteins (3,4). Studies in mycobacteria show that even 
when overexpressed, the two SecA proteins are unable to compensate for each other (5). Thus, 
each SecA protein has distinct functions in protein export. In Mycobacterium tuberculosis, 
SecA2 (MtbSecA2) is not essential for growth in culture, but it is essential for virulence in vivo 
(6,7). Furthermore, SecA2 is required for intracellular growth of M. tuberculosis in macrophages 
(8). The role of SecA2 in promoting growth in macrophages is attributed to a role in preventing 
phagosome maturation (9). In Mycobacterium marinum, export of protein kinase G (PknG) by 
the SecA2 pathway is suggested to at least be partially responsible for the SecA2 effect on 
phagosome maturation (10). In M. tuberculosis, the SecA2 pathway is additionally required to 
restrict apoptosis of infected macrophages. A possible explanation for the latter effect is the 
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SecA2-dependent secretion of superoxide dismutase, which may reduce reactive oxygen species 
(ROS)-mediated apoptosis (11, 12). An association between SecA2 and the secretion of 
virulence factors extends to other bacterial pathogens as well (13-16). There is also an intriguing 
association between the SecA2 pathway and the export of S-layer proteins by Gram-positive 
bacteria, such as Bacillus anthracis (17) and Clostridium difficile (18).  
It is unclear how MtbSecA2 carries out its unique function in protein export. In some 
organisms with two SecAs, there is a SecY paralog (SecY2), with which SecA2 likely interacts 
(19). In SecA2¬SecY2 systems, SecY2 and several accessory Sec proteins (Asp) are thought to 
form an accessory protein translocation channel in the cytoplasmic membrane (4). Mycobacteria, 
however, are in a group of bacteria referred to as “SecA2-only” systems that lack a second SecY 
ortholog (3). Mycobacteria, as well as several Gram-positive species, including Listeria 
monocytogenes (13), Corynebacterium glutamicum (20), and C. difficile (18), are in the 
“SecA2¬only” group. An important but unresolved question is whether SecA2 works with the 
canonical SecYEG channel to export proteins in these systems lacking a second SecY.  
The mycobacterial proteins currently known to be exported by SecA2 include examples 
with typical Sec signal sequences, as well as proteins lacking signal sequences altogether (3). 
Superoxide dismutase (SodA) in M. tuberculosis and PknG in M. tuberculosis and M. marinum 
are examples of proteins lacking signal sequences that are exported in a SecA2-dependent 
manner (7, 10, 21). Of the signal sequence-containing proteins exported by the SecA2 systems of 
Mycobacterium smegmatis (22), M. marinum (10), and M. tuberculosis (21), the most thoroughly 
studied proteins are the M. smegmatis 1704 (Ms1704) and Ms1712 proteins (22). Studies of 
Ms1704 and Ms1712 demonstrate that they require their signal sequence for export, but it is a 
feature of the mature portions of these proteins that necessitates export via the SecA2-dependent 
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pathway (23). Interestingly, when fused to a signal sequence for the twin-arginine translocation 
(Tat) pathway, the mature domain of Ms1704 is exported by the Tat pathway. This result 
suggests that the defining feature of SecA2 substrates may be a tendency to fold prior to export 
(23). This is because proteins that get translocated across the membrane by the Tat pathway must 
be folded in the cytoplasm prior to export (24). In contrast, preproteins exported by the canonical 
SecA must be unfolded (25), sometimes with the help of export chaperones (26, 27), due to the 
narrow diameter of the SecYEG central channel. Therefore, if SecA2 works with SecYEG, the 
role of SecA2 may be to facilitate the export of proteins that have a tendency to fold prior to 
export by either helping to maintain such proteins in an unfolded state or assisting in the 
recognition or export of such problematic substrates.  
There is only 38% amino acid sequence identity between the MtbSecA1 and MtbSecA2 
proteins. Yet, SecA2, like SecA1, has a DEAD box ATPase domain (28), and ATPase activity is 
required for SecA2 function (29). Furthermore, SecA2 variants lacking ATPase activity due to 
an amino acid substitution in the Walker box are dominant negative, and a secA2 dominant-
negative mutant exhibits secA2 mutant phenotypes (a growth defect on rich agar and azide 
sensitivity) that are more severe than those exhibited by a ∆secA2 null mutant (29). Extragenic 
suppressors of this dominant-negative secA2 allele map to the secY promoter, and increased 
SecY levels suppress the secA2 dominant-negative phenotype (30). These findings suggest that 
the SecA2 dominant-negative protein is locked in a nonproductive interaction with the essential 
SecYEG channel, which inhibits SecYEG function but can be overcome by increased SecY 
production. This is consistent with SecA2 working with SecYEG. In a recent study of the 
SecA2-only system of L. monocytogenes, suppressors of a secA2 mutation also mapped to secY 
(74). Furthermore, the behavior of a dominant-negative SecA1 mutant in the C. difficile system is 
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consistent with the SecYEG translocase used by SecA1 also being used by SecA2 (18). Thus, it 
seems likely that in these SecA2-only systems, SecY is involved. However, a direct interaction 
between SecA2 and SecYEG has not been demonstrated in any system.  
Previously, the crystal structure of the canonical SecA1 was solved in M. tuberculosis 
(31), as well as several other organisms, including Escherichia coli (32), Bacillus subtilis (33), 
Thermotoga maritima (34), and Thermus thermophilus (35). SecA structures contain five 
canonical domains, organized roughly in the shape of a barbell: a core helical scaffold domain 
(HSD), forming the “axis”; 2 nucleotide-binding domains (NBD1 and NBD2), which together 
form a DEAD box, RecA-like, or superfamily II helicase motor domain on one end of the 
barbell; and a helical-wing domain (HWD) and preprotein cross-linking domain (PPXD) on the 
other end of the barbell. In addition, a helix-loop-helix domain called IRA1 (for “intramolecular 
regulator of ATPase”) packs against the HSD, with helices aligned in parallel. The loop 
connecting the helices of IRA1 is known as the two-helix finger (2HF). The 2HF has been shown 
to insert into the SecYEG pore, and it is proposed to promote forward movement of the 
preprotein through the channel (34, 36), although the interaction between the 2HF and SecYEG 
could also serve an alternate role besides pushing the translocating protein through the channel 
(37). During preprotein translocation, SecA undergoes significant conformational changes, one 
of which involves the orientation of the PPXD domain. According to one model (38), the PPXD 
likely starts out oriented toward the HWD, forming a hydrophobic “cleft” for binding the signal 
sequence of the preprotein (39, 40), and then rotates toward NBD2 to form a “clamp” around the 
translocating polypeptide chain, which has been proposed to be initiated by docking with 
SecYEG (41).  
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In order to better understand the unique function of SecA2, we solved the crystal 
structure of MtbSecA2, which is the first SecA2 structure to be determined in any organism. The 
structure reveals that the HWD domain is completely absent in MtbSecA2. The HWD could play 
a role in interacting with protein substrates, as it forms part of a cleft with the PPXD that is 
implicated in peptide binding (40). Although the residues that directly bind the signal sequence 
(based on nuclear magnetic resonance [NMR] studies) are contributed by the PPXD and IRA1 
domains (40), the HWD would likely be physically proximal to the untranslocated portion of 
protein substrates. Furthermore, residues in the HWD of E. coli SecA (along with the PPXD and 
HSD) have been shown to crosslink with synthetic signal sequences in cysteine substitution 
experiments (42). The lack of an HWD in SecA2 leads to a signal sequence binding cleft that is 
more highly solvent exposed than in SecA1, which we propose could account for recognition of 
specific SecA2-dependent substrates and prevent export of the larger number of SecA1-
dependent preproteins. The structure also reveals conservation in MtbSecA2 of features critical 
to the interaction between SecA and SecYEG proteins. Finally, by mapping intragenic 
suppressor mutations onto the SecA2 structure, we show that the mutated residues appear in 
surface-exposed regions and map to three functional domains that are likely involved in 
mediating interactions with other protein partners, such as SecYEG.  
Materials and Methods 
Protein expression and purification. The 778-residue open reading frame (ORF) of MtbSecA2 
was cloned into expression vector pNR14. Several genomic databases list MtbSecA2 as having a 
total length of 808 amino acids (aa) (e.g., NCBI accession no. NP_216337). However, the start 
site in this annotation is likely to be incorrect, as the first 30 aa are not required for function and 
represent an N-terminal extension that is not observed in other SecA orthologs (28, 43). 
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Therefore, we designate the GTG codon corresponding to residue 31 in the NCBI annotation as 
the true start codon, yielding a total ORF length of 778 aa. The expression construct pNR14 
produces a tag-less form of the protein (28). Selenomethionyl protein was produced by 
transforming the E. coli methionine auxotroph B834(DE3) (Novagen) with the pNR14 
expression vector. A 6-liter culture was grown under standard conditions to mid-log phase. The 
cells were pelleted and used to inoculate 12 liters of M9 minimal medium supplemented with 50 
mg/liter of L-selenomethionine (SeMet), 50 mg/liter of standard L-amino acids (excluding 
methionine), 100 nM vitamin B12, and trace elements (44). Expression was induced with 0.5 
mM ITPG (isopropyl-β-D-thiogalactopyranoside) at 16°C for 12 h. Cells were then harvested 
and resuspended in lysis buffer containing 50 mM Tris (pH 8.0), 50 mM NaCl, 1 mM 
dithiothreitol (DTT), 10 mM MgCl2, 20 µg/ml DNase, and 1 x protease inhibitor cocktail V 
(EMD Biosciences). The cells were disrupted in a BeadBeater (Biospec) using 0.1-mm¬diameter 
glass beads. Cellular debris was cleared from the lysate by spinning at 27,200 x g for 2 h. The 
supernatant was then filtered and loaded onto a Blue Sepharose column (GE Healthcare) that had 
been equilibrated in a mixture of 50 mM Tris (pH 8.0), 50 mM NaCl, and 1 mM DTT. Protein 
collected from the flowthrough was further purified by anion-exchange chromatography using a 
HiTrap Q high-performance (HP) column (GE Healthcare). The purified protein was dialyzed 
overnight against buffer containing 50 mM Tris (pH 8.0), 50 mM NaCl, and 1 mM DTT and was 
then concentrated to 10 mg/ml using a Centriprep centrifugal concentrator (Milipore) and flash 
frozen until further use.  
Crystallization. Purified protein was crystallized in 20% polyethylene glycol 8000 (PEG 8000), 
0.1 M Tris (pH 8.0), 0.2 M NaCl, 3% ethylene glycol, and 8 mM 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS). Wells were set up using 
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sitting-drop vapor diffusion at 21°C, with drops consisting of 2 parts buffer and one part protein. 
Crystals grew to 100 µm within 3 to 4 days. Perfluoropolyether (Hampton Research) was used as 
a cryo-protectant. The protein crystallized in space group P21 with the unit cell parameters a 
=39, b =165, c = 67 Å, and β=97°. The corresponding unit cell volume can accommodate a 
single molecule in the asymmetric unit.  
Crystal dehydration. A crystal dehydration method was developed that significantly improved 
the mosaic spread and diffraction power of the crystals (45). Both the well and drop solution 
were replaced with mother liquor that had a 3 to 5% increase in precipitant concentration. 
Crystals were left to dehydrate for a minimum of 48 h before making another incremental 
increase in the precipitant. Successfully dehydrated crystals had a reduced b unit cell parameter 
of up to 15 Å, with the largest difference resulting in a 10.5% decrease in the unit cell volume. 
The crystal that produced the best diffraction data and led to structure solution had only a 3-Å 
difference in the b unit cell parameter.  
Data collection, structure determination, and refinement. The structure was solved by single-
wavelength anomalous dispersion (SAD) using a selenomethionine (SeMet) derivative (46). 
Anomalous diffraction data were collected at beamline 23-ID of the GM/CA-CAT facilities of 
the Advanced Photon Source, Argonne National Laboratory. Crystals were partitioned using the 
10-µm minibeam (47). This prevented global-scale radiation exposure and allowed for more data 
to be collected from a single crystal. The data were processed and reduced using the HKL2000 
software package (48). The locations of 3 Se sites were found using SHELX C/D and were used 
as a starting point for locating additional sites in autoSHARP (49, 50). The resulting 
experimental phases extended to a 3.8-Å resolution and produced an electron density map in 
which approximately 60% of the backbone could be placed in NBD1, NBD2, and parts of the 
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HSD. Model building was performed in Coot (51). The phases from the partial model were then 
combined with the experimental phases using SigmaA and used as a starting point for 
progressive runs of density modification in DM (52, 53). This facilitated the placement of the 
backbone in the PPXD as well as in other parts of the model. Initially, sequence was assigned by 
the positions of the Se atoms and from the density of large side chains. Then a real-space cross-
validation procedure called “ping-pong” cross-validation was used to complete the structure (54). 
Briefly, the model was split into two sets. Side chains that could be identified in the first set of 
residues were used during phase combination and density modification. The resulting map was 
used to place side chains for the second set of residues, and the process continued in alternation. 
Structure refinement was carried out in autoBuster (55).  
Suppressor screen and reconstruction. Spontaneous suppressors of the secA2 K129R strain were 
isolated by plating onto Mueller-Hinton agar at 37°C, as described previously (30). The secA2 
K129R strain has the chromosomal secA2 gene deleted and carries a copy of the secA2 gene 
encoding SecA2 K129R integrated at the chromosomal L5 att site. The secA2 K129R gene of the 
suppressors was PCR amplified and sequenced to identify intragenic suppressor mutations. To 
confirm that suppressor phenotypes were due to sequenced mutations in secA2 K129R, the 
intragenic suppressors were recreated in a fresh strain background. PCR-amplified secA2 K129R 
gene products from the intragenic suppressors were subcloned into pCR2.1 followed by cloning 
into pMV306. The resulting vectors were electroporated into the ∆secA2 mutant of M. 
smegmatis, and transformants were tested for sensitivity to sodium azide and SecA2 localization.  
Azide sensitivity assay. Cultures were plated for sensitivity to sodium azide as previously 
described (29). In brief, 200 µl of saturated (optical density at 600 nm [OD600] of 2.0) M. 
smegmatis culture was mixed with 3.5 ml of molten 7H9 top agar and then poured onto a 7H10 
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bottom agar plate lacking Tween. Sterile 6-mm-diameter filter discs were placed onto the surface 
of the cooled top agar. Ten microliters of 0.15 M sodium azide was then added to the disc. The 
plates were incubated for 2 days at 37°C, and the resulting zones of growth inhibition were 
measured. Each strain was tested in triplicate.  
Subcellular fractionation and immunoblotting. To determine the subcellular localization of 
SecA2 in M. smegmatis, we fractionated bacterial whole-cell lysates as described previously (22, 
29). Whole-cell lysates were generated by five passages through a French pressure cell. The 
lysates were separated into cell envelope (100,000 x g pellet) and soluble (100,000 x g 
supernatant) fractions. Protein derived from the same amount of starting cells for each fraction 
was analyzed by SDS-PAGE and immunoblots using an anti-SecA2 antibody at a 1:20,000 
dilution (56). For quantification, secondary antibody conjugated to alkaline phosphatase was 
used and detected using the ECF reagent (GE Healthcare). Fluorescence was quantified using a 
phosphorimager and ImageQuant 5.2 (Molecular Dynamics).  
Protein structure accession number. The structural coordinates of the MtbSecA2 model used in 
this study have been deposited in the Protein Data Bank under identification no. 4UAQ.  
Results 
Crystal structure of MtbSecA2. MtbSecA2 (Rv1821) was crystallized in space group P21, 
and the structure was solved by single-wavelength anomalous dispersion (SAD) (57) to a 
resolution of 2.8 Å. The asymmetric unit of the crystal contains a single monomer, and there is 
no indication of a higher-order oligomer in the crystal lattice. A total of 705 out of 778 residues 
of the apoprotein were visible in the electron density and could be built. The crystallographic 
statistics are shown in Table 2.1.  
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Broad structural similarity between MtbSecA1 and MtbSecA2. The tertiary structure of 
SecA2 is very similar overall to those of MtbSecA1 and other orthologs in the SecA family 
(Figure 2.1). SecA2 has a long 65-Å (45-amino-acid) helix scaffold domain (HSD), which 
interconnects four other domains, including two nucleotide-binding domains (NBD1 and NBD2), 
the IRA1 domain, and the PPXD domain. NBD1 and NBD2 pack together to form a DEAD box 
motor domain with an ATP-binding site between them. Catalytically important residues such as 
K115 and R545 are conserved, consistent with demonstrated ATPase activity of SecA2 (28). As 
in other SecA structures, the IRA1 domain consists of a pair of alpha-helices packed in parallel 
to the HSD (forming a 3-helix bundle) and connected by a 9-aa loop (known as the 2-helix finger 
[2HF]). SecA2 lacks the ~70-aa C-terminal domain (CTD) that is present in SecA1 orthologs. 
However, the short linker to this domain, called the C-terminal linker (CTL [residues 734 to 
778]), is retained in the SecA2 sequence. The CTL is largely disordered in the crystal structure. 
However, as observed in previous SecA structures (33) part of the CTL of SecA2 (residues 749 
to 759, shown in yellow in Figure 2.1) forms a third β-strand along the outside of the preprotein 
binding site. Note that this region is preceded by a disordered loop (residues 734 to 748), which 
appears as a discontinuity between IRA1 and CTL in the figure, and followed by only 19 
residues at the C terminus, which are also disordered. During model building, sequence 
assignment in this strand was aided by the location of SeMet757 and the density of bulky side 
chains, which helped to rule out the possibility of a bound preprotein substrate. 
 Differences between the structures of MtbSecA1 and MtbSecA2. Despite the overall 
similarity between the structures of SecA1 and SecA2, there are several notable differences. One 
structural difference between SecA1 and SecA2 is found in the nucleotide-binding region. SecA2 
lacks the VAR domain (58), which in other SecA orthologs consists of a pair of helices that 
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reach out from NBD2 and cover over the ATP-binding site (Figure 2.2). Consequently, the ATP 
binding site is more solvent exposed in SecA2. The VAR domain is present in some SecA 
orthologs, including MtbSecA1 (21) and E. coli SecA (32), but it is absent in others, such as B. 
subtilis SecA (33) and T. maritima SecA (TmSecA) (39). The functional significance of the 
absence of the VAR domain in SecA2 is unknown. 
 A second structural difference involves the orientation of the PPXD domain. As in other 
SecA structures, the PPXD domain consists of an α+β-fold that is attached to the NBD1 motor 
domain by a pair of anti-parallel β-strands that cross over the HSD. The PPXD of M. 
tuberculosis SecA2 occupies a distinct orientation compared to previous SecA structures, as 
illustrated in Figure 2.3. The PPXD in previous SecA structures has been observed in several 
different orientations, ranging from contact with the HWD (to form a “signal sequence binding-
cleft closed” conformation, as observed in 1nl3) to contact with NBD2 (to form a “preprotein 
clamp closed” conformation, as observed in PDB code 3DIN) (38, 39). The PPXD in SecA2 
occupies an intermediate position between these two extremes. 
  The most striking structural difference in SecA2 is that the HWD is missing (Figure 2.2) 
due to deletion of 70 aa that form a helical domain at the end of the HSD, as anticipated from the 
sequence alignment. In SecA2, the remaining 23 residues connect the HSD directly to IRA1, 
bypassing the helical wing domain. In other SecA structures, including MtbSecA2, the body of 
the HWD forms a deep hydrophobic cleft with PPXD, which can be open or close against it (39), 
with the signal sequence binding site at the base(formed by residues from PPXD and IRA1) (39, 
40). The absence of the HWD in SecA2 makes the cleft significantly more open and solvent 
exposed (Figure 2.4), which could help SecA2 recognize its unique substrates that are 
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distinguished by features of their mature domains – possibly a tendency to fold prior to export 
(23).  
The functionally important two-helix finger (2HF), which is a 9-residue loop connecting 
two helices in the IRA1 domain that inserts into the SecYEG pore, is conserved in the MtbSecA2 
structure (residues 695 to 703) (Table 2.2). However, the 2HF loop in MtbSecA2 adopts a 
different three-dimensional conformation compared to previous structures. In the MtbSecA2 
structure, the 2HF is observed to close down approximately 10 Å onto the HSD, like a jaw hinge 
(Figure 2.5), due to differences in how the ends of the helices unwind (even though the 2HF 
amino acid sequence itself is highly conserved, as shown in Table 2.2). This orientation contrasts 
with the conformation observed in most other SecA structure, in which the loop is more flipped 
out into solvent (Figure 2.5); however, the conformations of the 2HF loop are also quite variable 
among SecA crystal structures. Fluorescence studies also suggest that the 2HF loop is flexible 
and can adopt different conformations in solution (37).  
 Similarities between SecYEG binding regions of M. tuberculosis SecA1 and SecA2. The 
conservation of the overall structure of SecA2 is consistent with a model in which SecA2 works 
with SecYEG to translocate SecA2-dependent proteins across the membrane. Furthermore, the 
key regions of SecA2 that would interact with the SecYEG pore are conserved, including the 
2HF. The helix-terminating proline in the 2HFis present in SecA2 (Pro703), as it is in all SecA 
homologs (Table 2.2). Tyr794 in E. coli SecA is another critical residue in the 2HF (36). 
Although it is substituted for by Leu698 in MtbSecA2, this tyrosine is substituted by large 
hydrophobic residues in 20% of SecA homologs (methionine in MtbSecA1). Furthermore, 
structural data from the TmSecA-SecYEG complex supports that hydrophobic substitutions, such 
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as leucine, can be accommodated at this position, as the side chain sits in a hydrophobic pocket 
in SecY (34).  
 Structural superposition of MtbSecA2 onto TmSecA in the TmSecA-SecYEG complex 
(PDB code 3DIN [34]) (Figure 2.6) further indicates that SecA2 preserves many of the structural 
features of SecA implicated in binding to SecYEG. This includes amino acids in the MtbSecA2 
2HF and immediately adjacent regions of IRA1 that contact SecY in the TmSecA-SecYEG 
complex (aa 687 to 715 in SecA2) (Table 2.3 and Figure 2.6). There are also regions of NBD2 
and the HSD that are structurally conserved in the SecA2 structure and positioned for contact 
with SecY (Table 2.3 and Figure 2.6). These residues in NBD2, IRA1, and the HSD are clustered 
at the interface with SecY. In addition, although the PPXD of SecA2 is rotated away and does 
not appear to make direct contact with SecY in the superposition, if it were rotated into an 
orientation similar to that observed in TmSecA in the complex, it would place additional SecA2 
residues (listed in Table 2.3) in contact with SecY, as shown in Figure 2.6. It is notable that 
MtbSecA2 D607 (in the HSD) corresponds to one of the residues in E. coli SecA (position 640) 
that can be cross-linked with SecY using photoactivatable unnatural amino acids (60). 
 Mapping of suppressor mutations on the SecA2 structure. Prior studies indicate that a 
SecA2 dominant-negative protein with an amino acid substitution in the ATP binding Walker 
box, making it unable to bind ATP, is locked in a nonfunctional complex, likely with SecYEG, at 
the membrane (29). In order to identify important residues in SecA2, we identified intragenic 
suppressor mutations that could overcome the secA2 dominant-negative phenotypes (30) with the 
rationale being that such mutations might map to sites of protein interactions in SecA2 
complexes. For convenience, these experiments were performed with the M. smegmatis ortholog 
of SecA2, which has 83% amino acid identity to MtbSecA2 and is able to substitute for the 
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MtbSecA2 in cross-species complementation experiments (29). An M. smegmatis strain 
expressing the dominant-negative MsSecA2 K129R, which has an amino acid substitution in the 
Walker box (equivalent to K115 in MtbSecA2) was used. All suppressors identified reversed the 
severe dominant-negative phenotypes caused by SecA2 K129R, as assessed by azide sensitivity 
assays (5) and colony size on rich agar (30) (Figure 2.7 and data not shown), but they still 
exhibited a phenotype similar to that of a ∆secA2 null mutant. 
 Eight independent suppressors with mutations in the coding sequence of secA2 K129R 
were identified by sequencing, mapping to four different domains: NBD1, NBD2, PPXD, and 
IRA1 (Table 2.4). All eight suppressor mutants produced full-length SecA2 protein at normal 
levels, as confirmed by Western blot analysis. Each mutation was validated to be responsible for 
the suppression by retesting the phenotype of individual mutations when introduced into a fresh 
secA2 K129R mutant background (Figure 2.7).  
 When mapped to the SecA2 structure, all of the suppressor mutations were located on the 
surface of the protein (Figure 2.8). For simplicity, below we will refer to the suppressors using 
amino acid numbering that corresponds to MtbSecA2 (Table 2.4). There were three categories of 
suppressors. The first set of suppressor mutations affected the same surface loop of NBD1. There 
were two suppressors derived from independent cultures with identical mutations in NBD1 and a 
third suppressor with a different mutational alteration that mapped to the same site in NBD1. 




, in M. tuberculosis connecting a 
β-strand and an α-helix; this loop was deleted in one mutant and duplicated in another. It is 
currently unknown what role these residues play, but it is striking that three out of eight 
suppressor mutations involved this surface-localized loop of the nucleotide binding domain, 
suggesting it is a functionally important point of contact for SecA2. 
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 The second group of suppressors (three in total) clustered in the SecA “polypeptide 
clamp” region made up of PPXD and NBD2 domains. Two suppressor mutations mapped to the 
SecA2 PPXD domain: a nonsynonymous substitution, D316H, and an insertion of a second 
glutamate at E354. These amino acids are in separate loops in the PPXD domain, but they are 
proximal in the three-dimensional structure, approximately 7 Å apart (Figure 2.8a). The PPXD is 
positioned far from the NBD2 domain in the SecA2 structure. The distance between the closest 
residues of the two domains is 23 Å, representing a “clamp open” state. However, in the 
TmSecA-SecYEG complex, the corresponding PPXD loops to which these suppressor mutations 
map come in contact with NBD2. Moreover, the TmSecA residue corresponding to the D316H 
suppressor in the MtbSecA2 PPXD is in direct contact with NBD2 in the TmSecA-SecYEG 
complex (34) (Figure 2.8b). It should be noted that this TmSecA complex with SecYEG 
represents an extreme conformation (induced by ADP and BeFx in the crystallization buffer) in 
which the preprotein channel is entirely collapsed (i.e., a loop of the PPXD actually inserts into 
the preprotein binding channel). In a structure of SecA bound to a preprotein substrate (PDB 
code 3JV2 [61]), the PPXD does not rotate quite as far toward NBD2 as in the SecA-SecYEG 
complex, but the residues corresponding to the suppressor mutations are still on the surface of 
the PPXD in a region that would be in position to interact with SecYEG or the lipid bilayer 
(similar to the red residues highlighted in Figure 2.6). Thus, these suppressor mutations could 
disrupt intramolecular interactions when PPXD rotates to form the “clamp” around the 
translocating polypeptide (41) or could lock it in the extreme closed state such that the preprotein 
channel is collapsed altogether. Strikingly, the NBD2 suppressor T449I in M. tuberculosis also 
maps to the SecA “preprotein clamp” region and is proximal (within 10 Å) to the two PPXD 
suppressor mutations when the clamp is closed (based on the analogous residues in the TmSecA-
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SecYEG docked structure [34]) (Figure 2.8b). Thus, these three suppressors in NBD2 and PPXD 
could conceivably cause a defect in clamp closure during translocation. In light of past studies 
suggesting that interactions between SecA2 K129R and SecYEG are responsible for the 
dominant-negative phenotype (30), these results suggest that a defect in clamp closure may 
dislodge or prevent SecA2 interactions with SecYEG by disrupting interactions with the 
polypeptide being translocated through the channel. 
 The final group of intragenic suppressors identified have deletions in IRA1. One 
suppressor has a deletion of residues 714 to 721 in M. tuberculosis and another suppressor has a 
very similar, yet distinct, deletion of residues 712 to 719 in M. tuberculosis. These deletions are 
in the middle of one of the α-helices, just downstream from the 2HF that forms part of the 
interface with SecYEG (Figures 2.5 and 2.7, and Table 2.3), and similar mutations in IRA1 have 
previously been shown to disrupt binding to SecYEG (62). Furthermore, one of the deleted 
residues in both of the IRA1 suppressors is Phe715, which is a conserved residue predicted to 
contact SecY (colored red in Figure 2.6) that is equivalent to the highly conserved Phe798 (in 
TmSecA). In the TmSecA-SecYEG structure, Phe798 (in TmSecA) forms an aromatic stacking 
interaction with Tyr418 in the C-terminal tail of TmSecY (34). This interaction appears to be 
crucial to docking as the equivalent tyrosine residue in E. coli SecY (Tyr429) is the location of a 
cold-sensitive mutation that prevented insertion of SecA into the membrane channel (63). These 
interacting residues are highly conserved in all Sec systems, including MtbSecA2 (Phe715) and 
MtbSecY (Tyr436). The fact that this group of intragenic secA2 suppressor mutants harbors 
deletions in a structurally conserved and critical SecY-interacting region of IRA1 (Figure 2.6 and 
Table 2.3) is consistent with their mode of suppression being avoidance of complex formation 
between SecA2 K129R and SecYEG. 
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 Intragenic suppressors alter membrane localization of the dominant-negative SecA2. In 
the wild type, MsSecA2 is predominantly found in the soluble cytoplasm-containing fraction. In 
contrast, the localization of SecA2 K129R is almost exclusively in the membrane-containing cell 
envelope pellet (29) (Figure 2.9a). This is consistent with a model for SecA2 K129R being 
locked in a protein complex with SecYEG at the membrane. Since we predicted that some of the 
intragenic suppressors alleviate SecYEG interactions, we determined the membrane localization 
of SecA2 K129R in the intragenic suppressor mutant background. Strains were lysed and then 
fractionated into cell envelope (pellet) and soluble (cytoplasmic) fractions. Western blot analysis 
with anti-SecA2 antibodies on fractions was then carried out to localize the protein. In each of 
the representative intragenic suppressors analyzed, the distribution of SecA2 K129R shifted from 
the envelope, as seen in the starting secA2 K129R strain, to the soluble cytoplasmic fraction 
(Figure 2.9b). Suppressor mutations in the “clamp” (PPXD and NBD2) and IRA1 domains had 
the most dramatic effects, restoring partitioning of SecA2 between the cell envelope and 
cytoplasm to almost wild-type levels. These data support a model in which the intragenic 
suppressor mutations alleviate the dominant-negative phenotype by disrupting protein-protein 
interactions involving the SecYEG membrane complex and/or the translocating polypeptide. 
Discussion 
Over 30 years ago, SecA was identified as a critical component of the protein export 
system of bacteria (64). Since that time, there have been extensive genetic, molecular, 
biochemical, biophysical, and structural studies to understand SecA function. Of the two SecAs 
in M. tuberculosis, SecA1 is the counterpart of the well-studied canonical SecA, while SecA2 
has a distinct function from SecA1 and nonoverlapping substrate specificity profile. The 
structure of MtbSecA2 we report is the first structure of any SecA2 protein. The broad structural 
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similarity observed between the two solved MtbSecA structures indicates that, even after decades 
of mechanistic studies, gaps in our understanding of SecA proteins remain. 
 The smaller size of SecA2 versus SecA1 and canonical SecA proteins appears to come 
from the absence of the HWD, the VAR domain and a C-terminal domain (CTD [although it still 
retains the CTL linker]) reducing the overall size of the protein product from 949 aa to 778 aa. 
The lack of an HWD is the most striking structural difference in SecA2. Without the HWD, the 
signal sequence recognition site of SecA2 is more solvent exposed and thus more accessible to 
protein substrates. This structural difference may help explain the ability of SecA2 to export 
substrates with distinctive features of their mature domain, possibly a propensity to fold prior to 
export (23). The “open” nature of the cleft created by the absence of a HWD could provide a 
broad surface against which folded proteins could possibly dock and unfold for translocation 
through the SecYEG transmembrane pore. Several pieces of experimental evidence support the 
possibility that the HWD could interact with preproteins. While a nuclear magnetic resonance 
(NMR) structure of SecA bound to a signal sequence did not identify any residues of the HWD 
that directly interact with the signal sequence (40), several residues of the HWD were found to 
form cysteine-based crosslinks with a synthetic signal sequence (42), which may result from 
transient states (i.e., alternative conformations of the HWD) sampled dynamically in solution. In 
fact, the HWD is observed to rotate by up to 15° between different crystal structures, depending 
on the oligomeric state (39). This suggests the HWD itself is mobile in solution, which is 
supported by fluorescence-based (fluorescence resonance energy transfer [FRET]) studies (65). 
Furthermore, the mobility of the HWD appears to be influenced by the presence of a preprotein 
(66). Thus, the absence of the HWD in SecA2 could potentially affect substrate recognition. The 
70-residue deletion of the HWD observed in MtbSecA2 is a general feature among 
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actinomycetes (including Mycobacterium and Corynebacterium species) . It should be noted that 
other Gram-positive SecA2 proteins also appear to have a truncated version of this domain 
(deletions of 13 to 18 residues for Streptococcus gordonii and L. monocytogenes, respectively). 
Until structures of these other SecA2 orthologs are solved, the potential consequences of these 
HWD truncations remain unknown. It is possible that a reduced HWD could open up the signal 
sequence binding cleft and/or increase the site of interaction with preproteins, as we propose for 
MtbSecA2. To achieve a complete picture of SecA2 function going forward, the consequences of 
a truncated or deleted HWD will need to be explored in both mycobacterial and Gram-positive 
SecA2 proteins.  
The significance of the absence of the VAR domain in the SecA2 NBD region is less 
clear. The lack of the VAR domain leaves the nucleotide-binding site relatively solvent exposed. 
While other SecA2 orthologs also lack the VAR domain, one-third of bacterial SecA (1) proteins 
lack this domain as well (58). In E. coli SecA, the VAR domain has been shown to regulate 
ATPase activity and ADP release, as secA ∆var mutants display higher ATPase activity and 
faster ADP release rates (58). However, MtbSecA2 (28) was recently reported to release ADP 
more slowly (not more quickly) than the VAR-containing MtbSecA1 (67).  
Mycobacterial SecA2 proteins, as well as SecA2s in many other organisms, lack the C-
terminal domain (CTD). The CTD in SecA1 proteins consists of a tail of 70 aa that is disordered 
in all previous crystal structures (1). In most bacteria, the CTD of SecA contains a Zn
2+
 finger 
domain that binds to the protein export chaperone SecB (68). Mycobacteria are an exception, in 
that the CTD of SecA1 does not contain the conserved cysteines of a Zn
2+
 finger motif. However, 
this may not be too surprising because, like Gram-positive bacteria (69), no SecB ortholog with a 




 finger motif in the CTD of SecA1 and lack of a SecB ortholog, the absence of a CTD in 
MtbSecA2 seems unlikely to be a significant contributing factor to the unique function of SecA2.  
In comparison to all prior SecA structures, the SecA2 structure also revealed new 
orientations of the PPXD and the 2HF loop. However, these differences probably reflect the 
conformational plasticity of these two structural elements. Given the mobility of the PPXD 
domain already established for canonical SecA proteins, it seems likely that the PPXD 
orientation observed in SecA2 represents a previously unobserved structural intermediate in the 
transition of the preprotein binding clamp from the open to closed position (38). The unique 
orientation of the 2HF loop observed in SecA2, which occurs at a key point of interaction with 
the translocation channel and varies considerably among SecA structures, is probably a 
consequence of the flexibility of this loop in solution.  
Given that there is no corresponding SecY2 partner in the M. tuberculosis genome, an 
important mechanistic question to be answered is whether SecA2 works with the canonical 
SecYEG channel to export proteins. In prior studies, we described a dominant-negative secA2 
mutation that exhibits more severe phenotypes than a ∆secA2 deletion mutant (29). Such 
phenotypes often result from a dominant-negative protein being locked in a nonproductive 
complex with its normal binding partners. Furthermore, we showed extragenic suppressors that 
overexpress SecY suppress the secA2 K129R
 
dominant-negative phenotype, which argues for an 
interaction between SecA2 K129R and SecY (30). Here, we identified intragenic suppressors of 
secA2 K129R, and all of them mapped to the surface of the SecA2 structure. One group of 
suppressors mapped to the IRA1 domain of SecA2 in regions where similar mutations disrupt E. 
coli SecA binding to SecYEG (62). These IRA1 suppressors also restored cytoplasmic 
localization of SecA2 K129R. These results can be explained by the IRA1 suppressor mutations 
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preventing SecA2 K129R interactions at the membrane SecYEG channel, and they support the 
model for SecA2 working with SecY to promote export of its specific substrates. The 
suppressors that mapped to the “polypeptide clamp” region of SecA could similarly suppress the 
dominant-negative phenotype. However, in this case, the suppression would result from the 
inability of SecA2 to trap the translocating polypeptide in the center of the SecYEG channel, 
causing SecA2 to fail to engage SecYEG (without the substrate) or causing the ternary system 
(SecYEG-SecA2-preprotein) to dissociate.  
The SecA structure reported here is of a monomer. In other studies, SecA proteins have 
been crystallized as monomers (54) or dimers (39), and the issue of the oligomeric state of SecA 
during protein translocation has remained controversial (37, 70–72). A recent study 
demonstrated the ability of recombinant MtbSecA1 and MtbSecA2 to physically interact in vitro 
(73). If SecA1-SecA2 heterodimers form, it is possible that interactions between SecA1 and 
SecY avoid the need of SecA2 to directly interact with SecY. However, it is currently unclear if 
SecA1-SecA2 dimers exist and/or are functional in mycobacteria. Furthermore, the dominant-
negative SecA2 phenotypes and the intragenic suppressors reported here, combined with 
structural conservation of SecA-SecY contact sites in SecA2, argue for the ability of SecA2 and 
SecY to interact. Ultimately, to clarify the mechanistic details of SecA2-dependent protein 
export, it will be necessary to study the pathway with an in vitro reconstitution system, as was 
used to dissect the mechanistic details of the E. coli Sec pathway.  
Since the SecYEG channel requires that proteins be unfolded for translocation (25), the 
possibility of SecA2 working with the SecYEG channel is intriguing, in light of experiments 
suggesting that SecA2 substrates are distinguished by a tendency to fold in the cytoplasm (23). 
The role of SecA2 could be to promote recognition of proteins that would normally be 
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overlooked by the canonical SecA1-SecYEG translocase or to help maintain proteins in an 
unfolded state prior to or during export. The regions of structural difference and suppressor 
mutations identified in this study represent exciting new directions for exploring the functional 




The experiments in this work performed by me are described in Figure 2.7, Table 2.4 and 
Figure 2.9. Other experiments were performed by the authors listed in the footnote on page 47. 
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Table 2.1. Data collection and refinement statistics for SAD (SeMet) structure of SecA2 
Parameter Value(s) for SecA2
a
 
Data collection  
Space group P21 
Cell dimensions  
a, b, c (Å) 39.60, 162.09, 67.31 
α, β, γ (°) 90.00, 95.87, 90.00 
Wavelength (Å) 0.97949 
Resolution (Å) 35.64-2.8 (2.85-2.8) 
Rsym or Rmerge (%) 0.096 (0.171) 
Avg I/𝜎〈𝐼〉𝑐 24.3 (1.4) 
Completeness (%) 0.72 (0.168) 
Redundancy 4.1 (1.9) 
  
Refinement  
Resolution (Å) 2.8 
No. of reflections 16,255 
Rwork/Rfree 0.291 (0.212) 









Bond length (Å) 0.01 
Bond angle (°) 1.26 
a 
Values in parentheses are for the highest-resolution shell. 
b
 RMSD, root mean square deviation. 
c





Figure 2.1. Domain architecture of MtbSecA2. Orange, NBD1; green, NBD2; cyan, PPXD; 





Figure 2.2. Comparison of MtbSecA2 with MtbSecA1. Relative to SecA1 (gray backbone) (PDB 
code 1NL3), SecA2 (tan backbone) is smaller, lacking the HWD (red) and the VAR domain 





Figure 2.3. Comparison of different orientations of the PPXD domain. Shown are MtbSecA2 
(cyan), MtbSecA1 (PDB code 1NL3) (dark blue), B. subtilis SecA (PDB code 1TF2) (yellow), 
and the TmSecA-SecYEG complex (PDB code 3DIN) (red). All four PPXD domains are 
superposed onto the body of MtbSecA2 (orange). At one extreme, in the MtbSecA1 structure 
(right, dark blue), the PPXD is packed against the HWD (missing in SecA2), representing the 
signal sequence-recognition site closed conformation. At the other extreme (left, red), the PPXD 
from the T. maritima complex with SecYEG represents the “preprotein clamp closed” 
configuration, where contact is made with NBD2 (orange, lower left). The MtbSecA2 PPXD 




Figure 2.4. Illustration of how deletion of the HWD in SecA2 makes the signal peptide binding 
cleft more solvent-exposed. B. subtilis SecA (PDB ID: 1TF2) is shown on the left. NMR data 
suggests the signal sequence binds in the cleft formed between the PPXD (cyan), HWD (red), 
and IRA1 (magenta), indicated by the green arrow. MtbSecA2 is shown on the right. The green 
arrow shows the relatively more open signal peptide binding site created by the absence of the 
HWD.   
76 
Table 2.2. Conservation of the 2HF among SecA homologs 
Species Protein Sequence
a 
E. coli SecA1 LRGYAQKDP 
T. maritima SecA1 LRSYGQKDP 
M. tuberculosis SecA1 LRAMAQRDP 
M. smegmatis SecA1 LRAMAQRDP 
M. tuberculosis SecA2 LRALGRQNP 
M. avium SecA2 LRALGRQNP 
M. smegmatis SecA2 LRALGRQNP 
S. aureus SecA2 LRSYAQQNP 
L. monocytogenes SecA2 LRAYGQIDP 
S. gordonii SecA2 LRGYAQNNP 
C. difficile SecA2 LKSYAQKDP 
C. glutamicum SecA2 LRAIARETP 
a 







Figure 2.5. Conformation of the two-helix finger (2HF). The HSD of MtbSecA2 (cyan) is shown 
superposed on the apo structure of MtbSecA1 (purple). The loops connecting the two helices are 





Figure 2.6. Interface residues (red) of MtbSecA2 (tan) that would contact SecYEG (cyan), based 
on superposition with TmSecA (PDB code 3DIN). Note that the red residues highlighted in the 
PPXD correspond to residues of TmSecA that contact SecYEG as its PPXD is rotated into 
contact with SecYEG. 
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Table 2.3. Residues of MtbSecA2 predicted to be in contact with SecY based on structural 
superposition with TmSecA in complex with SecYEG (PDB code 3DIN) 
Domain MtbSecA2 residues predicted to contact SecY 
NBD1 None 
NBD2 E392, R395, Q396 
HSD V600, R604, D607, A610, R614 
IRA1 Most residues spanning 687-715 (includes residues of the 
2HF and surrounding IRA1 helices) 







Figure 2.7. Intragenic suppressors suppress the azide sensitivity phenotype of secA2 K129R. 
Lawns of the indicated strains were plated and tested for sensitivity to 10 μl of 0.15 M sodium 
azide (applied to a paper disk in the center of the plate) for 2 days at 37°C. Average inhibition 
was calculated by measuring the diameter of the zone of azide inhibition, and values are the 
means of three biological replicates. The ΔsecA2 mutant M. smegmatis strain was transformed 
with plasmids containing either secA2, secA2 K129R, or a reconstructed intragenic suppressor 
with the secA2 K129R mutation in combination with an intragenic suppressor mutation located in 
one of the following domains: NBD1, NBD2, PPXD, or IRA1. 
  
81 




 Effect on residue(s) in MsSecA2 Domain Corresponding residue(s) in 
MtbSecA2 
6S, 9S Deletion of residues 182-185 NBD1 168-171 (STPD) 
23S* Duplication of residues 182-185 NBD1 168-171 
2S Asp326 →His PPXD D316 
25S* Glu insertion at residue 364 PPXD E354 
34S* Thr459 →Ile NBD2 T449 
21B* Deletion of residues 734-741 IRA1 714-721 
38S Deletion of residues 732-739 IRA1 712-719 
a





Figure 2.8. Suppressor mutations from MsSecA2 K129R mapped onto (a) MtbSecA2. Mutations 
are shown as yellow spheres. (b) Suppressor mutations mapped onto the TmSecA complex with 
SecYEG (PDB code 3DIN). In the complex with SecYEG, SecA is in the “preprotein clamp 
closed” conformation, in which PPXD (cyan) is swung down (arrow) to make contact with 
NBD2 (green). In this conformation, the residues affected by the suppressor mutations in the 





Figure 2.9. Subcellular localization of SecA2 is altered in intragenic suppressors of secA2 
K129R. Whole-cell lysates of the indicated strains were fractionated into a cytoplasm-containing 
soluble fraction and membrane-containing cell envelope fraction. Representative intragenic 
suppressors (PPXD, NBD2, IRA1, and NBD1) are indicated. Protein derived from an equal 
number of cells was analyzed by SDS-PAGE, and quantitative immunoblot analysis with anti-
SecA2 antibodies was performed. The percentage of localization in a given fraction is plotted. 
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Mycobacterium tuberculosis SatS is a chaperone for the SecA2 protein export pathway 
 
The SecA2 protein export system is critical for the virulence of Mycobacterium 
tuberculosis. However, the mechanism of this export pathway remains unclear. Through a screen 
for suppressors of a secA2 mutant, we identified a new player in the mycobacterial SecA2 
pathway that we named SatS for SecA2 (two) Suppressor. In M. tuberculosis, SatS is required 
for the export of a subset of SecA2 substrates and for pathogenesis. We further identify a role for 
SatS as a protein export chaperone. SatS exhibits multiple properties of a chaperone, including 
the ability to bind to and protect substrates from aggregation. Our structural studies of SatS 
reveal a distinct combination of a new fold and hydrophobic grooves resembling preprotein-
binding sites of the SecB chaperone. These results are significant in better defining a molecular 
pathway for M. tuberculosis pathogenesis and in expanding our appreciation of the diversity 
among chaperones and protein export systems. 
Introduction  
With 1.7 million deaths from tuberculosis in 2016, Mycobacterium tuberculosis continues 
to have a significant impact on world health (1). For M. tuberculosis to cause disease, the 
bacillus must export effector proteins to the host-pathogen interface. These effectors enable M. 
tuberculosis to grow in macrophages and avoid clearance by the host immune response (2). At 
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least some of these effectors are exported by M. tuberculosis via the specialized SecA2 export 
pathway (3). 
The mechanism of SecA2 export remains poorly understood. SecA2 is a paralog of the 
SecA ATPase of the general Sec protein export pathway. The general Sec pathway transports 
preproteins with N-terminal signal sequences across the inner membrane through a channel 
composed of SecY, SecE and SecG proteins (4). Preproteins must be in an unfolded state to 
travel through the SecYEG channel and, in Gram-negative bacteria, the SecB chaperone binds a 
subset of preproteins to maintain them in an unfolded translocation competent state. Following 
export across the membrane, the signal sequence is cleaved and the mature protein is released 
(5). While all bacteria possess an essential Sec pathway that carries out the majority of protein 
export, only mycobacteria and a subset of Gram-positive bacteria possess specialized Sec export 
systems that are defined by a second SecA (6, 7). In these organisms, SecA1 is the name given to 
the canonical SecA and the specialized SecA is named SecA2. For the mycobacterial SecA2 
system, the housekeeping SecYEG channel, and possibly SecA1, as well, are also involved (8, 
9). However, SecA1 and SecA2 are functionally distinct, as shown by their inability to 
compensate for the loss of one another (10, 11), and it remains unclear how SecA2 functions to 
export its relatively small and specific subset of proteins.  
Here, we carried out a suppressor screen using a dominant negative secA2 K129R mutant 
of Mycobacterium smegmatis, a fast-growing model mycobacteria, as a means to identify new 
components of the mycobacterial SecA2 pathway. The K129R substitution is in the ATP binding 
site of SecA2, and past studies lead to a model where SecA2 K129R is defective for SecA2-
dependent export but still able to interact with its normal binding partners that include SecYEG 
(8, 11). As a result, SecA2 K129R disrupts SecYEG channels at the membrane, which hinders 
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both general Sec and specialized SecA2 export as evidenced by more severe phenotypes of 
secA2 K129R than a secA2 null mutation (8). A large collection of secA2 K129R suppressor 
mutations mapped to msmeg_1684, a gene of unknown function that we renamed satS for 
SecA2(two) Suppressor. SatS is also present in M. tuberculosis and, remarkably, the M. 
tuberculosis satS gene is in an operon with the gene encoding SapM, which is a secreted 
phosphatase exported by the SecA2 pathway (12).  
Here, we demonstrate that SatS, which we prove is required for M. tuberculosis growth in 
macrophages, functions in the export of SapM and an additional subset of the proteins exported 
by the SecA2 pathway. We further reveal properties of SatS that indicate a function as a protein 
export chaperone that protects its substrates from inappropriate interactions in the cytoplasm and 
additionally assists in their export. Finally, we determine the structure of the C-domain of SatS 
(SatSC), which reveals a new fold lacking similarities to any solved chaperone structures, yet 
contains surface hydrophobic grooves resembling those of the SecB chaperone. The 
identification of SatS expands our understanding of SecA2 export in mycobacteria and provides 
another example of the diversity of molecular chaperones across biological systems. 
Materials and Methods 
Plasmids, bacterial strains and culture conditions.  
For plasmid construction, PCR products were first ligated into TOPO cloning vectors 
(Invitrogen, Carlsbad, CA), digested with restriction enzymes described in Table 3.1, and ligated 
into their final vectors described in Table 3.2. In all cases, newly constructed plasmids were 
verified by sequencing and diagnostic digests. In the case of SatS G134D plasmids, satSMsm was 
amplified by PCR from the 3S suppressor and satSMtb G134D was designed using site directed 
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mutagenesis (SDM) on the satSMtb complementation plasmid pBM81. Amino acid G134 was 
confirmed to be highly conserved in mycobacterial SatS homologs using ConSurf (13). 
M. tuberculosis and M. smegmatis strains are described in Table 3.3. M. tuberculosis was 
grown at 37°C in Middlebrook 7H9/7H11 supplemented with 1x albumin dextrose saline (ADS), 
0.5% glycerol and 0.025% Tween 80.  M. smegmatis was grown at 37°C or 30°C in Middlebrook 
7H9/7H10 or Mueller-Hinton medium. Media were supplemented with 0.5% glycerol plus 0.2% 
glucose (7H9/7H10 medium only) and 0.05% Tween 80 (all media). For all mycobacteria, the 
antibiotics kanamycin (20 µg/mL) and hygromycin B (50 µg/mL) were added as needed. E. coli 
strains were grown at 37°C in Miller LB broth or on Miller LB agar. The antibiotics kanamycin 
(40 µg/mL) and hygromycin B (150 µg/mL) were added as needed.  





in the same medium and 100 µl were added to 96-well plates. After 24 h 
of growth at 37 °C, resazurin (12.5 µg ml−1 final concentration; Sigma-Aldrich, St. Louis, MO) 
was added and fluorescence with excitation at 530 nm and emission at 590 nm was monitored 
over time. M. tuberculosis growth was monitored by measuring the optical density (OD600) of 
liquid broth cultures over time. 
Suppressor collection and sequencing 
The suppressor screen was performed as described previously (8). Suppressors of the 
secA2 K129R allele were isolated by plating independently grown cultures of the secA2 K129R 
strain onto Mueller-Hinton agar at 37°C. Genomic DNA from six suppressors was submitted for 
whole genome sequencing at the High-Throughput Sequencing Facility at the University of 
North Carolina at Chapel Hill. Sequencing was performed using Illumina GA II technology. 
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Reads were aligned to the M. smegmatis mc
2
155 reference genome (NCBI RefSeq accession 
number NC_008596.1) using SOAP (14). 
M. smegmatis mutant construction 
The M. smegmatis unmarked ∆secA2/∆satS double mutant was created by two-step allelic 
exchange using plasmid pLL50 in the ∆secA2 mutant strain NR116, resulting in strain BAF1. 
Briefly, the suicide plasmid pLL50, containing a hygromycin-resistance selectable marker, a 
sacB counter-selectable marker, and flanking regions for satS was transformed into M. 
smegmatis. Transformants were selected by plating on media containing hygromycin B. 
Hygromycin-resistant transformants were grown to saturation, diluted 1:100 in media lacking 
hygromycin B, and then grown overnight at 37°C. Bacteria in which a second recombination 
event occurred were selected by plating on 7H10 supplemented with 0.2% glucose and 4.5% 
sucrose. BAF1 was assessed for the desired chromosomal deletion by PCR and Southern blot.  
The M. smegmatis unmarked ∆satS single mutant was created by adding back secA2 into 
the BAF1 strain by two-step allelic exchange using plasmid pBM11, resulting in strain BM10. 
BM10 was assessed for the desired chromosomal insertion by PCR and Southern blot. 
Additionally, immunoblots of SecA2 were performed to ensure SecA2 levels were fully restored.  
M. tuberculosis mutant construction 
The satS deletion mutant was created in H37Rv using the specialized transducing phage 
system as previously described (10). Briefly, cosmid pSM42 was created by subcloning satS 
upstream and downstream flanks into pYUB854 surrounding the hygromycin cassette. Cosmid 
pSM42 was ligated into phAE159 to generate recombinant phasmid pSM45. The recombinant 
phasmid, pSM45 was packaged into phage head using a λ in vitro packaging extract kit 
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(Gigapack III XL, Agilent, Santa Clara, CA) and was transduced into E. coli. Phasmid DNA was 
electroporated into M. smegmatis mc
2
155 to make phage (pSM60). Transduced phage was 
plaque purified and amplified for high titer phage lysate. H37Rv was transduced with high phage 
lysate as previously described (10). Transductants were grown at 37
o
C on Middlebrook 7H10 
plates containing hygromycin for 4 weeks. To confirm the satS deletion in transductants, PCR 
and Southern blotting were used.  
Azide sensitivity assays 
Cultures were plated for azide sensitivity as previously described, by mixing 200 μL of a 
saturated culture with 7H9 top agar and pouring over 7H10 agar plates lacking tween in three 
technical replicates (8). The diameter of the zone of inhibition was measured after two days and 
reported as a percentage of the entire plate diameter, yielding percent azide inhibition.  
Subcellular fractionation and Immunoblotting  
Subcellular fractionations of M. smegmatis and irradiated M. tuberculosis were isolated 
as previously described (15, 16). Briefly, cells suspended in 1X PBS containing protease 
inhibitors were lysed by passage through a French pressure cell. Unlysed cells were removed by 
centrifugation at 3,000 x g for 30 min to generate clarified whole cell lysates (WCLs). The 
WCLs were either spun at 100,000 x g for 2 hr to collect the cell envelope fraction containing 
both the cell wall and membrane (ENV) or at 27,000 x g for 30 min to pellet the cell wall 
fraction only (CW). The supernatant following CW isolation was spun at 100,000 x g for 2 hr to 
separate the membrane fraction (MEM) and collect the soluble cytoplasm-containing fraction 
(SOL). Protein concentrations were determined by bicinchoninic acid assay (Pierce, 
ThermoFisher, Waltham, MA).  
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Samples containing equal protein were separated by SDS-PAGE and transferred to 
nitrocellulose membranes. After blocking, proteins were detected using the following antibodies: 
αSatS, αSapM (provided by Vojo Deretic, University of New Mexico), αMce1A (17), αMce1E 
(17), αMce1D (15), α19kD (provided by Douglas Young, Imperial College, United Kingdom), 
αPhoS1 (IT23, NIH Biodefense and Emerging Infections Research Resources Repository, 
NIAID), αPknG (provided by Yossef Av-Gay, University of British Columbia, Canada), αSecA2 
(11), αSigA (provided by Murty Madiraju, The University of Texas Health Science Center 
Tyler), αMspA (16) and αSecY (8). FLAG-tagged proteins were detected with mouse αFLAG 
clone M2 antibody (Sigma-Aldrich) or rabbit αFLAG antibody (Sigma-Aldrich). HA-tagged 
proteins were detected with mouse αHA clone HA-7 (Sigma-Aldrich). αHis (Abgent, San Diego, 
CA) was used to detect the mycobacterial GroEL1 which has a string of endogenous histidines. 
αMouse and αRabbit IgG conjugated horseradish peroxidase secondary antibodies (Bio-Rad, 
Hercules, CA) were used and signal was detected using Western Lightning Plus-ECL 
chemiluminescent detection reagent (Perkin-Elmer, Waltham, MA). 
Culture filtrate protein preparation 
M. tuberculosis culture filtrates were collected as described previously (12). Briefly, 200 
mL cultures were grown in Sauton media at 37°C for 24 hours. The supernatants were double 
filtered through a 0.2 µm filter. Supernatant proteins were concentrated 200 fold using 3,000 
MW cut off centrifuge filters (Amicon) by centrifugation at 3,000 rpm at 4°C. For 
immunoblotting, protein was precipitated overnight at 4°C with 10% trichloroethanoic acid 
(TCA). Protein pellets were washed with acetone, resuspended in 250 uL of 1 x SDS-PAGE 
buffer.  
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For M. smegmatis culture filtrate collection, samples were obtained as previously described 
(16). In brief, 10 mL cultures were grown without Tween 80 to an OD600 nm of 0.4 to 0.7. 
Supernatant was separated from cells first by centrifugation at 3,000 x g and then filtration 
through a 0.2-μm-pore-size filter. Protein from 2 mL of supernatant was TCA precipitated as 
described above and then resuspended in 50 μL of 1× SDS-PAGE buffer. 
Phosphatase activity assay 
SapM activity was assayed as described previously (12, 18). In a 96 well plate, 3 µg of CFP 
protein was diluted with water and added to 10X buffer (1M Tris base pH 6.8) with 20 mM 
Sodium tartrate to reduce background phosphatase activity, and 50 mM p-nitrophenyl phosphate 
(pNPP) for a total volume of 200 µL (New England Biolabs, Ipswich, MA). Tartrate is an 
inhibitor of some phosphatases, but SapM activity is unaffected by tartrate (18). Despite the 
addition of tartrate, the phosphatase assay used is not specific for SapM. The residual activity in 
the ∆secA2 and ∆satS mutants can be attributed to SatS-independent phosphatases. The plate was 
incubated at 37°C in a plate reader, and the absorbance at 405 nm was measured every three 
minutes for four hours. Over the linear portion of the kinetic assay, we calculated the rate of 
pNPP conversion by calculating the slope of the line generated by plotting Abs405 nm as a function 
of time. These slopes were then normalized to the WT rate of change, which we set to 100%.  
Whole cell phosphatase activity assay 
To perform the whole cell phosphatase activity assay, M. smegmatis strains expressing SapM 
(+/- ss) or an empty vector were grown in 7H9 medium to an OD600 of 1, pelleted, and washed 
once in 7H9 medium. Cells were diluted to 6.25 x 10
5
 CFU/mL in 7H9 medium and 160 μL was 
added in triplicate to a 96-well plate. Plates were incubated at 37°C for 24 hours. After 24 hours, 
20 μL of 10X buffer (1M Tris base pH 6.8) with 20 mM Sodium tartrate and 50 mM p-
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nitrophenyl phosphate (pNPP) were added to the wells for a total volume of 200 µL. The plate 
was incubated at 37°C in a plate reader, and the absorbance at 405 nm was measured every three 
minutes for four hours. We calculated the rate of pNPP conversion as described above. 
Macrophage infection 
To assess M. tuberculosis survival in macrophages, 2 x 10
5 
BMDMs from C57BL/6 mice 
were seeded 1 day prior to infection with M. tuberculosis (H37Rv, ∆secA2, ∆satS, or 
∆satS+psatS) at an MOI of 1 as previously described (3, 12). At 4 hours post infection, 
macrophages were washed four times and at the indicated time points were lysed with 0.1% 
Triton X-100. Serial dilutions of the lysates were plated on 7H11 agar plates and CFUs were 
counted three weeks later.  
Reverse transcriptase-PCR 
To assess the operon nature of sapM and satS, RNA was extracted from mid-log phase 
cultures of M. tuberculosis H37Rv (see qRT-PCR for methods). Reverse transcription reaction 
was carried out using iScript cDNA Synthesis Kit (Bio-Rad) and random primers. PCR 
amplification of the intergenic regions on cDNA were performed using specific primers on sapM 
and satS (Supplemental File 1). Controls included primers for the housekeeping gene sigA, PCR 
amplification from genomic DNA, and PCR amplification from RNA lacking reverse 
transcriptase.  
Quantitative Real-Time PCR  
Triplicate M. tuberculosis cultures were grown in modified 7H9 medium to an OD600 of 1 
and RNA was isolated as previously described using a chloroform-methanol and Trizol 
(Invitrogen) extraction (15, 17). RNA samples were treated with DNase (Promega, Madison, WI) 
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and then column purified (Zymo RNA clean and concentrator Kit, Irvine, CA). Following RNA 
isolation, cDNA was synthesized with random primers using the iScript cDNA Synthesis Kit 
(Bio-Rad). Real-time PCR was completed using 25 ng of cDNA template in triplicate technical 
replicates using the SensiMix SYBR and fluorescein kit (Bioline, Toronto, Canada). Transcripts 
were normalized to the housekeeping gene sigA. Primer sequences are provided in Supplemental 
File 1.  
LacZ (β-galactosidase) activity assays 
LacZ activity assays in M. tuberculosis were performed using a modified protocol previously 
described for M. smegmatis (8). Strains were grown in 7AGT to mid-log phase and 800 μL was 
pelleted. Pellets were resuspend in 800 μL Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 
mM KCl, 1 mM MgSO4, 50 mM β-mercaptoethanol), then lysed with 35 μL chloroform and 1 
μL of 0.1% SDS by vortexing for 30 s followed by sonication. 640 µg of o-nitrophenyl-β-D-
galatopyranoside was added to each reaction and mixtures were incubated for 24 minutes at 
room temperature. Reactions were terminated by addition of 400 μL of 1 M Na2CO3. Debris was 
removed by centrifugation at 3,000 rpm for 10 minutes, and the OD420 nm was read from the 
supernatant. LacZ activity (Miller units) was calculated by the following formula: (1000 x OD420 
nm)/([reaction time in minutes] x [culture volume used in the reaction, in mL] x OD600 nm).  
SatS antiserum production 
To generate polyclonal antisera against SatS, purified SatSMtb was produced in E. coli and 
injected into two rabbits using Titermax adjuvant (ThermoFisher). The serum from both rabbits 
was tested against wild-type M. tuberculosis and M. smegmatis and the ∆satS mutants for 
specificity. The serum from rabbit PA6753 recognizes SatSMtb but does not recognize SatSMsm 
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and is only used for SatSMtb. The sera from rabbit PA6754 has a non-specific band at the same 
size as SatSMtb, but recognizes SatSMsm and is only used for SatSMsm.  
Co-immunoprecipitation 
For in vivo co-immunoprecipitation, M. smegmatis cells were transformed with SatSMtb (+/- 
HA) tag and SapM-FLAG (+/- signal sequence). Transformed cells were grown in 50 mL of 7H9 
medium to an OD600 nm of 0.5. Cells were pelleted and resuspended in 2.5 mL 1X PBS buffer 
containing a protease inhibitor cocktail. Cells were lysed by passage through a French pressure 
cell. Unlysed cells were removed by centrifugation at 3,000 x g for 30 min to generate clarified 
whole cell lysates (WCLs). 200 μL of lysate was diluted in 1 mL of 1X PBS + protease 
inhibitors, added to 25 μL anti-HA agarose (Sigma-Aldrich), and mixed end to end at 4°C for 4 
hrs, followed by four washes with 1X PBS. The immunoprecipitated SatS-HA along with co-
immunoprecipitated proteins were eluted in 25 μL of 1X SDS-PAGE buffer, run on 15% SDS-
PAGE gels for 4.5 hours, transferred onto nitrocellulose membranes, and immunoblotted. 
Cloning, expression, and purification of SapM inclusion bodies (IBs) 
The sapM full length gene was PCR amplified from genomic DNA of H37Rv using 
Phusion high-fidelity DNA polymerase and the primers sapM E. coli F and sapM E. coli R. The 
resulting PCR product treated with T4 polymerase and mixed with linear, T4 treated, pMSCG-28 
vector, and transformed into chemically competent BL21 (DE3) cells as previously described 
(19).  
SapM containing a C-His6-tag and tobacco etch virus (TEV) protease cleavage site were 
grown in Luria-Bertani (LB) broth containing 100 µg/mL carbenicillin at 37
o
C to an OD of 0.8 
(A600 nm). SapM expression was induced with the addition of 0.5 mM isopropyl-β-D-
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thiogalactoside (IPTG) and cells were grown for an additional 5 hours at 37
o
C. Cells were 
harvested and resuspended in lysis buffer (40 mM HEPES pH 7.4, 300 mM NaCl, 10 mM 
imidazole). Cells were broken using a high-pressure homogenizer in the presence of protease 
inhibitor cocktail (EMD Millipore, Burlington, MA) and centrifuged at 30,000 x g.  
In order to clarify SapM IBs, a modified protocol was adopted (20). The supernatant obtained 
after cell lysis was decanted and the pellet resuspended in 40 mM HEPES pH 7.4, 2% Triton X-
100, 5 mM EDTA. The suspension was then homogenized using sonication for 3 cycles for 30 
seconds each, centrifuged at 30,000 x g for 15 minutes, and the supernatant decanted. This was 
repeated 3 times to remove cell wall, membrane material, and lipid/membrane associated 
proteins. In the final step, detergent was omitted, and SapM purity of greater than 95% was 
confirmed via SDS-PAGE. 
Protein aggregation assay 
Inclusion bodies of SapM pre protein with a 6X C-terminal His tag were denatured in 8 M 
urea, 40 mM HEPES pH 7.4, 100 mM NaCl, 1 mM EDTA to a final concentration of 150 µM. 
Denatured SapM (1 µL) was rapidly diluted into buffer (150 µL) containing 40 mM HEPES pH 
7.4, 100 mM NaCl, and 1 mM EDTA. Protein aggregation was monitored in the absence or 
presence of SatS at 25
o
C by measuring light scattering in a time dependent manner using a Cary 
Eclipse Varian with excitation and emission at 350 nm.  
Cloning, expression, purification, and crystallization of SatS and SatSC 
The satS and satSC genes were PCR amplified from genomic DNA of H37Rv using 
Phusion high-fidelity DNA polymerase and the primers satS E. coli F, satSC E. coli F, and 
satS/satSC E. coli R. The resulting PCR products were digested with NdeI and HindIII, ligated 
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into Nde/HindIII digested Pet28b vector, and transformed into chemically competent BL21 
(DE3) cells.  
SatS and SatSC with a N-His6-tag and TEV protease cleavage site were grown separately 
in LB broth containing 50 µg/mL kanamycin at 37
o
C to an OD of 0.8 (A600 nm). SatS and SatSC 
expression was induced with the addition of 0.5 mM IPTG and cells were grown for an 
additional 5 hours at 37
o
C. Cells were harvested and resuspended in lysis buffer (40 mM HEPES 
pH 7.4, 300 mM NaCl, 10 mM imidazole). Cells were broken using a high-pressure homogenizer 
in the presence of protease inhibitor cocktail (EMD Millipore) and centrifuged at 30,000 x g. 
SatS and SatSC were purified using a cOmplete His-tag purification resin (Roche, Basel, 
Switzerland), followed by removal of the tag using TEV protease at 25
o
C and further purified by 
size exclusion chromatography using a Superdex 200 26/60 (GE Healthcare, Chicago, IL). 
Protein purity was greater than 95% as determined by SDS-PAGE. Protein concentration was 
measured spectrophotometrically at 595 nm using Bradford reagent.  
Crystals of SatS (20 mg/mL) were produced after screening 768 individual conditions 
using sitting drop vapor diffusion method at 16
o
C with a 50 µL well solution and a drop 
consisting of 1.2 µL of 0.6 µL protein and 0.6 µL of well solution. A single diffraction quality 
crystal appeared within 6 months in 3.5 M ammonium sulfate and 0.1 M sodium acetate 
trihydrate pH 4.6. SatS was indexed into space group P212121 with the unit cell parameters a = 
50, b = 51, c = 76. The unit cell was composed of a single molecule in the asymmetric unit.  
Crystals of SatSC (12mg/mL) were produced after screening 384 individual conditions using 
sitting drop vapor diffusion method at 16
o
C with a 50 µL well solution and a drop consisting of 
1.2 µL of 0.6 µL protein and 0.6 µL of well solution. Initial crystal hits were optimized using 
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hanging drop vapor diffusion method at 16
o
C with a 1 mL well solution and a 4.0 µL drop 
consisting of random ratios of protein to well solution. The highest quality crystals appeared 
overnight in 3.5 M ammonium citrate pH 6.4 and continued to mature for an additional 2 weeks. 
SatSC indexed into space group P212121 with the unit cell parameters a = 50, b = 51, c = 76. The 
unit cell was composed of a single molecule in the asymmetric unit. 
Data collection and structure determination of SatSC 
X-ray diffraction data were collected from a single crystal at beamline 23-ID of the GM/CA-
CAT facilities of the Advanced Photon Source, Argonne National Laboratory. The structure of 
SatS was solved by single-wavelength anomalous dispersion (SAD) using a Bromine (Br) 
derivative. The data was processed and reduced using the HKL3000 software package. A single 
Br site was identified using Phenix HySS, and Phenix AutoSol was used to produce the initial 
electron density map. Simultaneous rounds of model building and structure refinement were 
performed manually in Coot and Phenix Refine. Additional structures of SatSC were solved by 
molecular replacement using the initial structure of SatSC as a model in Phenix Phaser MR. 
Simultaneous rounds of model building and structure refinement were carried out in Coot and 
Phenix Refine.  
Statistical Analyses 
For comparisons between the groups for the determination of (i) phosphatase activity in 
the mycobacterial culture filtrates, (ii) whole cell phosphatase activity (iii) ‘lacZ reporter fusions 
and (iv) growth in macrophages, one-way analysis of variance (ANOVA) with the Tukey post 
test was employed. For the statistical analysis and generation of graphs, Prism 5 software 
(version 7; GraphPad Software Inc., CA) was used.  
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Results 
satS suppressors of secA2 K129R  
A secA2 K129R mutant of M. smegmatis exhibits more exacerbated phenotypes (i.e. 
azide sensitivity and poor growth on Mueller-Hinton agar) than a secA2 deletion mutant (8) 
(Figure 3.1A). Starting with cultures of ∆secA2 expressing the secA2 K129R allele on an 
integrating plasmid (this strain is referred to as secA2 K129R from hereon), we collected 
spontaneous suppressor mutants that restored growth on Mueller-Hinton agar. Whole-genome 
sequencing of six extragenic suppressors revealed mutations in the same gene msmeg_1684 
(Figure 3.1B). Three additional suppressors with mutations in msmeg_1684 were identified by 
directly sequencing the msmeg_1684 gene and upstream sequence in our pool of suppressors 
(Figure 3.1B). Msmeg_1684 is a highly acidic protein (pI 3.83) of unknown function with 
conserved homologs in all mycobacterial species, as well as other actinomycetes (21). However, 
no homologous proteins exist outside of actinomycetes and Msmeg_1684 does not have any 
conserved domains to predict function. Henceforth, we refer to msmeg_1684 as satS (secA2 
(two) suppressor). 
Seven of the nine suppressor mutations in satS were expected to be loss-of-function 
mutations (i.e frameshifts or truncations). To validate that loss of satS suppresses secA2 K129R 
phenotypes, we deleted satS in the secA2 K129R mutant background. For future experiments, we 
also constructed a ∆satS mutant in a secA2
+
 background. The ∆satS mutant has no in vitro 
growth defect compared to wild-type M. smegmatis mc
2
155 (Figure 3.2A). Deletion of satS 
suppressed the exacerbated phenotypes of secA2 K129R, and the suppression phenotype of satS 
could be complemented, as demonstrated by restoration of the severe secA2 K129R phenotypes 
upon adding back a copy of satS from M. smegmatis (Figure 3.1C). Complementation was also 
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successful with the M. tuberculosis satS homolog rv3311 indicating that SatS function is 
conserved in M. smegmatis and M. tuberculosis (Figure 3.1C).  
Unlike wild-type SecA2, which is predominantly in the cytoplasm, the majority of SecA2 
K129R is localized to the membrane-containing cell envelope fraction, consistent with SecA2 
K129R being trapped in a non-functional complex with SecYEG (11). We assessed the ability of 
∆satS to suppress the mislocalization of SecA2 K129R. Using immunoblot analysis of cell 
envelope (cell wall and membrane) and soluble (cytoplasm) fractions with SecA2 antibodies, we 
observed that the absence of SatS suppressed the aberrant localization of SecA2 K129R (i.e. in 
the ∆satS/secA2 K129R strain) such that SecA2 K129R was now primarily localized to the 
cytoplasm, similar to wild-type SecA2 (Figure 3.1D). We immunoblotted for the cell wall MspA 
porin and the cytoplasmic GroEL protein as fractionation controls (Figure 3.2B). SecA2 K129R 
is also associated with reduced levels of SecY, which is a presumed mechanism to eliminate 
jammed SecA2 K129R-SecYEG channels (8).  When we immunoblotted fractions from the 
∆satS/secA2 K129R strain with SecY antibodies, we observed that the absence of SatS 
suppressed the SecA2 K129R effect on SecY levels. Both the rescued localization of SecA2 
K129R and SecY levels observed in the ∆satS mutant background could be complemented by 
introduction of satSMsm (Figure 3.1D and 3.1E). These results indicate that SatS is required for 
SecA2 K129R retention at the membrane in non-productive complexes with SecYEG. By 
extension, these results suggest a role for SatS in the SecA2 export pathway.  
SatS is required for export of the SecA2-dependent SapM phosphatase  
In M. tuberculosis, the gene encoding SatS is immediately downstream of the gene 
encoding SapM. Reverse transcriptase (RT) PCR performed on RNA from wild-type M. 
tuberculosis strain H37Rv was used to demonstrate that sapM and satS are in an operon (Figure 
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3.3). This genomic arrangement is striking as SapM, a secreted phosphatase of M. tuberculosis is 
exported by the SecA2 pathway (12). While SapM does not have an ortholog in M. smegmatis, 
we identified 26 different mycobacterial species in which the sapM-satS gene arrangement is 
conserved (22).  
We constructed a ∆satS mutant of M. tuberculosis H37Rv to test if SatS is required for 
SapM secretion. The ∆satS mutant of M. tuberculosis did not exhibit an in vitro growth defect 
(Figure 3.4A). We monitored SapM secretion into culture media by immunoblotting culture 
filtrates prepared from H37Rv, the ∆secA2 mutant, the ∆satS mutant, and the ∆satS mutant 
complemented with satSMtb using SapM antibodies. As expected, a SapM secretion defect was 
observed in the ∆secA2 mutant. Even more striking was the SapM secretion defect of the ∆satS 
mutant, which was reproducibly more severe than the ∆secA2 mutant (Figure 3.5A). This 
phenotype could be complemented with a satSMtb plasmid (Figure 3.5A). As controls, we 
immunoblotted for the19kDa lipoprotein, which is exported in a SecA2-independent manner and 
was not affected by the ∆satS mutant, and also for the cytoplasmic SigA protein to rule out cell 
lysis contaminating the culture filtrates. Since SapM is a phosphatase, we also quantified SapM 
secretion by measuring phosphatase activity in the culture filtrates, using p-Nitrophenyl 
Phosphate (PNPP) as a substrate. Consistent with the immunoblot data, there was significantly 
less phosphatase activity in the supernatant of a ∆secA2 mutant compared to H37Rv, the ∆satS 
mutant exhibited an even more severe reduction in secreted phosphatase activity, and the ∆satS 
mutant phenotype could be complemented (Figure 3.5B). These results extend our identification 
of SatS as a SecA2 suppressor in M. smegmatis by revealing a role of SatS in the SecA2-
dependent secretion of SapM by M. tuberculosis. 
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Even though M. smegmatis lacks a SapM orthologue, when we expressed M. tuberculosis 
sapM in M. smegmatis, SapM was also secreted in a SecA2 and SatS dependent manner (Figure 
3.5C). Again, the SapM secretion defect of a ∆satS mutant was more severe than that of a 
∆secA2 mutant, and this phenotype could be complemented (Figure 3.5C). This result indicates 
functional conservation of SatS in M. smegmatis and M. tuberculosis, and it indicates that the 
more amenable M. smegmatis is a valid model for studying SatS function in SapM secretion.  
To develop a higher throughput and more quantitative method for monitoring SatS and 
SecA2-dependent secretion, we established a whole cell assay for measuring secreted SapM 
phosphatase activity from M. smegmatis grown in 96 well plates. Importantly, this assay is 
specific for secreted SapM; it did not detect cytoplasmic SapM, as demonstrated by background 
levels of phosphatase activity of a M. smegmatis strain expressing non-exported cytoplasmic 
SapM lacking a signal sequence (∆ss-SapM). In contrast, M. smegmatis expressing full length 
SapM preprotein, which is secreted, exhibited significantly greater activity (Figure 3.5D). When 
the ∆secA2 mutant and the ∆satS mutant were tested in this whole cell phosphatase assay, the 
results confirmed the immunoblot data. Secreted phosphatase activity was reduced in both ∆satS 
and ∆secA2 mutants, and the reduction was significantly more dramatic in the satS mutant 
(Figure 3.5D). The reduced activity of the ∆satS mutant could be complemented with either 
SatSMtb or SatSMsm (Figure 3.5D).  
Mce proteins exported by the SecA2 pathway require SatS for their export 
We tested if SatS is required for the export of additional SecA2 substrates. Multiple 
protein components of Mce transporters, which import lipids, depend on SecA2 to be exported to 
the cell wall (17). Immunoblot analysis of M. tuberculosis samples with Mce1A and Mce1E 
antibodies revealed that the levels of Mce1A and 1E were reduced in cell wall of a ∆satS mutant 
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(Figure 3.5E), with the defect in the ∆satS mutant again being more severe than the ∆secA2 
mutant. Mce importers are conserved in M. smegmatis and similar results were obtained upon 
immunoblotting M. smegmatis cell wall fractions with a Mce1D antibody (Figure 3.5F). The 
same effect was seen when a Mce4A-HA protein was expressed in M. smegmatis and localized 
to the cell wall (Figure 3.5F). In contrast to these results, the level of the SecA2-independent 19 
kDa lipoprotein in M. tuberculosis and MspA porin in M. smegmatis were unchanged in cell wall 
fractions of ∆satS mutants (Figure 3.5E and 3.5F).  
We next tested whether SatS contributes to export of the SecA2-dependent protein kinase 
PknG and solute binding protein PhoS1 of M. tuberculosis, as well as the solute binding protein 
Msmeg1704 of M. smegmatis (16, 17, 23). Immunoblotting of cell wall fractions confirmed that 
PknG, PhoS1, and Ms1704 depend on SecA2 for export; however, export of these proteins was 
not impaired in a ∆satS mutant (Figure 3.5G and 3.5H). These data demonstrate a level of 
specificity in the exported proteins affected by SatS. SatS affects multiple, but not all, of the 
proteins exported by the SecA2 pathway.  
SatS is required for M. tuberculosis growth in macrophages  
The dramatic reductions in export of SapM and Mce proteins in the ∆satS mutant 
suggested that SatS is required for the pathogenesis of M. tuberculosis. SapM functions in 
limiting M. tuberculosis delivery to degradative lysosomes in macrophages while Mce proteins 
import lipids and thereby contribute to M. tuberculosis growth in macrophages and persistence in 
the host (24-26). To test a role for SatS in pathogenesis, we infected murine bone marrow-
derived macrophages with M. tuberculosis H37Rv, the ∆secA2 mutant, ∆satS mutant, or ∆satS 
mutant complemented with satSMtb, and compared intracellular growth over time by plating 
macrophage lysates for viable bacilli. Compared to H37Rv, the ∆satS mutant demonstrated a 
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significant defect in intracellular growth that was comparable to the previously demonstrated, 
attenuated phenotype of the ∆secA2 mutant, and the ∆satS mutant phenotype could be 
complemented (Figure 3.6) (3, 27). Thus, like SecA2, SatS plays an important role in enabling 
M. tuberculosis growth in macrophages even though only a subset of SecA2 substrates are 
affected by SatS.  
SatS effects on cellular levels of its substrates 
In addition to the reduced levels of SapM and Mce protein in exported locations (culture 
filtrates and cell wall fractions), the total cellular (i.e. in whole cell lysate) and cytoplasmic levels 
of these proteins were dramatically reduced in the M. tuberculosis ∆satS mutant compared to 
H37Rv, the ∆secA2 mutant and the complemented ∆satS strains (Figure 3.7A and 3.7B). 
Notably, the reduction observed in the ∆satS mutant differed from a modest intracellular 
reduction of SapM and Mce1 proteins in the ∆secA2 mutant (Figure 3.7A and 3.7B). The effect 
of SatS on cellular SapM and Mce1 levels was specific, as the cellular levels of the 19 kDa 
lipoprotein were equivalent across strains (Figure 3.7A). The same results were obtained with 
SapM-expressing M. smegmatis strains (Figure 3.7C).  
The reduced cellular and cytoplasmic levels of SapM and Mce proteins in the ∆satS 
mutant could suggest transcriptional or translational effects of SatS on these proteins or that SatS 
acts post-translationally to stabilize the proteins prior to their export. Using quantitative Real-
Time PCR (qRT-PCR) (Figure 3.8A) and a translational sapM’-‘lacZ fusion (Figure 3.8B), we 
ruled out the possibilities of SatS functioning in transcription or translation. There was no 
difference in the level of sapM transcript or translation in the M. tuberculosis ∆satS mutant 
compared to H37Rv. Thus, the effect of SatS on SapM levels in the cytoplasm is post-
translational and the likely consequence of SatS protecting SapM prior to export. Notably, 
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protein export chaperones of Type III and Type VII secretion systems (T3SS and T7SS) exhibit 
this behavior of stabilizing their substrates in the cytoplasm and protecting them from 
degradation prior to assisting in their secretion (28, 29). Thus, we considered the possibility that 
SatS serves as a protein export chaperone for its specific substrates.  
SatS and SapM interact 
We next tested whether SatS interacts with SapM in mycobacteria, as required for a 
chaperone:substrate pair, using co-immunoprecipitation experiments. Immunoprecipitations were 
performed from M. smegmatis strains co-expressing C-terminally tagged SapM-FLAG and C-
terminally tagged SatS-HA proteins. These epitope tags did not disrupt SapM or SatS functions 
(Figure 3.9A and 3.9B).  
Reasoning that it may be easier to detect a SatS-SapM interaction when SapM export was 
compromised, we first performed co-immunoprecipitations in a ∆secA2 mutant background. For 
these experiments we used a ∆secA2/∆satS double mutant expressing SatSMtb +/- HA tag and 
SapM-FLAG and immunoprecipitated from whole cell lysates using anti-HA agarose. The 
resulting immunoprecipitates were analyzed by immunoblotting with FLAG antibodies to detect 
SapM and SatS antibodies to detect SatS. SapM-FLAG was detected in the immunoprecipitates 
of the samples from the strain expressing SatSMtb-HA (Figure 3.10A) indicating SatS and SapM 
interact. As a control, SapM-FLAG was not recovered when the anti-HA immunoprecipitation 
was performed from a strain expressing untagged SatSMtb. Using high percentage (15%) SDS-
PAGE, we are able to detect two SapM-FLAG species: a ~31 kDa product corresponding to full 
length preproptein and a ~29 kDa product corresponding to the cleaved exported product. We 
confirmed the assignment of the smaller species as mature, cleaved SapM by immunoblotting 
lysate from a strain expressing ∆ss-SapM-FLAG (Figure 3.10A). It is striking that while the 
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smaller exported species is more abundant in the input lysate, the full length preprotein SapM 
was the species that co-immunoprecipitated with SatS (Figure 3.10A). This is consistent with 
SatS interacting with SapM preprotein in the cytoplasm, prior to its export and signal sequence 
cleavage. We investigated whether the signal sequence of SapM is required for the SatS-SapM 
interaction by immunoprecipitating from a strain co-expressing SatS-HA and ∆ss-SapM-FLAG. 
SatS-HA and ∆ss-SapM-FLAG co-immunoprecipitated indicating that the signal sequence of 
SapM is not required for the SatS-SapM interaction (Figure 3.10A). 
We were also able to co-immunoprecipitate SapM-FLAG with SatS-HA from cell lysates 
of a M. smegmatis ∆satS strain expressing the same constructs (i.e. a secA2 wild-type 
background), although there was reproducibly less SapM-FLAG recovered when export was not 
inhibited (Figure 3.10B). Once again, the SapM preprotein species preferentially co-
immunoprecipitated. To address the specificity of SatS interacting with SapM, we also 
immunoblotted SatS immunoprecipitates with antibody to MspA, which is a cell wall porin that 
is exported in a SecA2 and SatS-independent manner (16, 30) (Figure 3.5F). MspA did not co-
immunoprecipitate with SatS (Figure 3.10B). 
The interaction between the preprotein species of SapM and SatS implies that SatS is a 
cytoplasmic protein. Using an antibody raised against SatS, we confirmed that in both M. 
tuberculosis and M. smegmatis SatS is cytoplasmic (Figure 3.4B and 3.2B ). Interestingly, SatS 
in M. tuberculosis and M. smegmatis migrated on SDS-PAGE at ~65 kDa rather than at its 
predicted molecular weight of 46 kDa. SatS purified from Escherichia coli also ran at 65 kDa 
(data not shown). 
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SatS functions prior to SecA2 
If SatS functions as a chaperone for preproteins exported by the SecA2 pathway, we 
predicted its role should come before the role of SecA2 in exporting SapM across the membrane. 
To test this order of events, we constructed a M. smegmatis ∆secA2/∆satS double mutant 
expressing SapM-FLAG and compared the cellular and secreted levels of SapM of the double 
mutant to the corresponding single ∆secA2 or ∆satS mutants. If SatS acts prior to SecA2 in 
exporting SapM, the ∆satS mutation should be epistatic to the ∆secA2 mutation, which proved to 
be the case. The ∆secA2/∆satS double mutant exhibited the equivalent dramatic reduction in 
cellular and secreted levels of SapM as exhibited by the ∆satS mutant (Figure 3.11A and 3.11B). 
Further, there was no additive effect evident on the SapM secretion defect in the ∆secA2/∆satS 
double mutant compared to the ∆satS mutant (Figure 3.11B).  
SatS behaves as a chaperone to prevent SapM aggregation  
The data so far is consistent with the hypothesis that SatS functions as a chaperone for a 
subset of SecA2 dependent substrates. The hallmark of a chaperone is that it binds to unfolded 
regions of proteins to prevent inappropriate interactions, such as aggregation (31). To obtain 
more direct evidence for chaperone activity of SatS, we purified SatSMtb and SapM-His from E. 
coli and tested the ability of SatS to prevent aggregation in vitro of SapM-His preprotein 
(containing the signal sequence). SapM-His was solubilized from inclusion bodies using 8 M 
urea, rapidly diluted into refolding buffer (150 fold), and its aggregation was followed by change 
in light scattering at 350 nm. In the absence of SatS, dilution of denatured SapM-His rapidly led 
to the formation of light scattering aggregates (Figure 3.12). However, inclusion of SatS in the 
dilution buffer prevented SapM-His aggregation in a dose-dependent manner (Figure 3.12). As 
controls, BSA and lysozyme did not reduce SapM-His aggregation (Figure 3.12). A SatS:SapM-
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His molar ratio of 2.5:1 was sufficient to completely ablate SapM-His aggregation and even a 
0.5:1 ratio was sufficient to reduce aggregation by 33%. The data from this in vitro anti-
aggregation assay provides strong support for SatS acting as a chaperone and for a direct 
interaction between SatS and SapM preprotein. 
SatS has a new fold and hydrophobic grooves that share similarity with the preprotein binding 
sites of the SecB chaperone 
Although the amino acid sequence of SatS bears no similarity to any known chaperones, 
the data above supports a role for SatS as a protein export chaperone. To gain further insight into 
SatS function, we collected diffraction quality crystals and determined the crystal structure of 
SatS to 2.3 Å (Table 3.4). Upon inspection, the electron density map only corresponded to the 
last 185 amino acids (L237-E420) C-domain of the SatS sequence (SatSC). The molecular weight 
of the SatSC crystal was ~25 kD as determined by SDS-PAGE, indicating that the protein 
underwent in situ proteolysis in the crystallization buffer. Further investigation revealed striking 
similarity between the experimentally derived SatSC secondary structure and the predicted 
secondary structure of the first ~180 amino acids of the N-domain of SatS (SatSN) (Figure 3.13A 
and 3.13B). The SatSC and SatSN domains are also similar in size with 41% sequence similarity 
at the amino acid level (Figure 3.13A and 3.13B). This raises the possibility that SatS is 
composed of two similar domains with an intervening ~60 amino acids that is predicted to be a 
flexible, disordered linker (Figure 3.13A and 3.13B). Subsequently, constructs expressing SatSC 
or SatSN in E. coli were used to purify the individual domains to homogeneity for crystallization 
trials. Currently, only SatSC has yielded diffraction quality crystals diffracting to 1.4 Å resolution 
(Table 3.4).  
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SatSC displays α/β secondary structure composed of a mostly parallel, four stranded β-
sheet core, flanked by seven α-helices (Figure 3.14A). The structure revealed a new fold sharing 
no similarities with any previously solved protein structure in the PDB based on DELTA-
BLAST and VAST similarity searches (32, 33). Although the overall polypeptide fold is not 
similar to known proteins, the surface of SatSC has pronounced electronegative charge potential 
that is comparable to many export chaperones, including SecB (34). Furthermore, the SatSC 
structure features two surface localized hydrophobic grooves, mapped by the Kyte-Doolittle 
hydrophobicity scale (35) (Figure 3.14B), that bear similarity to the hydrophobic grooves on 
SecB (Figure 3.14C and 3.14D) that serve as primary and secondary client binding sites to 
regions of unfolded preproteins (36). The proximity of the smaller hydrophobic groove in SatSC 
(Site 2) to the larger groove in SatSC (Site 1) as well as their amino acid composition (aromatic 
and bulky side chains) resemble the arrangement and composition of the client binding sites of 
SecB. Further, the larger of the two hydrophobic grooves in SatSC (Site 1) spans nearly the entire 
length of the domain and is comparable in total size to the ~60 Å long, main binding site in 
SecB. Because of the similarities between SecB and SatSC, we speculated that SatSC may be 
sufficient to perform SatS chaperone functions. In fact, when we tested SatSC for chaperone 
activity in the in vitro anti-aggregation assay, SatSC alone was sufficient to ablate SapM-HIS 
preprotein aggregation comparable to full length SatS (Figure 3.12).  
SatS has at least two separable roles in protein export 
The majority of satS suppressor mutations severely truncate SatS and are expected to 
behave like satS null mutations (Figure 3.1B). However, one mutation (3S) that caused a single 
amino acid substitution (G134D) produced wild-type levels of full length SatS protein when 
compared to wild-type SatS expressed from the same vector backbone (Figure 3.15A). Using this 
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expression plasmid, we tested the importance of the G134 residue, which maps to the SatSN 
domain and is ubiquitous in SatS homologs in mycobacteria.  
We first tested if satS G134D could complement the SapM-FLAG secretion defect of the 
M. smegmatis ∆satS mutant by immunoblotting culture filtrates. Since SatS G134D behaved like 
the ∆satS null mutant in suppressing secA2 K129R, we predicted that SatS G134D would fail to 
complement the SapM secretion defect of the ∆satS mutant. Along these lines, SatS G134D 
exhibited a SapM secretion defect (Figure 3.15A); however, the SapM secretion defect was 
comparable to the level of secretion in the ∆secA2 mutant. Using the whole cell secreted 
phosphatase activity assay, expression of either SatSMsmG134D or SatSMtbG134D in the ∆satS 
mutant resulted in a partial defect in secreted SapM, on the level exhibited by the ∆secA2 mutant 
(Figure 3.15B). These results reveal satS G134D to have a secretion defect, although the defect is 
comparable to that of a ∆secA2 mutant not a ∆satS mutant. 
We also evaluated the effect of SatS G134D on cellular SapM levels. To our surprise, 
satS G134D did not behave like a ∆satS mutant.  Rather, it fully complemented the dramatic 
∆satS reduction in SapM levels seen in whole cell lysates (Figure 3.15A). Furthermore, we were 
able to co-immunoprecipitate SatS G134D-HA and SapM-FLAG preprotein (Figure 3.15C) 
indicating that SatS G134D retains the ability to interact with SapM-FLAG. Our discovery that 
SatS G134D still binds SapM preprotein and maintains cellular levels of SapM, yet SatS G134D 
exhibits a defect in SapM secretion equivalent to that of a ∆secA2 mutant, indicates that SatS has 
more than one role in SapM secretion by the SecA2 pathway. Moreover, these multiple functions 
of SatS in export can be uncoupled.  
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Discussion 
As with all bacterial pathogens, the protein export pathways of M. tuberculosis are 
critical to virulence. Here, we identified SatS, a previously uncharacterized protein of unknown 
function, as a new protein export factor with a role in intracellular growth of M. tuberculosis. We 
further discovered multiple properties of SatS that indicate a function as a protein export 
chaperone. As the amino acid sequence of SatS bears no similarity to chaperones and the 
structure of the SatSC domain reveals a new fold, SatS appears to represent a new type of protein 
export chaperone.  
Suppressor analysis led to the identification of SatS 
Suppressor analysis is a classic approach for identifying genes in pathways, and it was 
used extensively in early studies of the general Sec pathway in E. coli (37, 38). Here, we carried 
out a suppressor screen using secA2 K129R, which encodes a variant of SecA2 that is unable to 
hydrolyze ATP (11). Past studies lead to a model where SecA2 K129R is locked in a 
nonfunctional complex with SecY while attempting to export its substrates (8). As a result, 
SecA2 K129R is trapped at the membrane and SecY proteins are degraded (8). Our discovery 
that loss-of-function satS mutations suppress secA2 K129R phenotypes suggests that SatS is 
required for the detrimental interaction of SecA2 K129R with SecYEG to occur. In fact, deletion 
of satS significantly reversed SecA2 K129R retention at the membrane and the associated SecY 
degradation, which is consistent with avoidance of the interaction. By extension, these results 
support a role for SatS in enabling wild-type SecA2 to interact with the SecYEG channel.  
One possibility for how SatS promotes SecA2 interactions with the SecYEG channel is 
that in order for SecA2 to be delivered to or engage the SecYEG channel it must first be bound 
to a substrate in a translocation competent state and that SatS functions as a protein export 
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chaperone that facilitates this SecA2-substrate interaction. We favor this role for SatS as it would 
not only explain why phenotypes of secA2 K129R depend on the presence of SatS but it is also 
consistent with our identification of an interaction between SatS and SapM and the chaperone 
activities of SatS. An alternate possibility is that SatS is a core component of a SecA2-specific 
export apparatus with a function mediating the interaction between SecA2 and SecYEG. 
However, if SatS were to function this way, we would expect all SecA2-dependent substrates 
would require SatS for export, which was not the case.  
SatS as a protein export chaperone  
Molecular chaperones are defined by their ability to transiently bind unfolded regions of 
proteins and, thereby, protect them from inappropriate interactions, such as aggregation, 
incorrect/premature folding or degradation (31). Chaperones are a common component of protein 
export systems, with SecB of the general Sec pathway in Gram-negative bacteria and Type III 
Secretion System Chaperones (T3SCs) being the best characterized examples. In mycobacteria, 
EspG proteins of Type VII Secretion Systems are the only protein export chaperones identified 
so far (39, 40). As a subset of molecular chaperones, protein export chaperones have additional 
functions in export, such as targeting substrates to export machinery. Although there is a notable 
lack of amino acid and structural similarity between different types of protein export chaperones, 
commonalities exist. Protein export chaperones are all highly acidic (pI<5.0) proteins that 
transiently interact with their substrates in the cytoplasm and remain in the cytoplasm when the 
substrate is exported (28, 40, 41) . Additionally, a hallmark of a protein export chaperone is that 
its role is limited to a subset of the proteins exported by a given system (39, 42, 43). Finally, in 
some cases, the genes encoding the chaperone and substrate are co-expressed and in an operon 
(44).  
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SatS has many features of a protein export chaperone. SatS is a highly acidic (pI 3.83), 
cytoplasmic protein with a role promoting export of a subset of the proteins exported by the 
SecA2 pathway. Further, the satS and sapM genes are co-transcribed in an operon and we 
obtained evidence of a SatS:SapM interaction occurring in mycobacteria. SatS preferentially 
interacted with the full-length preprotein of SapM indicating that the interaction occurs in the 
cytoplasm prior to SapM export. However, like other protein export chaperones (T3SCs, SecB, 
and EspG5) (40, 45, 46) where binding occurs in regions of the mature domain of the substrate, 
the signal sequence was not required for the SatS-SapM interaction. Finally, the in vitro anti-
aggregation effect of SatS on SapM preprotein provided the most direct proof of a SatS:SapM 
interaction and a chaperone function for SatS. 
Along with the above chaperone features, in the absence of SatS, the level of SapM in the 
cytoplasm was dramatically reduced. This effect of SatS on intracellular SapM levels is post-
translational and reminiscent of effects of T3SCs and EspG chaperones protecting their cognate 
substrates from degradation prior to export (29, 43). In comparison to the dramatic reduction in 
intracellular SapM in the ∆satS mutant, the ∆secA2 mutant exhibited only a modest effect on 
intracellular SapM levels. This difference explains why the ∆satS mutant secretion defect was 
much more dramatic than that of the ∆secA2 mutant.  
Because of the dramatically reduced levels of SapM in the whole cell lysate of the satS 
mutant, it was not immediately clear if the role of SatS in SapM secretion was solely to maintain 
intracellular levels of SapM preprotein or if SatS had additional roles. By evaluating the satS 
G134D mutant, we revealed the existence of at least one additional role for SatS in promoting 
SapM secretion. In the satS G134D mutant, intracellular SapM was maintained at wild-type 
levels; yet, there remained a SapM secretion defect. Future studies should address this second 
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function, which could be a role for SatS in targeting substrates to the SecA2 pathway and/or in 
maintaining SapM in an unfolded state for protein translocation across SecYEG.  
The SatS structure defines a new fold with hydrophobic grooves typical of substrate binding sites 
Although we set out to solve the structure of SatS in its entirety, we were only able to 
obtain structural information for the C-terminal half of the protein (SatSC), which arose during 
crystallization. However, the primary sequence and secondary structure similarity between the 
N-terminal and C-terminal halves of SatS raise the interesting possibility of SatS being 
composed of tandem SatSC-like domains. Investigation of the SatSC structure revealed a large 
network of negatively charged amino acids surrounding two surface exposed hydrophobic 
grooves, which are similar in arrangement, shape and size to the hydrophobic client binding sites 
of a SecB monomer (45). In the solution structure of SecB in complex with a preprotein, the 
unfolded preprotein wraps around the SecB tetramer through interactions with the hydrophobic 
client binding sites. This binding architecture helps explain the means by which SecB maintains 
Sec preproteins in an unfolded state, as is required for their transport through the SecYEG 
channel (5). The similarity in hydrophobic grooves in SatS and SecB is intriguing since SatS 
works with the SecA2 pathway, which also uses the SecYEG channel. Moreover, these 
similarities suggest that the hydrophobic grooves in SatS may serve as similar substrate binding 
sites. In fact, in the anti-aggregation assay the SatSC domain was sufficient for preventing SapM 
aggregation, indicating that SatSC is capable of directly interacting with SapM. Mycobacteria 
lack a canonical SecB protein export chaperone, although in M. tuberculosis there is a SecB-like 
protein that functions as a chaperone for a toxin-antitoxin system (47). Thus, even though SecB 
and SatS are not evolutionarily conserved, it is interesting to speculate a SecB-like function for 
SatS in the mycobacterial SecA2 pathway. It may be that SatS is a specific adaptation of the 
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mycobacterial/Actinomycetales SecA2 systems, since SecA2 systems outside of the order 
Actinomycetales do not have SatS orthologs 
SatS is required for growth of M. tuberculosis in macrophages 
Prior TraSH/Tnseq analyses using pooled libraries of transposon mutants predicted SatS 
to be required during murine and macrophage infections (48, 49); however, this prediction had 
never been validated. Here, using a ∆satS mutant and a complemented strain, we directly 
demonstrated a role for SatS in M. tuberculosis growth in macrophages. This data argues for an 
important role of SatS and its specific substrates in pathogenesis.  Given that only a subset of 
SecA2 substrates are affected by SatS, future studies should include investigation of SatS 
substrates and their contribution to pathogenesis. Since our approach for identifying SatS 
substrates was not exhaustive, there may also exist SatS-dependent proteins that remain to be 
identified. 
Conclusion  
By way of a genetic screen in M. smegmatis, we identified a new protein SatS with roles 
in protein export in M. tuberculosis.  This work not only expands our understanding of the 
specialized SecA2 protein export pathway of mycobacteria but it provides important functional 
information for a previously uncharacterized M. tuberculosis protein that contributes to 
pathogenesis.  Further, by assigning a chaperone function to SatS, our studies expand our 
appreciation of the diversity of chaperones in biological systems. Although chaperones have 
common functions, substantial structural diversity exists among these proteins, which is further 
highlighted by the new fold revealed in the structure of SatSC.  
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Table 3.1. Primers used in this study. 





Contains engineered KpnI site, used to 





Contains engineered XbaI site, used to 





Contains engineered HindIII site, used 





Contains engineered SpeI site, used to 





Contains engineered NdeI site, used to 





Contains engineered NheI site, used to 





Contains engineered NheI site, used to 





Contains engineered NdeI site, used to 





Contains engineered PacI site, used to 
construct satSMsm plasmids pBM4, 
pBM22, and pBM23 
1684-R AATGGCCACTACTCCTGACGGA
GCCGGGACTCCAC 
Contains engineered BalI site, used to 





Contains engineered HA tag and 
BamHI site, used to construct satSMsm-
HA plasmid pBM23 
Rv3311-F AATGGCCACTGACCTCGTACCC
ATCCGCTTGAG 
Contains engineered MscI site, used to 
construct satSMtb plasmids pBM13, 
pBM60, and pBM80 
Rv3311-R AATGGCCACTAGCCTTCGCCGG
CTGAC 
Contains engineered MscI site, used to 





Contains engineered HindIII site, used 






Used for site directed mutagenesis on 





Used for site directed mutagenesis on 
pBM80 to generate pBM87 
SapM-F TGGCCAACCGCGGAATCCAGGC
TCTC 
Contains engineered MscI site, used to 






Contains engineered MscI site, used to 





Contains engineered HindIII site, used 







Contains engineered linker-FLAG and 
HindIII site, used to construct sapM 





Used with EcoRI site in TOPO to 





Contains engineered BamHI site to 
construct sapM-lacZ reporter pBM94 
SapM-3311 
gap F 
GACGGGTTATGCGACCAATG Amplify the region between sapM and 
satS for RT-PCR 
SapM-3311 
gap R 
CTCAAGCGGATGGGTACGAG Amplify the region between sapM and 





Contains engineered EcoRV site, used 






Contains engineered HindIII site, used 
to construct mce4AMsmeg-HA plasmids 
pBM44 
sigA RT F AAGCGAACAGCGGCGAAGTC qRT-PCR primer for sigA 
sigA RT R TTCGGGATGGTGCTGGTCGTAG qRT-PCR primer for sigA 
sapM RT F ATCGTTGCTGGCCTCATGG qRT-PCR primer for sapM 











Used to express sapM in the E. coli 
pMSCG-28 vector 




Contains engineered NdeI site, used to 





Contains engineered NdeI site, used to 
express satSC in E. coli Pet28b vector 
satS/satSC  
E. coli R 
TTTTTTAAGCTTCTATTCGCGCC
TGAGCC 
Contains engineered HindIII site, used 










pMV261.kan Kan Multicopy mycobacterial vector with 
hsp60 promoter 
(50) 
pMV361.kan Kan Single-copy mycobacterial vector with 
hsp60 promoter, integrates in 
mycobacteriophage L5 attB site 
(50) 
pMV306.kan Kan Single-copy, promoterless mycobacterial 
vector, integrates in mycobacteriophage L5 
attB site 
(50) 
pJSC77 Kan Multicopy mycobacterial vector, HA tag 
cloned into pMV261 
(51) 
pLL2 Hyg single-copy mycobacterial shuttle vector, 
integrates in mycobacteriophage Tweety 
attB site 
(8) 
pYA810 Kan Integrating M. smegmatis secA2 
complementation plasmid in pMV361.kan 
(52) 
pNR25 Kan Integrating M. smegmatis secA2 K129R in 
pMV361.kan 
(11) 
pLL50 Hyg Suicide vector pMP62 containing flanking 
regions to delete satSMsm 
This work 
pBM11 Hyg Suicide vector pMP62 containing secA2Msm 
and flanking regions to reintroduce secA2 
to the BAF1 strain 
This work 
pBM4 Hyg satSMsm under native promoter in pLL2 This work 
pBM80 Hyg satSMtb under hsp60 promoter in pLL2 This work 
pSM42 Hyg satSMtb upstream and downstream flanks 
inserted into pYUB854 
This work 
pSM45 Hyg Phasmid for knocking out satSMtb This work 
pSM60 Hyg Phage for knocking out satSMtb This work 
pBM13 Kan satSMtb under hsp60 promoter in 
pMV306.kan 
This work 
pJTS130 Kan sapM under hsp60 promoter in 
pMV261.kan 
(12) 
pJTS132 Kan ∆ss-sapM under hsp60 promoter in 
pMV261.kan 
This work 
pYUB76 Kan Multicopy mycobacterial shuttle vector 
with promoterless lacZ gene 
(53) 
pBM94 Kan psapM-sapM’-‘lacZ in pYUB76 This work 
pBM56 Kan sapM under hsp60 promoter in 
pMV261.kan containing a C-terminal 
linker and FLAG tag 
This work 
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pBM60 Hyg satSMtb under hsp60 promoter in pLL2 
containing a C-terminal HA tag 
This work 
pBM61 Kan ∆ss-sapM under hsp60 promoter in 
pMV261.kan containing a C-terminal 
linker and FLAG tag 
This work 
pBM22 Hyg satSMsm under native promoter in pLL2 
amplified from suppressor 3S to contain 
the G134D point mutation 
This work 
pBM23 Hyg satSMsm under native promoter in pLL2 
amplified from suppressor 3S to contain 
the G134D point mutation and containing 
a C-terminal HA tag 
This work 
pBM87 Hyg satSMtb under hsp60 promoter in pLL2 with 
point mutation G134D generated by site 
directed mutagenesis 
This work 
pBM44 Kan Mce4AMsm under hsp60 promoter in 
pJSC77 containing a C-terminal HA tag 
This work 
pHSG58 Kan Multi-copy Ms1704-HA expression vector 
under hsp60 promoter 
(52) 
pRH1 Carb sapM in the E. coli pMSCG-28 vector 
containing a C terminal His tag 
This work 
pRH2 Kan satS in E. coli Pet28b vector This work 





Table 3.3. M. tuberculosis and M. smegmatis strains used in this study.  
M. tuberculosis Strain Description Source 
H37Rv M. tuberculosis wild-type (WT) + Ev 
(pMV306.kan) 
(12) 
MBTB443 ∆secA2 + Ev (pMV306.kan) (12) 
MBTB512 ∆satS + Ev (pMV306.kan) This work 
MBTB513 ∆satS + psatS (pBM13) This work 
M. smegmatis Strain   
mc
2
155 M. smegmatis wild-type (WT) (54) 
NR116 ∆secA2 (11) 
BAF1 ∆secA2/∆satS This work 






Figure 3.1. ∆satS mutant suppresses SecA2 K129R phenotypes (A) Mueller-Hinton growth 
phenotypes and azide sensitivity of M. smegmatis ∆secA2 mutant expressing wild-type secA2 
(∆secA2+psecA2), an empty vector, or secA2 K129R (secA2 K129R), and two representative 
suppressors. (B) Nine suppressor mutations affected satS (msmeg_1684). Red stars indicated 
approximate locations of suppressor mutations. For panels C, D, and E, wild-type M. smegmatis 
mc
2
155, ∆secA2, secA2 K129R, ∆satS/secA2 K129R, and ∆satS/secA2 K129R complemented 
with satSMsm or satSMtb were used. (C) Mueller-Hinton growth phenotypes and azide sensitivity 
of the strains described above. (D) Subcellular fractions were separated by SDS-PAGE, and 
SecA2 protein was detected by Immunoblot. Densitometry was used to quantify SecA2 levels in 
the soluble and envelope fractions (ImageJ). Percent localization to a given fraction for SecA2 is 
reported as the percentage of the total (soluble + envelope). Error bars indicate the standard 
deviation of the mean of three independent replicates for each strain. (E) Whole cell lysates 
(WCL) and subcellular envelope (ENV) and soluble (SOL) fractions were separated by SDS-
PAGE and SecY protein was detected by Immunoblot. All results shown are representative of at 
least three independent experiments.  
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Figure 3.2. Characterization of the M. smegmatis ∆satS mutant. (A)  Liquid cultures of M. 
smegmatis mc
2
155 and ΔsatS were grown in 96-well plates with a starting cell count of 1 x 10
4 
cells/well. After 24 h, resazurin was added and relative fluorescence units (RFU) were measured 
over the next 20 h. Polyclonal antibodies against SatS were generated in rabbits and used to 
localize SatS in M. smegmatis mc
2
155 by Immunoblot, using the ∆satS mutant as a control for 




Figure 3.3. satS and sapM are co-transcribed. Visualization of the operon structure of sapM and 
satS and the location of the primers used. Primer set FR flanking the intergenic region between 
sapM and satS and a control primer set in the housekeeping gene sigA were used to amplify M. 




Figure 3.4. Characterization of the M. tuberculosis ∆satS mutant. (A) The ΔsatS mutant of M. 
tuberculosis and the parental H37Rv strain were grown in liquid 7H9 medium with ADS 
supplementation. Growth was monitored by measuring optical density (OD600) over time. 
Polyclonal antibodies against SatS were generated in rabbits and used to localize SatS in M. 
tuberculosis H37Rv by Immunoblot, using the ∆satS mutant as a control for specificity. SigA, 







Figure 3.5. SatS is required for the export of SapM and Mce proteins (A) Equal protein from 
culture supernatants from M. tuberculosis H37Rv, ∆secA2, ∆satS and the complemented strain 
(∆satS+psatS) were immunoblotted for SapM, 19kDa, or the cytoplasmic protein SigA as a 
control for lysis. (B) Phosphatase activity in triplicate culture supernatant samples was examined 
by quantifying cleavage of pNPP. Rates of pNPP cleavage were normalized to H37Rv. (C) Equal 
protein from culture supernatants from M. smegmatis mc
2
155, ∆secA2, ∆satS and the 
complemented strain (∆satS+psatSmsm) were examined for levels of SapM by Immunoblot, using 
the cytoplasmic protein GroEL as a control for lysis. (D) Whole cell phosphatase activity assay 
in M. smegmatis. All strains are expressing SapM, SapM lacking its signal sequence (∆ss-SapM), 
or an empty vector as indicated. Triplicate wells containing 2x10
5
 cells/well were grown in a 96 
well plate for 24 hours at 37°C before measuring phosphatase activity by quantifying cleavage of 
pNPP. Rates were normalized to mc
2
155 + SapM. (E) Equalized cell wall fractions of M. 
tuberculosis H37Rv, ΔsecA2, ΔsatS and complemented (ΔsatS+psatSMtb) strains were analyzed 
by immunoblot using Mce1A, Mce1E, and 19KDa antibodies to monitor differences in protein 
levels. (F) Equalized M. smegmatis mc
2
155, ΔsecA2, ΔsatS, and ΔsatS+psatSMsm cell wall 
fractions were analyzed by immunoblot using HA (Mce4A-HA), Mce1D, and MspA antibodies. 
(G) Equalized cell wall fractions of M. tuberculosis H37Rv, ΔsecA2, and ΔsatS strains were 
analyzed by immunoblot using PknG, PhoS1, and 19kDa antibodies. (H)  Equalized M. 
smegmatis mc
2
155, ΔsecA2, and ΔsatS, cell wall fractions were analyzed by immunoblot using 
HA (Msmeg1704-HA) and MspA antibodies. All data is representative of at least three 
independent experiments and all error bars represent standard deviation of the mean of three 
independent replicates for each strain. n.s. – no significant difference; *, p < 0.05; **, p < 0.01; 





Figure 3.6. SatS contributes to M. tuberculosis virulence. Nonactivated BMDM were infected at 
an MOI of one with M. tuberculosis H37Rv, ΔsecA2, ΔsatS, or ΔsatS+psatS, and CFU burden 
was monitored over the course of a 4 day infection. The fold change in CFU over the course of 
the 4 day macrophage infection for each strain was calculated; the points represent means of 
triplicate wells, and the error bars represent standard deviations (SD). *, p < 0.01; when 
compared to H37Rv by ANOVA and Tukey’s post hoc test. Shown is a representative 




Figure 3.7. SatS effects cellular levels of its substrates (A) Equal protein levels from whole cell 
lysates or (B) the soluble, cytoplasmic fraction of M. tuberculosis H37Rv, ∆secA2, ∆satS and the 
complemented strain (∆satS+psatSMtb) were immunoblotted for SapM, Mce1A (Figure 4A only), 
Mce1E (Figure 4A only) and 19kDa. (C) Equal protein levels whole cell lysates of M. smegmatis 
mc
2
155, ∆secA2, ∆satS and the complemented strain (∆satS+psatSMsm) were immunoblotted for 




Figure 3.8. SatS does not affect sapM transcription or translation (A) RNA was isolated from M. 
tuberculosis H37Rv and ∆satS. sapM transcript levels were measured by quantitative RT-PCR 
and normalized to the level of sigA transcript. Data shown is for the mean of three biological 
replicates. (B) Expression of the promoterless lacZ gene in pYUB76 when fused to the 170-bp 
region upstream of sapM, containing the putative promoter and first 15 bp of sapM, was 
measured in liquid medium by measuring hydrolysis of o-nitrophenyl-β-D-galactoside. The 
results are from a representative experiment performed in triplicate. In all experiments, the error 
bars represent standard deviations. n.s. – no significant difference; ***, p < 0.001 when 




Figure 3.9. Epitope tags do not disrupt SapM or SatS functions (A) Whole cell phosphatase 
activity assay of M. smegmatis strains expressing SapM-FLAG or an empty vector. The error 
bars represent standard deviation from the mean of three independent replicates. *, p < 0.05; ***, 
p < 0.001; ****, p < 0.0001 by ANOVA. (B) Equal protein levels from whole cell lysates and 
culture supernatants of mc
2
155, ∆satS, and the HA-tagged complemented strain (∆satS+psatS-






Figure 3.10. SatS and SapM interact (A) Lysate from M. smegmatis ∆secA2/∆satS expressing 
SapM-FLAG and either SatSMtb-HA or SatSMtb without a tag, ∆satS expressing ∆ss-SapM-FLAG 
and SatSMtb-HA, or mc
2
155 with two empty vectors (as shown above the blot) were used for co-
immunoprecipitation using anti-HA conjugated beads. Lysates (left) and immunoprecipitations 
(right) for each strain were probed with SatS antibody and FLAG antibody for SapM. Two 
different sizes of SapM-FLAG corresponding to the full-length (signal sequence-containing) and 
mature (cleaved signal sequence) species were detected. (B) Lysate from M. smegmatis ∆satS 
expressing SapM-FLAG and either SatSMtb-HA or SatSMtb without a tag were used for co-
immunoprecipitation using anti-HA conjugated beads. Lysates (left) and co-
immunoprecipitations (right) for each strain were probed with SatS antibody, FLAG antibody, 
and MspA antibody. All data is representative of at least three independent experiments.  
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Figure 3.11. SatS functions prior to SecA2 (A) Equal protein from culture supernatants (CFP) 
and whole cell lysates (WCL) from M. smegmatis mc
2
155, ∆secA2, ∆satS, the ∆secA2∆satS 
double mutant, and ∆secA2∆satS expressing wild-type SatS (∆satS+psatSMsm) were examined for 
levels of SapM-FLAG, SatS, and GroEL by Immunoblot. (B) Whole cell phosphatase activity 
assay using the above M. smegmatis strains. All strains are expressing SapM, SapM lacking its 
signal sequence (∆ss-SapM), or an empty vector as indicated. Triplicate wells were grown in a 
96 well plate for 24 hours at 37°C before measuring phosphatase activity by quantifying 
cleavage of pNPP. Rates were normalized as described above. All data is representative of at 
least three independent experiments and all error bars represent standard deviation of the mean of 
three independent replicates for each strain. n.s. – no significant difference; **, p<0.01; ****, p 




Figure 3.12. SatS and SatSC prevent aggregation of SapM in vitro. Denatured SapM-His was 
diluted 150 fold to a final concentration of 1 µM in 40 mM HEPES, 100 mM NaCl, pH 7.4. 
SapM-His aggregation was monitored by light scattered (350 nm) at 25
o
C in the presence or 
absence of SatS/SatSC or, as controls, lysozyme or BSA. A molar ratio of 2.5:1 of SatS:SapM-
His could prevent SapM-His aggregation and aggregation was significantly reduced using a 
molar ratio of 0.5:1.  
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Table 3.4. SatSC X-ray Structure Validation Details. 
 SatSC(Br) SatSC(Apo) 
PDB ID 6DRQ 6DNM 
Data collection   
Space group P 212121 P 212121 
Cell dimensions    
a, b, c (Å) 48.8, 50.6, 76.1 48.9, 50.6, 76.5 
α, β, γ (°) 90, 90, 90 90, 90, 90 
Resolution (Å) 2.3 1.4 
Rmerge 0.050 (0.105) 0.081 (0.254) 
I/σ(I) 27.4 14.4 
Completeness (%) 99.2 (100) 92.6 (70.4) 
Redundancy 7.0 (7.3) 5.9 (1.4) 
Refinement   
Resolution (Å) 42.129-2.3 21.19-1.4 
No. reflections 8721 35457 
Rwork/Rfree 0.2095/0.2973 0.193/0.231 
No. atoms   
Protein 1463 1467 
Ligand/ion 3  
Water 13 110 
B-factors   
Protein 40 19.9 
Ligand/ion 44  
R.m.s. deviations   
Bond lengths (Å) 0.007 0.005 





Figure 3.13. SatSC secondary structure and the predicted secondary structure of SatSN (A) SatS 
is composed of two domains of similar secondary structure joined by a potential linker of 60 
amino acids with little predicted secondary structure. The disordered linker region was predicted 
using PrDOS (56). (B) Multiple sequence alignment of N-domain (SatSN) with C-domain 
(SatSC) without the linker region. Secondary structure elements for each domain are depicted 
above and below their corresponding sequence. SatSN has 22% sequence identity (highlighted in 




Figure 3.14. SatS has a new fold and hydrophobic grooves that share similarity with the 
preprotein binding sites of the SecB chaperone. (A) The overall secondary structure of SatSC. (B) 
The hydrophilicity of SatSC is a colored gradient from cyan (hydrophilic) to maroon 
(hydrophobic). SatSC exposes ~2,900 Å
2
 of hydrophobic surface. The predicted primary and 
secondary polypeptide binding site(s) are delineated. (C) The overall secondary structure of 
SecB monomer (PDB ID:1QYN) (1). (D) The hydrophilicity of SecB is a colored gradient from 
cyan (hydrophilic) to maroon (hydrophobic). The primary and secondary client binding site(s) 
are delineated. Each SecB monomer exposes ~1,900 Å
2
 of hydrophobic surface for client protein 
interactions (45). Molecular graphics and analyses were performed with the UCSF Chimera 





Figure 3.15. SatS has at least two separable roles in protein export  (A) Equal protein from 
culture supernatants (CFP) and whole cell lysates (WCL) from M. smegmatis mc
2
155, ∆secA2, 
∆satS and the ∆satS mutant expressing either wild-type SatS (∆satS+psatSMsm) or SatS G134D 
(∆satS+psatSMsmG134D) were examined for levels of SapM-FLAG, SatS, and GroEL by 
Immunoblot. (B) Whole cell phosphatase activity assay of M. smegmatis strains expressing 
SapM. Triplicate wells were grown in a 96 well plate for 24 hours at 37°C before measuring 
phosphatase activity by quantifying cleavage of pNPP. Rates were normalized as described 
above. (C) Lysate from M. smegmatis ∆satS expressing SapM-FLAG and either SatSMtbG134D-
HA or SatSMtbG134D without a tag were used for co-immunoprecipitation using anti-HA 
conjugated beads. Lysates (left) and co-immunoprecipitations (right) for each strain were probed 
with SatS antibody and FLAG antibody. All data is representative of at least three independent 
experiments and all error bars represent standard deviation of the mean of three independent 
replicates for each strain. n.s. – no significant difference; ****, p < 0.0001 by ANOVA and 
Tukey’s post hoc test.  
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Mycobacterium tuberculosis, the causative agent of the disease tuberculosis, is 
responsible for approximately 1.8 million deaths each year, the equivalent of a death every 20 
seconds (1). Moreover, a staggering one third of the world’s population is estimated to be 
infected with M. tuberculosis. While antibiotic treatment for tuberculosis exists, the drug 
regimen is lengthy, which is a challenge for full patient compliance. Furthermore, 600,000 
people infected with M. tuberculosis will not respond to standard drug treatment due to the 
emergence of multi-drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis. 
Drug resistant M. tuberculosis requires more expensive treatment that takes longer to complete, 
has more severe side effects, and is unsuccessful in 50% of cases (1). Combined with the lack of 
an efficacious vaccine, the challenges of effectively treating M. tuberculosis have created a 
global health emergency that necessitates a better understanding of the mechanisms of M. 
tuberculosis pathogenesis. 
In order to promote disease, bacteria export proteins outside of the bacterial cell into the 
host environment where the proteins can interfere with host defense mechanisms that would 
otherwise stop the infection. Specialized protein export pathways are often used by bacterial 
pathogens to export virulence factors into the host. M. tuberculosis possesses several specialized 
protein export pathways, including the SecA2 pathway. The SecA2 protein export pathway is 
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defined by the presence of a paralog of the essential SecA1 ATPase, which is called SecA2. 
Unlike the SecA1 ATPase, which is responsible for the bulk of housekeeping export and is 
essential for bacterial viability, SecA2 is a non-essential specialized SecA ATPase that is 
required for the virulence of M. tuberculosis in both murine and macrophage models of infection 
(2, 3). The SecA2 pathway is required for the export of a relatively small subset of proteins, 
some of which contribute to M. tuberculosis pathogenesis (4, 5).  
SecA1 and SecA2 have unique functions; the two proteins are not functionally redundant. 
Overexpression of SecA1 does not compensate for the absence of SecA2 and vice versa (6). The 
differences between SecA1 and SecA2 are likely due to different activities and/or different 
proteins with which they interact even though current data support a model where SecA2 works 
with the same SecY channel protein as SecA1 to export its substrates. The goal of my 
dissertation research was to learn more about the mechanism of SecA2-dependent protein export. 
This dissertation describes the characterization of spontaneous intragenic and extragenic 
suppressors of the exacerbated rich agar growth defect of the M. smegmatis secA2 K129R strain. 
As discussed in Chapter 2, the intragenic suppressors mapped to different subdomains of SecA2. 
These intragenic suppressors may disrupt SecA2 interactions with SecY, its substrates, or other 
proteins. As discussed in Chapter 3, we identified extragenic suppressors with loss-of-function 
mutations in satS that suppressed secA2 K129R phenotypes. We continued our investigation of 
SatS, a previously uncharacterized protein of unknown function, and identified it as a new 
protein export chaperone with a role in intracellular growth of M. tuberculosis in murine 
macrophages. As the amino acid sequence of SatS bears no similarity to chaperones and the 
structure of the SatSC domain reveals a new fold, SatS appears to represent a new type of protein 
export chaperone.  
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SecA2 K129R: tool for studying the SecA2 pathway 
 Suppressor analysis is a classical genetic method that can be used to identify unknown 
genes involved in various bacterial pathways, and has been used extensively to study the Sec 
system in E. coli (7). Here, we described the analysis of both intragenic and extragenic 
suppressors of the M. smegmatis secA2 K129R allele. Our original suppressor collection included 
sixty-two independent suppressor strains capable of improved growth on Mueller-Hinton agar 
relative to the parent strain secA2 K129R (8). Of these sixty-two suppressors, forty suppressors 
lost expression of the secA2 K129R allele and were not studied further, since the loss of SecA2 
K129R expression explains the suppression in these strains. These suppressors likely had an 
additional mutation in secA2 K129R or its promoter that alleviated secA2 K129R phenotypes by 
preventing SecA2 K129R production. In addition to the suppressors of M. smegmatis secA2 
K129R, we isolated a separate group of seven suppressors from an M. smegmatis strain 
expressing M. tuberculosis secA2 K115R (an equivalent mutation to M. smegmatis secA2 K129R) 
(8). These two separate screens resulted in a total of twenty-seven suppressors that expressed full 
length SecA2 protein (Table 4.1). Ten of these suppressors have intragenic mutations within the 
secA2Msm K129R or secA2Mtb K115R allele (Table 4.1, Chapter 2). The remaining seventeen 
suppressors expressing SecA2 protein do not have mutations in the secA2 K129R allele and are 
extragenic suppressors. Among the seventeen extragenic suppressors, two have mutations in the 
promoter of secY [Table 4.1 and (9)] and twelve have mutations either in the satS gene or 
upstream of satS in its untranslated region (Table 4.1 and Chapter 3).  
One interesting group of suppressors is made up of three suppressors with large 
overlapping chromosomal deletions (Table 4.1). Suppressors 7S, 20B, and SSW2 have a 
genomic deletion spanning more than 43 kbp and > 42 genes from msmeg1684 (satS) to 
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msmeg1726. After identifying suppressors that mapped to satS, we realized that the loss of satS 
might explain the suppression associated with these large deletion mutants. Importantly, adding 
back satS to 7S (∆msmeg1678-msmeg1726) was sufficient to restore the SecA2 K129R 
phenotypes in this strain (Figure 4.1), which is consistent with suppression phenotypes of these 
large deletion mutants being due to the loss of satS. Several genes at the right end of the 7S and 
20B deletions are annotated to encode transposase enzymes. These genes could conceivably have 
played a role in initiating deletion of this large region of the M. smegmatis genome. 
Currently, there remain four suppressors whose suppressing mutations remain to be 
identified. These strains do not carry mutations in secA2 K129R, the secY promoter, or satS 
including its promoter. Three of the unknown suppressors, strains 5S, 13B, and SSW10, express 
SecA2 K129R at very low levels relative to the parent secA2 K129R strain and one additional 
suppressor, strain 7B, does not express SatS despite having no mutations in satS or its promoter. 
The reduced level of SecA2 K129R or SatS in these strains is likely responsible for the 
suppression, but we do not know what mutations are causing the reduction. In contrast to these 
other four remaining suppressors, 39S is a strong suppressor that produces wild type levels of 
SecA2 K129R, SecY and SatS (data not shown). Furthermore, 39S has no mutations in secA2 
K129R, the secY promoter, or satS. Given how useful secA2 K129R suppressors have been in 
identifying members of the SecA2 export pathway thus far, whole genome sequencing of 39S in 
the future is warranted as it may provide additional new information about the SecA2 pathway.   
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The SecA2 crystal structure paired with intragenic suppressors provide insight into 
important domains of SecA2 
Structural comparison of SecA2 and SecA1 
M. tuberculosis SecA1 and SecA2 are 50% similar to each other by amino acid sequence. 
Sequence alignments prior to our solved SecA2 structure revealed that the similarity is spread 
throughout much of the two proteins, even though SecA1 is 20 kDa larger than SecA2. Using 
these sequence alignments, we originally predicted that the smaller size of SecA2 came from the 
loss of the variable domain (VAR) and helical wing domain (HWD), both of which are present in 
SecA1 and canonical SecA proteins (8). Genomic databases annotate M. tuberculosis SecA2 as 
having a total length of 808 amino acids (AA) (e.g., NCBI accession no. NP_216337). However, 
the start site in this annotation is likely incorrect, as the first 30 AA are not required for function 
and represent an N-terminal extension that is not observed in other SecA orthologs (10, 11). 
Therefore, we designate the GTG codon corresponding to residue 31 in the NCBI annotation as 
the true start codon, yielding a total SecA2 ORF length of 778 AA. 
The structure of SecA2 we report in Chapter 2 is the first, and so far only, structure of 
any SecA2 protein.  The structure first confirmed that M. tuberculosis SecA2 contains key 
functional domains conserved in all SecA proteins. These domains are made up of the following 
amino acids in SecA2: nucleotide binding domain 1 (NBD1) 1-229; preprotein cross-linking 
domain (PPXD) 240-360; NBD2 369-562; intramolecular regulator of ATPase (IRA1) [includes 
the helical scaffold domain (HSD) and two helix finger (2HF)] 590-733 [HSD 591-634; 2HF 
695-703]; and C-terminal linker (CTL) 734-778 (Thomas Ioerger, Texas A&M University, 
personal communication). In addition to its structural domains, SecA2 has two important surface 
features that are conserved in SecA proteins. The first is a “substrate clamp” that is formed from 
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PPXD, HSD, and NBD2 and is where SecA interacts with the mature domain of its substrates 
(12). Upon interaction with a substrate, the flexible PPXD domain rotates and wraps around the 
substrate, resulting in a “closed clamp” conformation (12). The second important surface feature 
of SecA proteins is a “signal peptide binding cleft” that is formed from PPXD, IRA1, and HWD 
which is the docking site for the signal peptide of its substrates (13). 
The crystal structure also confirmed differences predicted by sequence alignment; the 
smaller size of SecA2 versus SecA1 and canonical SecA proteins comes from the absence of the 
HWD and the VAR domain. The lack of a HWD is the most striking structural difference in 
SecA2. Without the HWD, the signal peptide recognition cleft of SecA2 is larger and more 
solvent exposed in SecA2 (Figure 2.4). This could make the cleft more accessible to substrates 
and affect the substrates that SecA2 recognizes. However, the function of the HWD is not well 
understood in any SecA proteins. Thus, alternate or additional consequences of its absence in 
SecA2, beyond exposing a larger signal peptide cleft, may exist. Absence or truncation of the 
HWD is a general feature among SecA2 proteins in actinomycetes (including Mycobacterium 
and Corynebacterium species) (Figure 4.2). Interestingly, the SecA2 protein of the SecA2/SecY2 
system in Streptococcus gordonii and the SecA2 protein of the SecA2-only system in L. 
monocytogenes also appear to have truncated versions of the HWD (deletions of 13 or 18 
residues for S. gordonii or L. monocytogenes, respectively) based on sequence alignments. 
However, until structures of these other SecA2 orthologues are solved, the potential 
consequences of these HWD truncations remain unknown. To our knowledge, no mutational 
studies have been performed on the HWD of any SecA protein, and our understanding of its 
function comes primarily from crystal structures and cross linking experiments (12, 13). To 
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achieve a complete picture of SecA2 function, the consequences of a truncated or deleted HWD 
will need to be explored in SecA2, SecA1 and canonical SecA proteins.  
The significance of the absence of the VAR domain in the SecA2 NBD region is also 
unclear. The lack of the VAR domain leaves the nucleotide-binding site relatively solvent 
exposed. While other SecA2 orthologues also lack the VAR domain, one-third of bacterial SecA 
proteins lack this domain as well (14). In E. coli SecA, the VAR domain regulates ATPase 
activity and ADP release, as secA ∆var mutants display higher ATPase activity and faster ADP 
release rates (14). However, M. tuberculosis SecA2 is reported to release ADP more slowly (not 
more quickly) than the VAR-containing M. tuberculosis SecA1 (15). Constructing a 
mycobacteria secA1 ∆var mutant may reveal insights into the function of the VAR domain and 
the consequences of its absence in SecA2. 
Suppressors with mutations in SecA2 map to specific regions 
Intragenic suppressors of secA2 K129R map to the surface of SecA2. The suppressors can 
be organized into three groups based on the location of the amino acid alterations: suppressors 
with mutations in the IRA1 domain, suppressors with mutations in PPXD or NBD2 domains, and 
suppressors with mutations in the NBD1 domain. We subcloned and retested a representative 
intragenic suppressor from each of these groups to confirm the intragenic mutation was the 
source of the suppression and to investigate how these suppressors’ mutations affect the 
subcellular localization of SecA2 K129R. While wildtype SecA2 is primarily cytoplasmic, 
SecA2 K129R is retained at the membrane (6), presumably because it is locked in a complex 
with SecY. SecA2 K129R jamming the SecY channel is thought to be the source of its 
exacerbated phenotypes on sodium azide and Mueller-Hinton plates. The group of suppressors 
that mapped to IRA1 fully restored cytoplasmic localization of SecA2 K129R (Figure 2.9). 
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Because similar mutations in the IRA1 domain of E. coli SecA disrupt SecA binding to SecYEG 
(16), these results are consistent with IRA1 suppressor mutations preventing SecA2 K129R 
interactions at the membrane SecYEG channel, which supports the model for SecA2 working 
with SecY to promote export of its specific substrates.  
The second group of suppressors mapped to the “substrate clamp” of SecA2. We 
identified suppressors with mutations on both sides of the clamp, one on the NBD2 domain and 
two on the PPXD domain. The clamp suppressors restored cytoplasmic localization of SecA2 
K129R to levels comparable to wildtype SecA2, suggesting that these mutations prevent SecA2 
K129R from jamming the channel (Figure 2.9). For this group of suppressors, the suppression 
may result from an inability of SecA2 to either interact with its substrate or to trap the substrate 
in the SecYEG channel. This model may also suggest that SecA2 K129R can only jam the 
channel if it is first bound to a substrate.  
The last group of suppressors mapped to a surface loop near the top of the NBD1 domain, 
close to the IRA1 domain, in a region of NBD1 that has not been assigned a function. This group 
of suppressors either resulted in a deletion or duplication of the same loop (residues 168 to 171). 
Interestingly, the NBD1 suppressors only partially restore cytoplasmic localization of SecA2 
K129R (Figure 2.9), despite their full suppression of the secA2 K129R phenotype on sodium 
azide plates. The inability of these suppressors to fully restore SecA2 K129R localization to the 
cytoplasm suggests that even with these secondary mutations, some SecA2 K129R is still able to 
jam in the SecYEG channel (although the occurrence is rare enough to alleviate sensitivity to 
sodium azide). It is noteworthy that when SecA2 K129R is suppressed by ∆satS null mutations, 
we also observe a partial (not complete) restoration of SecA2 K129R localization to the 
cytoplasm (Figure 3.1D). One possibility for the partial restoration of SecA2 K129R localization 
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is that some SecA2 K129R can still bind to substrates and engage the channel in a ∆satS null 
strain and that full suppression of SecA2 K129R is not required to alleviate sensitivity to sodium 
azide (Figure 3.1A). There are examples of SecA2 substrates that do not require SatS for export. 
In our model, when presented with a SatS-independent substrate such as Msmeg1704, SecA2 
K129R can still initiate export and jam SecYEG, even in the absence of SatS. The similarities 
between the NBD1 domain suppressors and the satS null suppressors, that they both restore 
resistance to sodium azide to that of a ∆secA2 strain while only partially restoring SecA2 K129R 
localization to the cytoplasm, raise the possibility that the NBD1 suppressors may map to a 
region of SecA2 that is important for interacting with SatS. However, in order to test this 
hypothesis, we will first need to establish that SatS and SecA2 interact. 
In addition to the intragenic suppressors described in Chapter 2, we identified two 
additional intragenic suppressors that map to secA2 in our suppressor screen of the M. 
tuberculosis SecA2 K115R allele. SSW11 has a 7 amino acid deletion from amino acid 651 to 
658, and SSW8 has a single amino acid substitution from Val 528 to Gly (Table 4.1 and Figure 
4.3). The SSW11 deletion maps to the surface of the IRA1 domain (Figure 4.3). Intriguingly, the 
residues deleted in SSW11 are adjacent to the region of the IRA1 domain that typically forms the 
HWD of SecA and are not conserved in SecA1 (Figure 4.2).  SSW11 is interesting as it suggests 
that despite the lack of a HWD, SecA2 requires residues in this region in order to function 
properly and it identifies a fourth location on the SecA2 structure as affecting SecA2KR 
phenotypes. To begin characterizing the cause of suppression in SSW11, it will be important to 
determine the subcellular localization of SecA2 K115R in this suppressor to classify it either as a 
suppressor that completely restores cytoplasmic localization (like the PPXD, NBD1, and other 
class of IRA1 suppressors) or only partially restores cytoplasmic localization (like the NBD2 
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suppressors). If the SSW11 suppressor also partially restores SecA2 K115R localization, 
residues 651 to 658 will be another good candidate for a SatS-interacting site on SecA2, 
particularly because this site is unique to SecA2; in SecA1 the same region is occupied by the 
HWD. The SSW8 substitution is in the NBD2 domain with substitution from Val528 to Gly. 
Val528 is near the residue mutated in NBD2 suppressor 34S; however, Val528 is not surface 
exposed (Figure 4.3). Of note, of all the intragenic suppressors identified thus far SSW8 is the 
only one affecting residues that are not localized to the surface of SecA2.  
In general, we predict that our intragenic suppressors map to sites on SecA2 that are 
important for its interactions with other proteins, such as SecY and its substrates. We also predict 
that SecA2 interacts with SatS, potentially as SatS hands off its substrates to SecA2. In this case, 
some of our suppressors could be in sites on SecA2 that are required for interacting with SatS. 
Thus far, we have not been able to establish a direct interaction between SecA2 and SatS by 
coimmunoprecipitation. In the absence of a physical interaction, it is difficult to test whether any 
of the suppressors affect SecA2:SatS interactions. An alternative approach would be to ask 
whether these intragenic mutations, in the context of the wild type K129, prevent SecA2 from 
exporting both SatS-dependent and SatS-independent substrates. We can use site-directed 
mutagenesis to restore the Walker Box of these intragenic suppressors, resulting in secA2 mutant 
alleles with the ATP binding site restored. Three of these suppressor alleles have already been 
made (8). By expressing these mutant secA2 alleles in a ∆secA2 strain, we can investigate their 
ability to secrete SatS-dependent and independent substrates. We would expect that mutations in 
the presumed SecY binding site on the IRA1 domain would reduce export of all SecA2-
dependent substrates. Alternatively, if the mutations disrupt SecA2 interactions with SatS, we 
would expect that only export of SecA2-dependent and SatS-dependent substrates, such as 
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SapM, would be compromised. In this case, substrates such as Msmeg1704 and Msmeg1712 
would have wildtype levels of export, despite mutations in secA2. Evaluating suppressors for 
their effects on different substrates could provide mechanistic insights on the relationship 
between SecA2 and SatS without requiring us to first establish protein-protein interactions. 
Identifying regions of SecA2 required for working with SatS may guide efforts to demonstrate a 
direct interaction between SatS and SecA2. 
Extragenic suppressors lead to the identification of a new player of the SecA2 export 
pathway 
In Chapter 3, we identified ten suppressors of the M. smegmatis secA2 K129R allele with 
unique mutations in the same gene, msmeg_1684 which we renamed satS. We subsequently 
validated that loss of SatS function suppresses secA2 K129R phenotypes. Because previously 
characterized suppressors restored secY expression and/or reduced SecA2 K129R levels (9), we 
first ruled out the possibility of these suppressors in satS affecting transcription or translation of 
secY or reducing SecA2 K129R levels. Loss-of-function satS suppressors restore SecY levels but 
do not affect secY transcription (9), and SecA2 K129R levels are equivalent in the presence or 
absence of SatS (data not shown). However, deletion of satS significantly reversed SecA2 
K129R retention at the membrane and the associated SecY degradation. As described above, 
when SecA2 K129R is suppressed by ∆satS null mutations, we also observe a partial (not 
complete) restoration of SecA2 K129R localization to the cytoplasm (Figure 3.1D).  These data 
suggest that in the absence of SatS, SecA2 K129R cannot engage in detrimental interactions with 
SecYEG. By extension, these results support a role for SatS in enabling wild-type SecA2 to 
interact with the SecYEG channel. We identified SecA2-dependent substrates that require SatS 
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for export, namely SapM and Mce proteins. We also identified SecA2-dependent proteins that do 
not require SatS for export, such as the solute binding protein Msmeg1704.  
One possibility for how SatS promotes SecA2 interactions with the SecYEG channel is 
that in order for SecA2 to be delivered to or engage the SecYEG channel it must first be bound 
to a substrate in a translocation competent state and that SatS functions as a protein export 
chaperone that facilitates a SecA2-substrate interaction for some of the substrates. We favor this 
role for SatS as it would not only explain why phenotypes of secA2 K129R depend on the 
presence of SatS but it is also consistent with our identification of an interaction between SatS 
and SapM and the chaperone activities of SatS. An alternate possibility is that SatS is a core 
component of a SecA2-specific export apparatus with a function mediating the interaction 
between SecA2 and SecYEG. However, if SatS were to function this way, we would expect all 
SecA2-dependent substrates would require SatS for export, which was not the case. The 
existence of SatS-independent substrates raises the question of how loss-of-function mutations in 
satS are able to suppress SecA2 K129R, since some substrates can still engage SecA2 K129R in 
the absence of SatS. We reason that the loss of SatS results in enough SecA2 K129R being 
diverted from the SecYEG channel that the detrimental phenotypes are alleviated. The 
incomplete restorating of SecA2 K129R to the cytoplasm in a satS null suppressor is reminiscent 
of the intragenic suppressors in the SecA2 NBD1 domain described earlier.  
SatS has many similarities with protein export chaperones  
Our hypothesis that SatS functions as a protein export chaperone stems from our initial 
observation that in the absence of SatS, cytoplasmic levels of its substrate SapM are dramatically 
reduced. After ruling out the possibility of SatS affecting transcription or translation of sapM, we 
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hypothesized that SatS acts as a protein export chaperone with functions that include post-
translational stabilization of SapM prior to its export from the cytoplasm. 
In Chapter 1, we reviewed common features of well-studied protein export chaperones 
(Table 1.1). Nearly all of these features are also shared by SatS (Table 4.2). SatS is a highly 
acidic (pI 3.83), cytoplasmic protein that promotes the export of a subset, but not all, of the 
proteins exported by the SecA2 pathway. Further, the satS and sapM genes are co-transcribed in 
an operon and SatS interacts with SapM in mycobacteria. SatS preferentially interacts with the 
full-length preprotein of SapM indicating that the interaction occurs in the cytoplasm prior to 
SapM export. Further, like other protein export chaperones where binding occurs in regions of 
the mature domain of the substrate (17-19) , the signal sequence of SapM is not required for SatS 
and SapM to interact. The SatS interaction with SapM is much easier to detect in a ∆secA2 
mutant versus a secA2
WT
 background. We reason that interactions between SatS and SapM are 
transient in the presence of a functional SecA2 system and that in the absence of SapM export 
(i.e. in a ∆secA2 mutant) there is more SatS:SapM complex in the cytoplasm to detect. Of note, 
in studying the interaction between the ESX chaperone EspG5 and its PE/PPE substrate pair in 
M. marinum a similar strategy of using an export defective mutant background was utilized (20).  
The in vitro anti-aggregation effect of SatS on SapM preprotein provided additional proof 
of a SatS:SapM interaction and the most direct evidence of a chaperone function for SatS. Anti-
aggregation activity is also reported for the SecB, EspG5, and the Yersinia T3SC SycO protein 
export chaperones (21-23). Interestingly, SecB can prevent aggregation of non-exported, 
cytoplasmic proteins such as luciferase (21). In the future, it will be interesting to perform in 
vitro aggregation assays with SatS using non-exported proteins, such as luciferase or citrate 
synthase, to determine the specificity of the anti-aggregation effect of SatS. 
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Along with the above chaperone features, in the absence of SatS, the level of SapM in the 
cytoplasm was dramatically reduced. The effect of SatS on intracellular SapM levels is post-
translational and reminiscent of effects of T3SCs and EspG chaperones protecting their cognate 
substrates from degradation prior to export.  
SatS alignments and structure reveal two highly similar domains 
Although we set out to solve the structure of SatS in its entirety, we were only able to 
obtain structural information for the C-terminal half of the protein (SatSC), which arose during 
crystallization. The structure of SatSC revealed a new fold sharing no similarities with any 
previously solved protein structure in the PDB based on DELTA-BLAST and VAST similarity 
searches (24, 25). Interestingly, inspection of the full length SatS sequence reveals 26% identity 
and 44% similarity in amino acid sequence between the N-terminal (SatSN) and C-terminal 
halves of SatS. There is additionally striking similarity in the predicted secondary structure of 
SatSN and SatSC (Figure 3.14), which raises the interesting possibility of SatS being composed of 
tandem SatSC-like domains.  Comparison of the experimentally derived SatSC structure (AA 
242-420) with an in silico model of SatSN (AA 1-178) revealed exceptional conservation 
between the two domains (RMSD of 0.234) (Figure 4.4). The close predicted structural similarity 
between SatSN and SatSC suggests that SatS proteins may have evolved by an intergenic 
duplication event, with the two duplicated domains connected by a variable linker. Among SatS 
homologs, the linker varies widely in both amino acid sequence (Figure 4.5A) and length (Figure 
4.5B). The linker is predicted by IUPred2A to be disordered (Figure 4.5C) (26). It is worth 
noting that the mycobacterial protein export chaperone EspG also consists of two subdomains 
that are twofold symmetrical to one another. However, in the case of EspG the subdomains only 
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share 13% sequence identity and there does not appear to be a linker between the two 
subdomains (22).  
If SatS is composed of two structurally similar domains, it raises the question of whether 
the individual SatS domain (SatSN or SatSC) have identical functions and/or are sufficient to 
carry out SatS function. In the in vitro anti-aggregation assay, the SatSC domain was sufficient 
for preventing SapM aggregation, indicating that SatSC is capable of directly interacting with 
SapM and is sufficient to carry out at least this function of SatS on its own. In the future, the in 
vitro anti-aggregation assay should be performed with purified SatSN to ask whether it is also 
sufficient to prevent SapM aggregation. Future experiments should also address whether single 
domains of SatS can complement the ∆satS mutant phenotypes of mycobacteria (i.e. the reduced 
stability and secretion of SapM) and whether SatSN and SatSC are capable of interacting with 
SapM as assessed by coimmunoprecipitation. Our preliminary data reveal that expressing SatSN 
is sufficient to restore SapM levels in the whole cell lysate (i.e. restore SapM stability), 
suggesting that SatSN can also interact with SapM (Figure 4.6A). Understanding the functions of 
the two domains of SatS will be an important next step in our investigation of SatS as a new type 
of protein export chaperone.  
Differences in electrostatic surface potential of SatSN and SatSC 
In accordance with their acidic pI, both SatSN (pI 4.29) and SatSC (pI 4.40) have 
significant levels of negatively charged electrostatic surface area (Figure 4.7A and 4.7B). 
Interestingly, the distribution of negative and positive charges on the SatSN model and SatSC 
structure are not mirror images of one another. While both surfaces are overall dominated by 
negative charges, SatSC has a large stretch of positive, basic residues going along the length of 
the domain (Figure 4.7A). Alternatively, SatSN is predicted to have a positive, basic tip at the 
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bottom of the domain (Figure 4.7B). In general, protein export chaperones have an abundance of 
electronegative charges distributed broadly over their surfaces, but the function of their 
negatively charged areas is unknown. In one study of the T3SC SigE, substitutions of 
electronegative surface residues for alanines results in decreased substrate secretion but no 
decrease in substrate stability, suggesting that these mutations are not defective in substrate 
binding but rather in other chaperones functions, possibly in targeting (27). The observation that 
SatSN and SatSC have different surface charge distributions may indicate that the two domains 
perform different roles in protein export. 
Hydrophobic grooves in SatSC resemble SecB substrate binding sites 
 Investigation of the SatSC structure revealed a large network of negatively charged amino 
acids surrounding two surface exposed hydrophobic grooves, which are similar in arrangement, 
shape and size to the hydrophobic client binding sites of a SecB monomer (Figure 3.13 and 
Figure 4.7C). In the solution structure of SecB in complex with a preprotein, the unfolded 
preprotein wraps around the SecB tetramer through interactions with the hydrophobic client 
binding sites. This binding architecture helps explain the means by which SecB maintains Sec 
preproteins in an unfolded state, as is required for their transport through the SecYEG channel 
(17). The similarity in hydrophobic grooves in SatS and SecB is intriguing since SatS works with 
the SecA2 pathway that, like SecB and SecA of Gram negative bacteria, uses the SecYEG 
channel to export proteins. Moreover, these similarities suggest that the hydrophobic grooves in 
SatS are substrate binding sites.  
Whether SatS uses these hydrophobic grooves to interact with its substrates remains to be 
investigated. Structure-based mutagenesis of SatS will be an important next step in identifying 
regions (i.e. Site 1 and Site 2) and residues that are important for substrate interactions. For 
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example, amino acid substitutions in the substrate-binding grooves in SecB resulted in a 
substantial decrease in the affinity for unfolded proteins and a strong reduction in its antifolding 
activity (28). These decreases were observed after the cumulative substitution of three 
hydrophobic residues (V40/L42/L44) to alanines in the primary substrate binding groove of 
SecB. SatSC has hydrophobic residues in Sites 1 and 2 that are good candidates for participating 
in substrate binding based on the criteria that they are (i) surface exposed, (ii) clustered with 
other hydrophobic residues, and (iii) located in a concave groove on the SatS surface (criteria 
established with Konstantin Korotkov, University of Kentucky, personal communication). 
Within Site 1, there are two distinguishable grooves which we annotated middle and low (Figure 
4.8A). Within these grooves, we selected several residues, highlighted in Figure 4.8A, for future 
evaluation in substrate binding using SDM . In the middle of Site 1, residues Val323, Val328 and 
Leu352 form a continuous groove along the side of SatSC. In the low part of Site 1, residues 
Val354, Val383 and Leu387 form a concave pocket. Site 2 is considerably smaller than Site 1, 
but still has several good candidates for SDM including Ile248, Leu267, Ile272, and Leu304 that 
also form a concave pocket. By substituting alanines for these residues, we can ask whether 
disruption of the hydrophobic grooves in SatS affects binding to SapM using our 
coimmunoprecipitation assay.  
SatSN also has two surface exposed grooves containing hydrophobic residues: Site A and 
Site B (Figure 4.7D). Although the model of SatSN is structurally very similar to the solved 
SatSC structure, the distribution of surface hydrophobic residues in our model SatSN structure is 
not a mirror image of Site 1 and Site 2 of SatSC. The most pronounced difference between the 
sites on SatSN and SatSC is their proximity to one another. Sites 1 and 2 on SatSC are close 
together whereas sites A and B on SatSN are on opposite sides of the domain (Figure 4.7C and 
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D). Within Site A, Leu5, Val6, Leu20, and Leu72 are good candidate amino acids for SDM to 
disrupt a deep hydrophobic groove (Figure 4.8B). In Site B, two adjacent areas are good targets 
for SDM and are annotated as the Site Bi and the Site Bii in Figure 4.8B. Site Bi is made up of 
residues Leu10, Leu12, Leu90, Ile119 and Ile172. The hydrophobic residues in Site Bii that 
would make good candidates for SDM are Leu125 and Ile178. Structure-based mutagenesis 
targeting the hydrophobic sites on SatS, as well as solving a structure for SatS bound to a 
substrate, such as SapM, will be important steps to determine whether SatS interacts with its 
substrates in a similar manner to other protein export chaperones. As was the case for SecB, it 
may be difficult to generate a crystal structure of SatS bound to unfolded SapM. However, the 
structure of unfolded PhoA bound to SecB was recently solved using nuclear magnetic resonance 
(NMR) and isotope labelling (17). Prior to the solved structures, the recognition motif of SecB 
was identified by screening cellulose-bound, short (13-mer) peptides derived from different 
substrates (21). If we cannot obtain a cocrystal of SatS and SapM, these would be viable 
alternative approaches to study how SatS and SapM interact. 
While evaluating the surface of SatSN and SatSC for hydrophobic residues that met our 
criteria listed above, we observed that each domain had a single, surface exposed cysteine in one 
of the hydrophobic grooves (Figure 4.8 A and B). We compared the amino acid sequence of 150 
SatS homologs throughout actinomycetes using ConSurf (29) and discovered that these two 
cysteine residues are universally conserved in all 150 SatS proteins examined. While cysteine 
residues have not specifically been demonstrated to be important for SecB, T3SCs or EspG 
substrate interactions, these two residues are also appealing candidates for SDM based on their 
high conservation and proximity to a hydrophobic groove. 
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Consideration of SatS being a SecB counterpart for the SecA2 pathway 
The similar hydrophobic grooves on SatSC and SecB are intriguing since SatS works with 
the SecA2 pathway, which uses the SecYEG channel as is also the case for SecB working with 
SecA in Gram negative bacteria. Thus, even though SecB and SatS are not evolutionarily 
conserved, it is interesting to speculate a SecB-like function for SatS in the mycobacterial SecA2 
pathway. Mycobacteria lack a canonical SecB protein export chaperone. However, in M. 
tuberculosis there is a SecB-like protein Rv1957 that functions as a chaperone for the HigB-
HigA stress responsive toxin-antitoxin system by preventing aggregation of the HigA antitoxin 
(30). Although Rv1957 shares only 13% sequence identity with E. coli SecB, Rv1957 is 
designated a SecB-like protein because overexpression of Rv1957 in E. coli can substitute for 
SecB export function and prevent aggregation of SecB substrates (30). However, it is important 
to note that there is no evidence that Rv1957, which is not conserved across mycobacteria, 
functions in mycobacterial protein export. Our attempts at complementing E. coli ∆secB mutant 
phenotypes by overexpressing SatS have been unsuccessful (data not shown).  Considering that 
Rv1957 is able to suppress ∆secB mutant phenotypes, we find this negative result interesting in 
suggesting that SatS may not be a true SecB homolog for the mycobacterial SecA2 pathway. 
Rather, the novel fold and interesting functions of SatS suggest to us that SatS is the founding 
member of a new class of protein export chaperones. 
SatS forms a multimer 
SecB and T3SCs form multimers; SecB forms a tetramer and T3SCs form dimers. In 
their multimeric state, both of these chaperones interact with one substrate. EspG on the other 
hand does not oligomerize, and binds a PE-PPE substrate pair. Understanding the functional 
quaternary structure of SatS will be another important step in its characterization. We began 
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studying SatS multimerization using a bacterial two hybrid system (BACTH). BACTH is a 
commonly used approach to monitor protein-protein interactions in E. coli. In this system, 
Bordetella pertussis adenylate cyclase CyaA is cleaved into two domains, T25 and T18, which 
cannot interact on their own. When fused to two interacting proteins, T25 and T18 can be 
brought together to reconstitute CyaA activity. These domains were separately fused to SatS and 
expressed in E. coli lacking an endogenous CyaA. SatS:SatS interactions resulted in 
reconstituted CyaA, as assessed by CyaA activation of downstream gene expression including 
both an operon required for fermenting maltose as well as β-galactosidase (Figure 4.9A and B). 
Surprisingly, detecting a positive SatS:SatS interaction is limited to specific SatS-CyaA domain 
fusions. Specifically, we are able to detect a positive SatS-SatS interaction using BACTH when 
one CyaA domain (either T25 or T18) is fused onto the N-terminus of SatS and the other CyaA 
domain is fused onto the C-terminus of SatS (Figure 4.9C). If both CyaA domains are fused to 
the N-terminus or C-terminus of SatS proteins, we do not observe an interaction. Our 
interpretation of this result is that due to the size of SatS, the orientation of the CyaA domains is 
important to obtaining a positive interaction. SatS oligomerization may be head-to-tail such that 
the N terminus of one SatS monomer comes in contact with the C terminus of another SatS 
monomer. Unfortunately, BACTH cannot distinguish between different multimeric states. We 
will need to use different approaches, such as size exclusion chromatography, to determine if 
SatS forms a dimer or a larger homomeric complex. 
SatS is the founding member of a new class of protein export chaperones 
 SatS shares many conceptual and functional characteristics with well-studied protein 
export chaperones: SecB, Type III secretion chaperones (T3SCs), and EspG (Table 4.2). These 
similarities initially led us to hypothesize a protein export chaperone function for SatS. However, 
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there are also key differences between SatS and other protein export chaperones. The structure of 
SatSC is a new fold lacking similarities to any solved structure. Additionally, SatS is larger than 
these other export chaperones; the predicted molecular weight of SatS is 43 kDa. SecB, T3SCs 
and EspG are smaller (between 15 and 30 kDa in size). Furthermore, when run on an SDS-PAGE 
gel, SatS migrates at a predicted size of 67 kDa regardless of whether SatS is expressed in M. 
tuberculosis, M. smegmatis (Figure 4.6B), or E. coli. We have confirmed the identity of the 
aberrantly migrating band as SatS using polyclonal antibodies raised against SatS, mass 
spectrometry, and Edman sequencing. The altered migration may be due to the high percentage 
(20%) of acidic residues in the SatS sequence (resulting in a pI of 3.8), which can alter protein 
migration on SDS-PAGE (31). However, SecB (pI 4.1) migrates close to its predicted MW of 17 
kDa [(32) and data not shown] and the T3SC SycP (pI 4.5) also runs at 16 kDa, its predicted 
MW (33). The difference in size and migration pattern of SatS on SDS-PAGE as compared to 
other protein export chaperones may be important in distinguishing how SatS carries out its 
functions in protein export. 
What are the functions of SatS? 
We first identified a role for SatS in stabilizing its substrates in the cytoplasm prior to 
export. Because of the dramatically reduced levels of SapM in the whole cell lysate of the satS 
mutant, it was not immediately clear if the role of SatS in SapM secretion was solely to maintain 
intracellular levels of SapM preprotein or if SatS had additional roles. By evaluating the satS 
G134D mutant, we revealed the existence of at least one additional role for SatS in promoting 
SapM secretion. In the satS G134D mutant, intracellular SapM was maintained at wild-type 
levels; yet, there remained a SapM secretion defect. Furthermore, SatS G134D is still able to 
interact with SapM in the cytoplasm of M. smegmatis. Based on our modeled SatSN structure, the 
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G134 residue is surface exposed and is not located in either of the predicted hydrophobic groove 
sites (Figure 4.4). Instead, G134 appears to be in the positively charged tip of SatSN (Figure 
4.7B). When overlapping the structure of SatSC with the modeled structure of SatSN, T375 
occupies nearly the same space as G134 (Figure 4.4). Future experiments should also include site 
directed mutagenesis of T375 to ask whether mutations in the same area on the C domain of SatS 
produce similar phenotypes to the G134D allele. 
SatS G134D can still bind to and stabilize SapM, but is deficient for SapM export. With 
other protein export chaperones, there are also examples of mutations that eliminate one 
chaperone function while retaining others. The E77K amino acid substitution in SecB blocks 
productive interactions with SecA without significantly disrupting its oligomeric state or 
SecB:substrate complex formation (34). In other words, SecB E77K can still bind to its 
substrates and keep them unfolded, but cannot target them to SecA. Likewise, the E142G amino 
acid substitution in the T3SC chaperone CesT blocks CesT interactions with the T3SS ATPase 
EscN without disrupting its ability to bind its substrate Tir (35). The CesT E142G mutant still 
stabilizes Tir, but is deficient for Tir export because it cannot target it to the T3SS. Future studies 
should address the additional function(s) of SatS, which we predict to be a role in targeting 
substrates to the SecA2 pathway. Alternatively (or in addition), SatS could have a separate role 
maintaining SapM in an unfolded state for protein translocation across SecYEG. 
A SecA2-targeting role for SatS  
To begin addressing the second role of SatS, beyond stabilizing substrates, that is 
disrupted in G134D we asked if the role affected by the G134D mutation is specific to the SecA2 
pathway. In our whole cell phosphatase activity assay (described in Chapter 3) the ∆secA2/∆satS 
double mutant can be complemented by expressing wild type SatS to restore secreted SapM 
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phosphatase activity to that of a ∆secA2-only mutant. If we instead express SatS G134D in the 
∆secA2/∆satS double mutant, we can ask whether SatS G134D restores secreted SapM 
phosphatase activity in this background. If the G134D mutation only affects export of SapM 
through the SecA2 pathway, we would expect the phosphatase activity of the ∆secA2/∆satS 
double mutant expressing SatS G134D to be equivalent to the ∆secA2-only mutant. 
Alternatively, if the G134D mutation affected export of SapM through multiple pathways (e.g. 
the SecA1 and SecA2 pathways), we would expect the phosphatase activity of the ∆secA2/∆satS 
double mutant expressing SatS G134D to be less than the ∆secA2-only mutant, which still allows 
a residual level of SapM export.  
Expression of satS G134D in the ∆secA2/∆satS double mutant restored secreted SapM 
phosphatase activity to the level of a ∆secA2-only mutant (Figure 4.10). This result suggests that 
the function of SatS affected by the G134D mutation is specific to the SecA2 pathway. These 
preliminary data suggest that SatS may have a role in targeting its substrates to the SecA2 
pathway and that the targeting function is disrupted in SatS G134D. This interpretation is 
consistent with the fact that the secretion defect in a ∆satS mutant complemented with SatS 
G134D is at the level of a ∆secA2 mutant and not more severe (Figure 3.15). 
If SatS has a role in targeting SapM to the SecA2 pathway, we expect that the affected 
role in SatS G134D occurs after stabilization of SapM. To validate this hypothesis, it is 
worthwhile to purify SatS G134D and test its ability to prevent SapM aggregation in our in vitro 
aggregation assay. If stabilizing SapM in the cytoplasm prior to export and preventing its 
aggregation are coupled, SatS G134D should behave like wildtype SatS in this assay. We expect 
that SatS G134D will prevent SapM aggregation, since we can still observe a SatS G134D:SapM 
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interaction. To study a direct role of SatS in targeting SapM to the SecA2 pathway, we will 
ultimately need to identify new interacting partners of SatS. 
SatS substrates beyond SapM 
Besides SapM, we found that SatS was required for the stability and export of multiple 
components of the SecA2-dependent Mce1 and Mce4 lipid transporters. The interpretation of the 
effects on multiple Mce proteins is complicated because the stability of multi-protein Mce 
transporter complexes could be affected by the removal of a single component (36). 
Multiple Mce proteins from the same transporter were reduced in the whole cell lysate 
and cell wall of a ∆satS mutant. This could reflect a role for SatS in exporting numerous Mce 
transporter components. However, it is also possible that the role of SatS is in the export of only 
one Mce component, and that a defect in localizing that single Mce protein destabilizes the entire 
complex. To begin addressing which Mce proteins directly depend on SatS, we performed 
coimmunoprecipitations between SatS and different components of the M. smegmatis Mce4 
transporter. When we pulled down Mce4E expressing an HA tag, it coimmunoprecipitated with 
SatS (lacking an epitope tag) (Figure 4.11). This result is significant for two reasons. First, it 
indicates that at least one component of the Mce4 transporter physically interacts with SatS. We 
interpret these results to suggest that Mce4E is a specific substrate of SatS. Secondly, these 
results demonstrate that we can immunoprecipitate a substrate and detect an interaction with 
SatS. We had previously only been able to detect SatS interactions in the the reverse 
coimmunprecipitation (i.e. immunoprecipitate SatS and detect an interaction with the substrate 
SapM). Since these results do not indicate whether Mce4E is the only Mce4 substrate of SatS, 
future studies should include looking at SatS interactions with other Mce proteins. 
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Thus far, our approach to identifying SatS-dependent substrates has been biased towards 
our panel of validated SecA2-dependent substrates, plus two SecA2-independent loading 
controls, 19 kDa and MspA. From this panel, we have identified a group of SecA2-dependent 
substrates that also require SatS for export and a group that does not require SatS. While this 
approach was extremely useful in providing us with tools to study SatS function, it limits the 
scope of possible SatS-dependent substrates. In particular, we have not addressed the possibility 
that SatS could also be required for export of substrates through other pathways, specifically the 
SecA1 pathway. Because of the strong phenotype in a ∆satS mutant (i.e. a dramatic reduction of 
both pre-exported and exported levels of substrates), a good approach to address this question 
will be to do quantitative proteomics in the whole cell lysate, the cell wall, and the culture filtrate 
(fully secreted proteins) of a ∆satS mutant compared to wild type M. tuberculosis. The 
possibility of SatS-dependent, SecA2-independent substrates could introduce a role for SatS 
beyond the SecA2 pathway. There is precedent for Sec protein export chaperones working with 
more than one export pathway. In Serratia marcesens, SecB is required for the secretion of HasA 
through a Type I secretion system (T1SS) in addition to its role in Sec protein export (37). 
Learning more about the SatS exportome would be extremely useful not only for determining the 
role of SatS in M. tuberculosis but also in determining what features of an exported protein 
define it as SatS-dependent for export. Currently, we do not have an obvious connection between 
SapM and Mce proteins to account for them being SatS-dependent substrates. 
SatS is required for growth of M. tuberculosis in macrophages 
Prior TraSH/Tnseq analyses using pooled libraries of transposon mutants predicts SatS to 
be required during murine and macrophage infections; however, this prediction was never 
validated. In Chapter 3, using a ∆satS mutant and a complemented strain, we directly 
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demonstrated a role for SatS in M. tuberculosis growth in macrophages. Our results from these 
macrophage infections should be expanded to investigate a role for SatS in M. tuberculosis 
virulence in mice. SapM is known to be important early in infection, dues to its role in 
preventing phagosome maturation arrest (5, 38). In contrast, cholesterol import by Mce4 is 
important during the persistence phase of infection (39). The requirement of SatS for the export 
of both of these proteins suggests that SatS may be important throughout infection, with a role in 
both acute establishment of disease as well as persistence in the host. Furthermore, the different 
effects on export of the ∆satS and ∆secA2 mutants suggest that the phenotypes of these two 
strains during infection may be different, and teasing apart those differences may teach us more 
about M. tuberculosis pathogenesis. 
Conclusions 
By way of a genetic suppressor screen in M. smegmatis, we identified structural 
differences between SecA1 and SecA2, identified suppressors in SecA2 that map to SecY and 
substrate interacting sites, and characterized SatS as a new protein with roles in protein export 
and virulence in M. tuberculosis. The regions of structural difference between SecA2 and SecA1 
and suppressor mutations identified in this dissertation represent exciting new directions for 
exploring the functional differences between SecA2 and SecA1 proteins. This work not only 
expands our understanding of the specialized SecA2 protein export pathway of mycobacteria but 
it provides important functional information for a previously uncharacterized M. tuberculosis 
protein that contributes to protein export and pathogenesis. Further, by identifying SatS as a 
protein export chaperone, our studies expand our appreciation of the diversity of chaperones in 
biological systems. Although chaperones have common functions and features, substantial 
structural diversity exists among these proteins, which is further highlighted by the new fold 
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revealed in the structure of SatSC. Molecular chaperones are emerging as candidates for being 
new targets for drug therapies of microbial virulence (40, 41). The importance of SatS in 
mycobacterial pathogenesis presents us with an opportunity to exploit its functions in the search 
for novel and effective anti-mycobacterial drugs. Our whole cell SapM phosphatase activity 
assay is a high throughput approach to monitor secretion of SapM and could be used to identify 
inhibitory compounds of SapM, SatS, or other components of SecA2-dependent protein export 
through the high throughput screening of large chemical libraries. Taken together, the work 
presented in this dissertation allowed us to achieve our original goal: to improve our 
understanding of SecA2 and the SecA2 pathway. By identifying SatS, this work helped map 
molecular details of an M. tuberculosis pathway required for virulence. Our results reveal new 
questions that can be addressed in the future to continue improving our understanding of the 
mechanism of SecA2-dependent export and the role of the SecA2 pathway in pathogenesis. 
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Table 4.1. All suppressor mutations identified using M. smegmatis SecA2 K129R or M. 
tuberculosis SecA2 K115R
 
Isolate(s) Effect on residue(s) in 
MsSecA2 
Effect on residue(s) 
in MsSecY 
Effect on residues in MsSatS 
6S, 9S Deletion of AA 182-185 DNS
a
 DNS 
23S Duplication of AA 182-185 DNS DNS 
2S Asp326 →His DNS DNS 
25S Glu insertion at AA 364 DNS DNS 






SSW11 Deletion of AA 651-658* NM NM 
21B Deletion of AA 734-741 DNS DNS 
38S Deletion of AA 732-739 DNS DNS 
4S NM 2 bp insertion at -137 DNS 
24S NM C→G at -134 DNS 
7S NM NM Large chromosomal deletion 
including satS 
20B NM NM Large chromosomal deletion 
including satS 
SSW2 NM NM Large chromosomal deletion 
including satS 
10S NM NM T →C at -6 
33S NM NM Frameshift at Trp25 
33B NM NM Cys123 →STOP 
3S
 d
 NM NM Gly134 →Asp 
SSW7 DNS NM Frameshift at Trp168 
SSW9 DNS NM Frameshift at Asp169 
29S NM NM Frameshift at Pro261 
1S NM NM Deletion of AA 269-270 
SSW1
d
 DNS NM Frameshift at Asp407 
5S  NM (Low SecA2 via WB) NM NM 
SSW10 NM (Low SecA2 via WB) DNS NM 
13B NM (Low SecA2 via WB) NM NM 
7B NM NM NM (No SatS via WB) 
39S NM NM NM 
a
 DNS – Did not sequence 
b
 SSW suppressors were isolated from an M. smegmatis strain expressing M. tuberculosis secA2 
K115R, which is comparable to the M. smegmatis secA2 K129R allele.  
c
 NM – no mutations 
d 
SatS still detectable via WB 
* These suppressors were isolated from MtbSecA2 K115R so the amino acids are listed for 




Figure 4.1. Adding back satS to the extragenic suppressor 7S (containing a large chromosomal 
deletion from msmeg1684 to msmeg1726) is sufficient to restore SecA2 K129R phenotypes in 
this strain. Azide sensitivity and Muller-Hinton agar growth phenotypes for the indicated strains 




Figure 4.2. SecA2 orthologs with a truncated or missing HWD. Multiple sequence alignments of 
SecA2 and SecA2 orthologs, specifically the portion of the IRA1 domain (MtbSecA2 residues 
590-733) that contains the Helical Wing Domain (HWD) shown in red. The alignment was 
constructed with CLUSTALW 2.1. mt = M. tuberculosis, ms = M. smegmatis, cg = C. 
glutamicum, lm = L. monocytogenes, sg = S. gordonii, ec = E. coli. The residues deleted in 
suppressor SSW11 are highlighted in purple: AA 651-658 YEELSDK. * = fully conserved 






Figure 4.3. Intragenic suppressor mutations of M. tuberculosis SecA2 K115R mapped onto M. 
tuberculosis SecA2 structure using Pymol. Mutations of the two new suppressors are shown as 
yellow spheres and are labelled with boxes. SSW11 is a seven amino acid deletion at the tip of 
the IRA1 domain, in a region that usually contains the HWD (M. tuberculosis SecA lacks the 
HWD). SSW8 is a single amino acid substitution of a valine for a glycine located near a 
previously identified suppressor in the NBD2 domain. Mutations identified in suppressors of M. 
smegmatis SecA2 K139R in chapter 2 are shown in white spheres.   
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Table 4.2. Protein export chaperone features shared by SatS 
 
Generalized Export Chaperone Feature
a 
SatS 
Highly acidic (pI<5.0) pI = 3.8 
Cytoplasmic location SatS is exclusively in the cytoplasm 
Required for export of a subset of proteins of a 
specific pathway 
SatS is required for SapM and Mce export 
but not for SecA2-exported SBPs or PknG 
T3SCs  and EspG commonly located in an 
operon with substrates 
sapM-satS are in an operon  
Interacts with substrate SatS interacts with SapM as shown by Co-IP 
from mycobacteria and effects in the 
aggregation assay  
Protects substrate from inappropriate 
interactions (aggregation, folding/misfolding, 
degradation) 
SatS protects SapM precursor from 
aggregation in vitro. SatS maintains cellular 
levels of SapM and Mce proteins, consistent 
with a role preventing degradation 
Targets substrates to machinery Unknown, but the G134D mutation indicates 
at least two separable roles in export 
a




Figure 4.4. SatSN structure is predicted to be remarkably similar to SatSC structure. Tan ribbon 
structure is the solved SatSC domain (AA 242-420). Modeled on top of the SatSC structure is the 
predicted tertiary structure of the SatSN domain (AA 1-178) in blue. The residue mutated in 
suppressor 3S (G134) is indicated in yellow. The equivalent residue on the C domain (T375) is 
indicated in green. Both residues are indicated by a black arrow. T375 is exposed to the surface 




Figure 4.5. SatSN and SatSC domains are separated by a variable linker. A) PRALINE 
alignments of five closely related SatS homologs from mycobacteria showing residue 
conservation of the SatSN and SatSC domains (outlined in black) and the variable region (outlined 
in purple). Highly conserved residues are highlighted in red and unconserved residues are 
highlighted in blue. B) Histogram of variable region lengths in 150 SatS homologs. Homolog list 
was generated using Consurf. The red bar includes the length for M. tuberculosis SatS variable 
region (42 amino acids). C) Prediction of disordered regions in SatS generated by IUPred. A 




Figure 4.6. SatSN domain can restore stability of SapM in a ∆satS mutant. A) Equal protein from 
whole cell lysates (WCL) of M. smegmatis mc
2
155, ∆satS, ∆satS expressing wild-type SatS 
(∆satS+psatS) with or without an HA tag, and ∆satS expressing SatSN (∆satS+psatSN) with or 
without an HA tag were examined for levels of SapM-FLAG and GroEL by immunoblot. Note, 
this construct contains some of the disordered linker between SatSN and SatSC (AA 179-218). A 
similar construct made for the C domain containing some of the disordered linker (AA 215-420) 
does not express and was not used in these experiments as shown in panel B. B) Equal protein 
from WCL of M. smegmatis ∆satS expressing various SatS single domain constructs as labelled 






Figure 4.7. The N domain and C domain of SatSMtb display different surface characteristics. A) 
SatSC surface colored according to electrostatic surface potential with red corresponding to a 
negative and blue to a positive potential. B) SatSN model structure surface colored according to 
electrostatic surface potential. C) SatSC surface colored according to hydrophobicity with purple 
corresponding to hydrophobic and cyan to hydrophilic residues. Sites with hydrophobic grooves 
circled in dashed lines and labelled Site 1 and Site 2. D) SatSN as shown in Figure 4.3 surface 
colored according to hydrophobicity as described for panel A. SatSN has two hydrophobic sites 
(Site A and Site B) outlined. The four images in each panel are 90° rotations of the two SatS 




Figure 4.8. Hydrophobic grooves in SatS with candidate residues for mutagenesis to test for 
roles in substrate binding. A) The solved structure of SatSC surface colored according to 
hydrophobicity with purple corresponding to hydrophobic and cyan to hydrophilic residues. 
Candidate residues occupying hydrophobic grooves are highlighted in green and labelled in the 
pop-out figures. The conserved cysteine residue is highlighted in yellow. B) The modeled 
structure of SatSN surface colored according to hydrophobicity. Candidate residues occupying 
hydrophobic grooves are highlighted in green and labelled in the pop-out figures. The conserved 
cysteine residue is highlighted in yellow. All images were generated with USCF Chimera (29).  
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Figure 4.9. SatS forms an orientation-specific multimer in a bacterial two-hybrid assay. A and 
B) SatS-CyaA domain fusions are defined by the CyaA domain fused (T18 or T25) and the order 
of SatS and the domain. BTH101 E. coli, lacking an endogenous CyaA, is transformed with two 
expression vectors each containing a domain of SatS fused to T18 or T25, as indicated in the 
table. 2 µL of culture are spotted onto (A) MacConkey media supplemented with 2% maltose or 
(B) LB media containing 40 µg/mL X-gal. C) Cartoon of a SatS multimer model that could 
account for the results in panels A and B. SatSN and SatSC refer to the two domains of SatS.  
186 
 
Figure 4.10. SatS G134D affects a SecA2-specific role of SatS. Whole cell phosphatase activity 
assay using M. smegmatis mc
2
155, ∆secA2, ∆satS, the ∆secA2∆satS double mutant, ∆secA2∆satS 
expressing wild-type SatS (∆satS+psatSMsm), and ∆secA2∆satS expressing the SatS G134D 
mutant (∆satS+psatSMsmG134D). All strains are expressing SapM or an empty vector as 
indicated (mc
2
155 No SapM). Triplicate wells were grown in a 96 well plate for 24 hours at 
37°C before measuring phosphatase activity by quantifying cleavage of pNPP. Rates were 
normalized as described in Chapter 3. Data is representative of five independent experiments. 
Error bars represent standard deviation of the mean of three independent replicates for each 
strain. n.s. – no significant difference; **, p<0.01; ****, p < 0.0001 by ANOVA and Tukey’s 




Figure 4.11. SatS and Mce4E interact in M. smegmatis. Lysates from M. smegmatis 
∆secA2/∆satS expressing SatSMtb and Mce4EMsm-HA or only expressing SatSMtb were used for 
co-immunoprecipitation using anti-HA conjugated beads. Lysates (left) and 
immunoprecipitations (right) for each strain were probed with SatS antibody and rabbit HA 
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